dextrothyroxine has been researched along with Onchocerciasis in 824 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 74 (8.98) | 18.7374 |
1990's | 206 (25.00) | 18.2507 |
2000's | 203 (24.64) | 29.6817 |
2010's | 226 (27.43) | 24.3611 |
2020's | 115 (13.96) | 2.80 |
Authors | Studies |
---|---|
Basanez, MG; Colebunders, R; Enyong, PA; Hendy, A; Mengnjo, MK; Nfor, LN; Ngarka, L; Njamnshi, AK; Njamnshi, WY; Palmer, D; Siewe Fodjo, JN; Vieri, MK | 1 |
Boussinesq, M; Domche, A; Kamgno, J; Nana-Djeunga, HC; Nanga, CL; Njiokou, F; Pion, S; Yemeli, LD | 1 |
Boussinesq, M; Colebunders, R; De Witte, J; Dujardin, JC; Enyong, P; Hendy, A; Kamgno, J; Krit, M; Laemmer, C; Nana-Djeunga, HC; Njamnshi, AK; Nwane, P; O'Neill, S; Pfarr, K; Post, R | 1 |
Afor, AR; Bamou Heumou, R; Bopda, J; Nana Djeunga, HC; Ntonifor, NH; Ondoua Nganjou, GS; Sumo, L | 1 |
Chithenga, S; Doe, F; Fischer, PU; Gyasi, ME; Hong, AR; King, CL; Lew, D; Opoku, NO; Weil, GJ | 1 |
Basáñez, MG; Colebunders, R; Kaiser, C; Lakwo, T; Olliaro, P; Siewe Fodjo, JN | 1 |
Amoah, B; Atsame, J; Biamonte, M; Diggle, PJ; Ella, SN; Fronterrè, C; Gass, K; Giorgi, E; Hundley, L; Johnson, O; Ogoussan, K | 1 |
Ayana, M; Gebrezgabiher, G; Hailu, A; Mekonnen, Z; Yewhalaw, D | 1 |
Agyemang, D; Akilah, J; Anyaike, C; Downs, P; Hamill, L; Hill, B; Igbe, M; Isiyaku, S; Jones, I; MacKenzie, C; Marfo, B; Nyior, A; Pavluck, A; Trotignon, G; William, A; Yumba, D | 1 |
Attah, SK; Awadzi, K; Fleckenstein, L; Kuesel, AC; Lazdins-Helds, J; Opoku, N; Rayner, C; Ryg-Cornejo, V; Sullivan, M; Tan, B | 1 |
Basáñez, MG; Koala, L; Melachio, TT; Thomsen, E; Tirados, I; Worrall, E | 1 |
Bolay, FK; Curtis, K; Eneanya, OA; Fischer, K; Fischer, PU; Gankpala, L; Goss, CW; Gray, EB; Momolu, AT; Nyan, ES; Weil, GJ | 1 |
Adeleke, MA; Akindele, AA; Busari, LO; Fasasi, KA; Ojurongbe, O; Surakat, OA | 1 |
Asare, S; Attah, SK; Bakajika, D; Bolay, KM; Halleux, CM; Howard, HM; Kanza, EM; Kataliko, K; Kennedy, KK; Kuesel, AC; Mambandu, GL; Masembe, SL; Mumbere, M; Nigo, MM; Nyathirombo, A; Olipoh, G; Opoku, NO; Vaillant, M | 1 |
Balog, YA; Bopda, JG; Djune-Yemeli, L; Domche, A; Donfo-Azafack, C; Efon-Ekangouo, A; Kamgno, J; Lenou-Nanga, C; Mbickmen-Tchana, S; Nana-Djeunga, HC; Ntoumi, F; Nzune-Toche, N; Penlap-Beng, V; Velavan, TP | 1 |
Djune-Yemeli, L; Domché, A; Donfo-Azafack, C; Kamgno, J; Lenou-Nanga, CG; Masumbe-Netongo, P; Nana-Djeunga, HC | 1 |
Andress, BC; Bhagwat, EA; Bryant, CA; Chandrapu, VR; Desmonts, CG; Jacobsen, KH; Matthews, TM; Ogunkoya, A; Wheeler, TJ; Williams, AS | 1 |
Banla, M; Gantin, RG; Halatoko, WA; Johanns, SI; Karabou, P; Köhler, C; Komlan, K; Luty, AJ; Schulz-Key, H; Soboslay, PT; Wangala, B | 1 |
Atmakuri, S; Khatri, D; Nene, S; Singh, SB; Sinha, VR; Srivastava, S | 1 |
Abubakar Umar, Z; Amazigo, UV; Anagbogu, IN; Barbre, K; Davies, E; Ekpo, UF; Gideon Nteun, U; Igbe, M; Jacob, SM; Nyior, A; Okoronkwo, C; Oyale, P; Saka, YA; Surakat, OA | 1 |
Abong, RA; Amuam, A; Cho, JF; Ekanya, R; Enyong, P; Esum, ME; Hamill, L; Ndzeshang, BL; Njouendou, AJ; Nkimbeng, DA; Obie, ED; Taylor, MJ; Thorogood, S; Turner, JD; Wanji, S | 1 |
Grant, WN; Hedtke, SM; McCulloch, K; Shrestha, H | 1 |
Gebrezgabiher, G; Hailu, A; Mekonnen, Z; Yewhalaw, D | 2 |
Biamonte, MA; Cantey, PT; Coulibaly, YI; Gass, KM; Hamill, LC; Hanna, C; Kamgno, J; Lammie, PJ; Nutman, TB; Oguttu, DW; Sankara, DP; Stolk, WA; Unnasch, TR | 1 |
Cromwell, EA; Donkers, KM; Hay, SI; Hill, E; Johnson, KB; Pigott, DM; Schipp, MF; Schmidt, CA | 1 |
Boussinesq, M; Domche, A; Kamgno, J; Nana Djeunga, HC; Njiokou, F; Njitchouang, GR; Nwane, PB; Pion, SD | 1 |
Abdullahi, A; Adamani, W; Akpan, NM; Aleiro, A; Anyaike, C; Bush, S; Elhassan, E; Hamill, LC; Igbe, M; Isiyaku, S; Joel, A; Labbo, A; Madaki, S; Mafuyai, HB; Ndongmo, P; Nwoke, BEB; Nyior, A; Saka, Y; Shu'aibu, J | 1 |
Amsalu, T; Ayalew, A; De Vries, H; Enbiale, W; Manaye, N; Van Griensven, J; Workineh, A | 1 |
Domche, A; Efon-Ekangouo, A; Geiger, A; Kamgno, J; Lisongue-Tonga, E; Nana-Djeunga, HC; Nwane, P; Osei-Atweneboana, MY; Sumo, L | 1 |
Ekpo, UF; Eneanya, OA; Fischer, PU; Nwankwo, EN; Nwaorgu, OC; Soneye, IY; Weil, GJ | 1 |
Enyong, PA; Ngarka, L; Njamnshi, AK; Njamnshi, WY; Siewe Fodjo, JN; Zoung-Kanyi Bissek, AC | 1 |
Adelamo, S; Akilah, J; Akpan, N; Coalson, J; Danboyi, J; Eigege, A; Griswold, E; Igbe, M; Kadimbo, J; Kahansim, B; Mafuyai, H; Makata, E; Mancha, B; Miri, ES; Noland, GS; Nwodu, K; Nwoke, BEB; Rakers, L; Richards, FO; Sambo, Y; Umaru, J; Unnasch, TR | 1 |
Amaral, LJ; Colebunders, R; Hadermann, A; Siewe Fodjo, JN; Van Cutsem, G | 1 |
Atekem, K; Ayisi, F; Biholong, B; Boakye, D; Dixon, R; Djeunga, HN; Kamgno, J; Nditanchou, R; Nwane, P; Oye, J; Schmidt, E; Senyonjo, L; Wilhelm, A | 1 |
Boullé, C; Boussinesq, M; Chesnais, CB; Chippaux, JP; Garcia, A; Gardon, J; Kamgno, J; Pion, SD; Ranque, S | 1 |
Ayiseh, RB; Cho-Ngwa, F; Lustigman, S; Mbah, GE; Monya, E; Ndi, EM; Sakanari, J | 1 |
Rowland Yeo, K; Wesche, D | 1 |
Bhwana, D; Challe, DP; Colebunders, R; Dusabimana, A; Fodjo, JNS; Makunde, WH; Mhina, A; Mmbando, BP | 1 |
Jesudason, T | 1 |
Ambomatei, C; Mengnjo, MK; Nfor, LN; Ngarka, L; Njamnshi, AK; Njamnshi, WY; Siewe Fodjo, JN; Taryunyu Njamnshi, JN | 1 |
Agyei, SK; Ankomah, SE; Atta, JA; Fusheini, A; Kokuro, C; Kumah, E; Mensah-Acheampong, F; Otchere, G; Owusu, P | 1 |
Al-Akeel, RK; Alexiou, A; Batiha, GE; Chikezie, FM; Opara, KN; Osei-Atweneboana, MY; Papadakis, M; Ubulom, PME; Yaro, CA | 1 |
Akongo, S; Atekem, K; Ayisi, F; Bakajika, D; Basnet, S; Biholong, B; Boakye, D; Dixon, R; Kamgno, J; Nditanchou, R; Nwane, P; Oye, J; Schmidt, E; Selby, R; Senyonjo, L; Wanji, S; Wilhelm, A | 1 |
Bopda, J; Dongmo-Yemele, R; Efon-Ekangouo, A; Geiger, A; Kamgno, J; Nana-Djeunga, HC; Nutman, TB; Nzune-Toche, N; Ongbassomben, V; Sumo, L | 1 |
Donfo-Azafack, C; Dongmo-Yemele, R; Kamgno, J; Nana-Djeunga, HC; Wafeu-Sadeu, G | 1 |
Ayiseh, RB; Cho-Ngwa, F; Kulu, TK; Lustigman, S; Mainsah, EN; Manfo, FPT; Mbah, GE; Monya, E; Ndi, EM; Njotu, FN; Sakanari, J; Tumanjong, IM | 1 |
Abah, SO; Ezenwosu, IL; Nwobi, EA; Ossai, EN; Otache, AE; Uzochukwu, BS | 1 |
Doe, F; Dubben, B; Fetcho, N; Fischer, K; Fischer, PU; Gordor, S; Goss, CW; Gyasi, ME; Hoerauf, A; Hong, AR; Kanza, E; King, CL; Laryea, R; Lew, D; Opoku, NO; Seidu, MA; Weil, GJ | 1 |
Bhattacharyya, S; Coffeng, LE; Colebunders, R; Logora, MY; Siewe Fodjo, JN; Stolk, WA; Vinkeles Melchers, NVS; Vutha, A | 1 |
Bouyou-Akotet, MK; Ekomi, B; Mawili-Mboumba, DP; Mourou, JR; Moutombi Ditombi, B; Moutongo Mouandza, R; Roger Sibi Matotou, H | 1 |
Amaral, LJ; Bhwana, D; Colebunders, R; Francis, F; Hayuma, PM; Mhina, A; Mmbando, BP; Siewe Fodjo, JN | 1 |
Atekem, K; Biholong, B; Boakye, D; Dixon, R; Kamgno, J; Nditanchou, R; Oye, J; Schmidt, E; Selby, R; Senyonjo, L; Wilhelm, A | 1 |
Boakye, D; Heggen, A; Leff, S; Mackenzie, C; Nadjilar, L; Sow, M; Tallant, J | 1 |
Amaral, LJ; Bol, YY; Carter, JY; Colebunders, R; Fodjo, JNS; Hadermann, A; Hopkins, A; Jada, SR; Lakwo, T; Logora, MY; Rovarini, J | 1 |
Ayong, L; Ghogomu, SM; Ngwese, RA; Njemini, R; Shey, RA; Shintouo, CM; Souopgui, J; Teh, RN; Vanhamme, L; Yaah, NE; Yengo, BN | 1 |
Ameyaw, J; Ankrah, B; Antwi-Berko, D; Avarikame, FA; Babae, TN; Bamfo, JG; Bart-Plange, EJ; Basáñez, MG; Colebunders, R; Darko, VA; Donkoh, ES; Fodjo, JNS; Kudzordzi, PC; Ofori-Appiah, FO; Otabil, KB; Sakibu, RA; Schallig, HDFH | 1 |
Asare, S; Attah, SK; Bakajika, DK; Basáñez, MG; Halleux, CM; Hamley, JID; Hopkins, A; Howard, H; Kanza, EM; Kataliko, K; Kennedy, KK; Kinrade, S; Kuesel, AC; Kura, K; Mambandu, GL; Milton, P; Mumbere, M; Nigo, MM; Olipoh, G; Opoku, NO; Walker, M | 1 |
Ababio, R; Ameyaw, J; Ankrah, B; Babae, TN; Bamfo, JG; Bart-Plange, EJ; Basáñez, MG; Colebunders, R; Darko, VA; Hadermann, A; Hagan, R; Kudzordzi, PC; Kyei, DO; Opoku, SA; Otabil, KB; Raji, AS; Schallig, HDFH | 1 |
Atekem, K; Biholong, D; Dixon, R; Jones, I; Kamgno, J; Nditanchou, R; Senyonjo, L; Trotignon, G | 1 |
Downs, P; Jeyam, A; Kebede, F; Selby, R; Tate, A | 1 |
Febrer-Sendra, B; Fernández-Soto, P; Guevara, Á; López-Abán, J; Morales, D; Muro, A; Quinatoa, P; Salazar, E | 1 |
Boakye, D; Coulibaly, M; Coulibaly, ME; Coulibaly, YI; Dembele, B; Diarra, D; Dicko, B; Dolo, H; Doumbia, M; Doumbia, S; Guindo, B; Hamill, L; Keita, M; Mackenzie, C; Nutman, TB; Sangare, M; Sangare, Y; Sangho, H; Sanogo, A; Soumaoro, L; Sow, M; Tallant, J; Yaro, AS; Zhang, Y | 1 |
Ankrah, B; Babae, TN; Bart-Plange, EJ; Basáñez, MG; Boakye, AA; Colebunders, R; Darko, VA; Datsa, L; Fodjo, JNS; Kudzordzi, PC; Otabil, KB; Raji, AS; Schallig, HDFH; Yeboah, MT | 1 |
Bisanzio, D; Bisoffi, Z; Buonfrate, D; Montresor, A; Tamarozzi, F | 1 |
Coppieters, Y; Ilunga-Ilunga, F; Makenga Bof, JC; Mansiangi, P; Muteba, D | 1 |
Colebunders, R; Hendy, A; Hotterbeekx, A; Kugler, M; Siewe Fodjo, JN; Van Geertruyden, JP | 1 |
Al-Qubati, Y; Kapila, R; Schwartz, RA; Shah, R; Zieleniewski, Ł | 1 |
Ayisi-Boateng, NK; Batsa Debrah, L; Debrah, AY; Dubben, B; Fimmers, R; Fischer, K; Gruetzmacher, B; Hoerauf, A; Kazura, JW; King, CL; Klarmann-Schulz, U; Konadu, P; Mubarik, Y; Nadal, J; Osei-Mensah, J; Ricchiuto, A; Weil, G | 1 |
Boussinesq, M; Chesnais, CB; Deléglise, H; Fletcher, DA; Kamgno, J; Klion, AD; Mackenzie, C; Nana-Djeunga, H; Niamsi-Emalio, Y; Nutman, TB; Pion, SD; Stolk, W | 1 |
Colebunders, R; Hotterbeekx, A; Siewe-Fodjo, JN; Wafula, ST | 1 |
Abong, RA; Amuam, A; Dean, L; Ekanya, R; Enyong, P; Forrer, A; Fung, EG; Hamill, L; Kah, E; Khan, JAM; Murdoch, ME; Ndongmo, WPC; Ndzeshang, BL; Niessen, L; Nji, TM; Njouendou, AJ; Njoumemi, Z; Nkimbeng, DA; Nnamdi, DB; Obie, ED; Ozano, K; Piotrowski, H; Taylor, MJ; Teghen, S; Theobald, S; Thomson, R; Turner, JD; Wanji, S; Watson, V; Woode, ME | 1 |
Baker, M; Bisanzio, D; Chowdhury, D; Conteh, A; Hodges, MH; Kamara, W; Koroma, JB; Macarthy, F; Magbity, E; Samai, M; Sonnie, M; Toubali, EH; Zoerhoff, KL | 1 |
Abhafule, G; Colebunders, R; Dusabimana, A; Haesendonckx, S; Hotterbeekx, A; Jakwong, JM; Lokonda, R; Mandro, M; Meganck, J; Menon, S; Mukendi, D; Nakato, S; Nyisi, F; Siewe Fodjo, JN; Suykerbuyk, P; Wonya'Rossi, D | 1 |
Coppieters, Y; Ilunga-Ilunga, F; Makenga Bof, JC; Mansiangi Mankadi, P; Mpunga Mukendi, D; Ntumba Tshitoka, F | 1 |
Adeniran, AA; Fernández-Santos, NA; Martínez-Montoya, H; Prado-Velasco, FG; Rodríguez-Luna, IC; Rodríguez-Pérez, MA; Unnasch, TR | 1 |
Asmare, T; Aziz, NM; Bekele, F; Birhanu, H; Bitew, Y; Boakye, D; Elmubark, WA; Endeshaw, T; Feleke, SM; Griswold, E; Hassen, M; Higazi, T; Kamal, H; Katabarwa, MN; Mackenzie, C; Meribo, K; Mohammed, A; Negussu, N; Post, R; Richards, F; Samuel, F; Seid, T; Shumo, Z; Tadesse, Z; Tillahun, A; Unnasch, T; Yilak, A; Zarroug, IMA | 1 |
Adelamo, S; Anyaike, C; Danboyi, J; Eigege, A; Griswold, E; Igbe, M; Kadimbo, J; Kahansim, B; Mafuyai, H; Miri, E; Noland, GS; Nwoke, BEB; Rakers, L; Richards, FO; Saka, Y; Umaru, J; Unnasch, TR | 1 |
Evans, DS | 1 |
Colebunders, R; Gumisiriza, N; Hotterbeekx, A; Idro, R; Kaducu, J; Lakwo, T; Makumbi, I; Mbonye Kayitale, M; Mubiru, F; Opar, B; Siewe Fodjo, JN; Wamala, JF | 1 |
Colebunders, R; Preux, PM; Remme, JHF; Siewe Fodjo, JN | 1 |
Basáñez, MG; Colebunders, R; Coulibaly, ME; Coulibaly, SY; Coulibaly, YI; Dembélé, M; Diallo, AA; Diarra, D; Dicko, I; Dolo, H; Doumbia, SS; Nutman, TB; Sangare, MB; Soumaoro, L; Sow, M; Walker, M | 1 |
Hassan, A; Shaban, N | 1 |
Murdoch, ME | 2 |
Awuah, E; Gyasi, SF; Kessie, JA; Obeng-Ofori, D; Otabil, KB; Schallig, HDFH; Tenkorang, SB | 1 |
Boussinesq, M; Campillo, JT; Chesnais, CB; Gardon, J; Kamgno, J; Pion, SDS | 1 |
Boussinesq, M; Chounna-Ndongmo, P; Enyong, P; Gaudriault, G; Njouendou, AJ; Pion, SD; Rech, A; Roberge, C; Wanji, S | 1 |
Basáñez, MG; Hamley, JID; Milton, P; Monnot, F; Pedrique, B; Walker, M | 1 |
Akampurira, P; Bernard, L; Bwenume, F; Byamukama, E; Habomugisha, P; Isingooma, T; Katabarwa, MN; Katamanywa, J; Khainza, A; Nahabwe, C; Ngabirano, M; Oguttu, D; Richards, F; Unnasch, TR | 1 |
Cho, JF; Cumber, SN; Fokam, EB; Keka, EI; Nkfusai, CN; Nyagang, SM; Tsoka-Gwegweni, JM; Wepngong, E | 1 |
Basáñez, MG; Hamley, JID; Milton, P; Walker, M | 1 |
Gamago, GA; Pone, JW; Teukeng, FFD; Todjom, FG; Tsapi, EM | 1 |
Agbi, P; Anyaike, C; Davies, E; Emukah, E; Griswold, E; Ityonzughul, C; Kahansim, B; Miri, ES; Nwoke, BEB; Rakers, LJ; Richards, FO | 1 |
Fischer, PU; Goss, CW; Koudou, BG; Lew, D; Loukouri, A; Méité, A; N'Goran, EK; Weil, GJ | 1 |
Abong, RA; Amambo, GN; Beng, AA; Carlow, CKS; Chounna Ndongmo, PW; Deribe, K; Enyong, PI; Esum, ME; Fombad, FF; Fru-Cho, J; Hoerauf, A; Nji, TM; Njouendou, AJ; Pfarr, K; Poole, CB; Ritter, M; Wanji, S | 1 |
Aza'ah, RA; Bamou, RH; Bopda, J; Nana-Djeunga, HC; Ntonifor, NH; Sumo, L | 1 |
Blok, DJ; Boussinesq, M; Chesnais, CB; de Vlas, SJ; Fletcher, DA; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Niamsi-Emalio, Y; Nutman, TB; Pion, SD; Stolk, WA | 1 |
Amazigo, UV; Asiedu, O; Biritwum, NK; de Souza, DK; Gyapong, JO; Marfo, B | 1 |
Abong, RA; Ashu, EE; Beng, AA; Dean, L; Ekanya, R; Enyong, P; Eyong, ME; Forrer, A; Fung, EG; Hamill, L; Kah, E; Murdoch, MM; Ndongmo, WPC; Ndzeshang, BL; Nji, TM; Njouendou, AJ; Nkimbeng, DA; Nnamdi, DB; Obie, ED; Ozano, K; Piotrowski, H; Suireng, A; Taylor, MJ; Teghen, S; Theobald, S; Thomson, R; Turner, JD; Wanji, S | 1 |
Abong, RA; Amambo, GN; Beng, AA; Carlow, C; Cho, JF; Deribe, K; Enow, BA; Enyong, PI; Esum, ME; Fombad, FF; Hamid, AA; Hoerauf, A; Nietcho, FN; Nji, TM; Njouendou, AJ; Pfarr, K; Poole, C; Ritter, M; Wanji, S | 1 |
Basáñez, MG; Blok, DJ; de Vlas, SJ; Downs, P; Hamill, LC; Hamley, JID; Hopkins, AD; Milton, P; Stolk, WA; Walker, M | 1 |
Aboulaye, M; Elvis, AA; Eneanya, OA; Fischer, PU; Kouakou, MM; Koudou, BG; Souleymane, Y; Weil, GJ | 1 |
Bulman, CA; Jawahar, S; Lustigman, S; Sakanari, J; Tricoche, N | 1 |
Eyo, JE; Onah, IE; Ubachukwu, PO | 1 |
Colebunders, R; Dierickx, S; Ekukole, S; Gryseels, C; Irani, J; Njamnshi, AK; O'Neill, S; Peeters Grietens, K; Ronse, M; Smekens, T; Tatah Ntaimah, P; Teh Monteh, C; Verdonck, K | 1 |
Bougouma, C; Dabiré, RK; Kafando, CM; Kambiré, RS; Koala, L; Nikièma, AS; Paré, AB; Post, RJ; Sondo, AK; Sow, B; Traoré, S | 1 |
Amazigo, UV; Boatin, B; Crump, A; Diop Ly, M; Isiyaku, S; Leak, SGA; Okeibunor, JC; Okoronkwo, C; Zoure, HGM | 1 |
Ardila, EKG; Bravo, LE; Guerrero, E; Guerrero, R; Muñoz, E | 1 |
Basáñez, MG; Boussinesq, M; Chesnais, CB; Kamgno, J; Nana-Djeunga, HC; Niamsi-Emalio, Y; Pion, SDS; Tchatchueng-Mbougua, JB | 1 |
Basáñez, MG; Blok, DJ; Cantey, PT; de Vlas, SJ; Hamley, JID; Stolk, WA; Walker, M | 1 |
Coffeng, LE; de Vlas, SJ; de Vos, AS; Stolk, WA | 1 |
Colebunders, R; Logora, MY; Rafiq, K; Vieri, MK | 1 |
Dean, L; Dum-Buo, N; Fung, EG; Nji, TM; Ozano, K; Piotrowski, H; Theobald, S; Thomson, R; Wanji, S | 1 |
Bakker, R; Coffeng, LE; de Vlas, SJ; Kloek, M; Murdoch, ME; Pedrique, B; Stolk, WA; Vinkeles Melchers, NVS | 1 |
Akafyi, DE; Chechet, G; Ndams, IS; Nock, IH; Renz, A | 1 |
Adekanmbi, V; Adetokunboh, OO; Afarideh, M; Ahmadpour, E; Ahmed, MB; Akalu, TY; Al-Aly, Z; Alanezi, FM; Alanzi, TM; Alipour, V; Andrei, CL; Ansari, F; Ansha, MG; Anvari, D; Appiah, SCY; Arabloo, J; Arnold, BF; Ausloos, M; Ayanore, MA; Baig, AA; Banach, M; Barac, A; Barbre, KA; Bärnighausen, TW; Basáñez, MG; Bayati, M; Bhattacharyya, K; Bhutta, ZA; Bibi, S; Bijani, A; Bohlouli, S; Bohluli, M; Brady, OJ; Bragazzi, NL; Butt, ZA; Carvalho, F; Chatterjee, S; Chattu, SK; Chattu, VK; Cormier, NM; Cromwell, EA; Dahlawi, SMA; Damiani, G; Daoud, F; Darwesh, AM; Daryani, A; Deribe, K; Dharmaratne, SD; Diaz, D; Do, HT; Donkers, KM; El Sayed Zaki, M; El Tantawi, M; Elemineh, DA; Faraj, A; Fasihi Harandi, M; Fatahi, Y; Feigin, VL; Fernandes, E; Foigt, NA; Foroutan, M; Franklin, RC; Gass, KM; Gubari, MIM; Guido, D; Guo, Y; Haj-Mirzaian, A; Hamagharib Abdullah, K; Hamidi, S; Hay, SI; Herteliu, C; Hidru, HD; Higazi, TB; Hill, E; Hossain, N; Hosseinzadeh, M; Househ, M; Ilesanmi, OS; Ilic, IM; Ilic, MD; Iqbal, U; Irvani, SSN; Jha, RP; Johnson, KB; Joukar, F; Jozwiak, JJ; Kabir, Z; Kalankesh, LR; Kalhor, R; Karami Matin, B; Karimi, SE; Kasaeian, A; Kavetskyy, T; Kayode, GA; Kazemi Karyani, A; Kelbore, AG; Keramati, M; Khalilov, R; Khan, EA; Khan, MNN; Khatab, K; Khater, MM; Kianipour, N; Kibret, KT; Kim, YJ; Kosen, S; Krohn, KJ; Kusuma, D; La Vecchia, C; Lansingh, VC; Lee, PH; LeGrand, KE; Li, S; Longbottom, J; Magdy Abd El Razek, H; Magdy Abd El Razek, M; Maleki, A; Mamun, AA; Manafi, A; Manafi, N; Mansournia, MA; Martins-Melo, FR; Mazidi, M; McAlinden, C; Meharie, BG; Mendoza, W; Mengesha, EW; Mengistu, DT; Mereta, ST; Mestrovic, T; Miller, TR; Miri, M; Moghadaszadeh, M; Mohammadian-Hafshejani, A; Mohammadpourhodki, R; Mohammed, S; Moradi, M; Moradzadeh, R; Moraga, P; Mosser, JF; Naderi, M; Nagarajan, AJ; Naik, G; Negoi, I; Nguyen, CT; Nguyen, HLT; Nguyen, TH; Nikbakhsh, R; Oancea, B; Olagunju, AT; Olagunju, TO; Omar Bali, A; Onwujekwe, OE; Osborne, JCP; Pana, A; Pigott, DM; Pourjafar, H; Rahim, F; Rahman, MHU; Rathi, P; Rawaf, DL; Rawaf, S; Rawassizadeh, R; Resnikoff, S; Reta, MA; Rezapour, A; Rubagotti, E; Rubino, S; Sadeghi, E; Saghafipour, A; Sajadi, SM; Samy, AM; Sarmiento-Suárez, R; Sawhney, M; Schipp, MF; Schmidt, CA; Shaheen, AA; Shaikh, MA; Shamsizadeh, M; Sharafi, K; Sheikh, A; Shetty, BSK; Shin, JI; Shirude, S; Shivakumar, KM; Simonetti, B; Singh, JA; Skiadaresi, E; Soheili, A; Soltani, S; Spurlock, EE; Sufiyan, MB; Tabuchi, T; Tapak, L; Thompson, RL; Thomson, AJ; Traini, E; Tran, BX; Ullah, I; Ullah, S; Uneke, CJ; Unnasch, TR; Unnikrishnan, B; Uthman, OA; Vinkeles Melchers, NVS; Violante, FS; Wolde, HF; Wonde, TE; Yamada, T; Yaya, S; Yazdi-Feyzabadi, V; Yip, P; Yonemoto, N; Yousof, HSA; Yu, C; Yu, Y; Yusefzadeh, H; Zaki, L; Zaman, SB; Zamanian, M; Zhang, Y; Zhang, ZJ; Ziapour, A | 1 |
Bradley, J; D'Alessandro, U; Hutchins, H; Kositz, C; Last, A; Marks, M | 1 |
Cupp, EW; Eberhard, ML; Katholi, CR; Richards, FO; Unnasch, TR | 1 |
Barda, B; Hattendorf, J; Huwyler, J; Keiser, J; Keoduangsy, K; Odermatt, P; Phongluxa, K; Puchkov, M; Sayasone, S; Xayavong, S | 1 |
Amazigo, U; Crump, A; Godal, T | 1 |
Osue, HO | 1 |
Begon, M; Bonareri Osoro, C; Colebunders, R; Ensoy-Musoro, C; Falay, D; Kashama, JM; Komba, M; Laudisoit, A; Levick, B; Mandro, M; Suykerbuyk, P; Tagoto, A; Tepage, F | 1 |
Cama, V; Cantey, PT; Kalinga, A; Mwingira, U; Nshala, A; Paulin, HN; Wiegand, R | 1 |
Basáñez, MG; Boakye, DA; Bopda, J; Bourguinat, C; Boussinesq, M; Che, H; Doyle, SR; Grant, WN; Kamgno, J; Kengne-Ouafo, JA; Kuesel, AC; Nana-Djeunga, HC; Osei-Atweneboana, MY; Pion, SDS; Prichard, RK; Walker, M; Wanji, S | 1 |
Biholong, BD; Dissak-Delon, FN; Ghogomu, SM; Kamga, GR; Kamgno, J; Nana-Djeunga, HC; Robert, A; Souopgui, J | 2 |
Dissak-Delon, FN; Essi, MJ; Ghogomu, SM; Godin, I; Humblet, PC; Kamga, GR; Kamgno, J; Robert, A; Souopgui, J | 1 |
Deribe, K; Feleke, SM; Kebede, B; Mengistu, B; Meribo, K; Mulugeta, A; Samuel, A; Sileshi, M; Tadesse, Z | 1 |
Bakalar, MH; Boussinesq, M; Chesnais, CB; D'Ambrosio, MV; Fletcher, DA; Gounoue-Kamkumo, R; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Njitchouang, GR; Nutman, TB; Nwane, P; Pion, SD; Stolk, WA; Tchatchueng-Mbouga, JB; Wanji, S | 1 |
Richards, FO | 1 |
Chounna Ndongmo, WP; Datchoua-Poutcheu, FR; Duamor, CT; Enyong, PA; Kah, E; Kengne-Ouaffo, JA; Maingeh, MS; Njukang, E; Tayong, DB; Wanji, S; Yoah, AT | 1 |
Nyabadza, F; Omondi, EO; Orwa, TO | 1 |
Colatrella, BD; Gustavsen, KM; McCoy, T | 1 |
Chandler, RE | 1 |
Auma, AM; Byamukama, E; Gabriel, M; Habomugisha, P; Katabarwa, M; Luroni, LT; Nyaraga, M; Oguttu, D; Onapa, AW; Tinkitina, B; Tukahebwa, E; Tukesiga, E; Unnasch, TR | 1 |
Aparicio, P; Benito, A; Canorea, I; Cenzual, G; Crainey, JL; Lanza, M; Miguel-Oteo, M; Moya, L; Nguema, J; Rubio, JM; Ta, TH | 1 |
Asare, S; Attah, SK; Bakajika, DK; Bolay, F; Bolay, KM; Halleux, CM; Howard, H; Kanza, EM; Kasonia, K; Kataliko, K; Kpawor, M; Kuesel, AC; Larbelee, JP; Mambandu, GL; Masembe, SL; Mumbere, M; Nigo, MM; Nyathirombo, A; Olipoh, G; Opoku, NO; Vaillant, M | 1 |
Basáñez, MG; Cano, J; O'Hanlon, SJ; Pullan, RL; Rebollo, MP; Tekle, AH; Wanji, S; Zouré, HG | 1 |
Colebunders, R; De Witte, J; Dujardin, JC; Hendy, A; Kalinga, A; Kibweja, A; Krüger, A; Mwingira, U; O'Neill, S; Pfarr, K; Post, R | 1 |
Rakers, LJ; Richards, FO; Sauerbrey, M | 1 |
Byamukama, E; Garms, R; Habomugisha, P; Hudson-Davis, L; Katabarwa, MN; Khainza, A; Lakwo, T; Ngorok, J; Richards, FO; Tukahebwa, E; Unnasch, TR | 1 |
Cama, V; Cantey, PT; Golden, A; Unnasch, TR | 1 |
Bush, S; Elhassan, E; Kollmann, MKH; Molyneux, D; Richards, F; Sodahlon, Y; Zhang, Y | 1 |
Boussinesq, M; Chesnais, CB; Kamgno, J; Klion, AD; Mackenzie, CD; Nana-Djeunga, HC; Nutman, TB; Pion, SD | 1 |
Cantey, PT; Ogoussan, K; Ottesen, EA; Rebollo, MP; Sodahlon, Y; Zoure, H | 1 |
Al-Kubati, AS; Al-Qubati, Y; Al-Samie, AR; Awad, IE; Boakye, D; Hopkins, A; Mackenzie, CD; Thylefors, B | 1 |
Boussinesq, M; Fobi, G; Kuesel, AC | 1 |
Boussinesq, M; Kamgno, J; Pion, SD | 1 |
Chmiel, ER; Currie, BJ; Woolnough, EL | 1 |
Abdul-Ghani, R; Abdulrahman, TAA; Al-Eryani, SMA; Al-Mekhlafi, AM; Alhaidari, SAA; Azazy, AA; Mahdy, MAK | 1 |
Gass, KM | 1 |
Colebunders, R; Greter, H; Kakorozya, A; Makunde, W; Matuja, W; Mmbando, B; Mnacho, M; Suykerbuyk, P | 1 |
Bah, M; Bockarie, MJ; Conteh, A; Hodges, MH; Koroma, JB; Koudou, B; Paye, J; Sesay, S; Sonnie, M; Zhang, Y | 1 |
Cooper, PJ; Guderian, RH; Guevara, Á; Lovato, R; Proaño, R; Rodriguez-Perez, MA; Unnasch, T | 1 |
Baleguel, D; Basañez, MG; Bhatt, S; Cheke, RA; Dobson, HM; Matthews, GA; Nkot, PB; Routledge, I; Walker, M; Wiles, TL | 1 |
Basáñez, MG; Boakye, DA; Boussinesq, M; de Vlas, SJ; Fobi, G; Kim, YE; Kuesel, AC; Stolk, WA; Tekle, AH; Verver, S; Walker, M; Wanji, S; Zouré, HGM | 1 |
Colebunders, R; Greter, H; Hendy, A; Kakorozya, A; Makunde, WH; Matuja, W; Mmbando, BP; Mnacho, M; Suykerbuyk, P | 1 |
Agyemang, ANO; Badu, K; Baffour-Awuah, S; Biritwum, NK; Garms, R; Kruppa, TF; Owusu-Dabo, E | 1 |
Adelamo, S; Anagbogu, I; Eigege, A; Emukah, E; Griswold, E; Ikogho, C; Ityonzughul, C; Kadiri, S; Miri, ES; Richards, FO; Saka, YA; Ugbadamu, P | 1 |
Amazigo, UV; Boatin, BA; Dadzie, Y; Sékétéli, A | 1 |
Djafsia, B; Liebau, E; Ndjonka, D | 1 |
Aziz, NA; Bekele, F; Dominguez-Vazquez, A; Fernández-Santos, NA; Habomugisha, P; Katabarwa, M; Lovato Silva, R; Mohammed, A; Morales Monroy, Z; Oguttu, DW; Richards, FO; Rizzo, N; Rodriguez-Perez, MA; Sauerbrey, M; Schuler Martínez, HR; Tadesse, Z; Unnasch, TR; Zarroug, IMA | 1 |
Dyson, L; Hollingsworth, TD | 1 |
Goodhew, B; Kasubi, M; Lammie, P; Martin, D; Mkocha, H; Wiegand, R | 1 |
Byamukama, E; Cupp, EW; Habomugisha, P; Jacob, BG; Katholi, CR; Lakwo, TL; Loum, D; Tukahebwa, E; Unnasch, TR | 1 |
Abanda, MH; Aminde, LN; Ngwasiri, CA | 1 |
Asaba, G; Kaiser, C; Kipp, W; Rubaale, T; Tukesiga, E | 1 |
Bockarie, M; Chounna Ndongmo, WP; Enyong, PA; Fobi, G; Fombad, FF; Kengne-Ouafo, JA; Koudou, B; Longang Tchounkeu, YF; Njouendou, AJ; Roungou, JB; Wanji, S | 1 |
Whitworth, JAG | 1 |
Gainkam, LOT; Ghogomu, SM; Humblet, P; Kamgno, J; Lelubre, C; Munyampundu, JP; Mutesa, L; Njume, FN; Poelvoorde, P; Robert, A; Shey, RA; Souopgui, J; Vanhamme, L | 1 |
Aba, E; Brika, P; Fischer, PU; King, CL; Kouakou, MM; Kouakou, R; Koudou, BG; Meite, A; Ouattara, AF; Weil, GJ; Yeo, S | 1 |
Bouchat, RR; Ledder, G; Sylvester, D; Thiel, JA | 1 |
Abd-Elfarag, G; Carter, JY; Colebunders, R; Lako, R; Logora, MY; Menon, S; Ojok, M; Songok, J; Wit, F | 1 |
Hotterbeekx, A; Idro, R; Lakwo, T; Namale Ssonko, V; Oyet, W | 1 |
Abd-Elfarag, G; Bhattacharyya, S; Colebunders, R; Ensoy-Musoro, C; Lako, R; Logora, MY; Menon, S; Ojok, M; Olore, PC; Puok, K; Y Carter, J | 1 |
Bissek, AZ; Boussinesq, M; Chesnais, CB; Chokote, SE; Colebunders, R; Dema, F; Mengnjo, MK; Nfor, LN; Ngarka, L; Njamnshi, AK; Nkoro, G; Ntone, FE; Siewe Fodjo, JN; Sitouok, AT; Tabah, EN; Tatah, G | 1 |
Belem, AMG; Boakye, DA; Dabiré, RK; Drabo, F; Koala, L; Nikièma, AS; Paré, AB; Toé, LD; Traoré, S | 1 |
Akumtoh, DN; Aljayyoussi, G; Baeten, B; Chounna, PWN; Chunda, VC; Engelen, M; Fombad, FF; Gandjui, NVT; Lachaud, S; Metuge, HM; Ndzeshang, BL; Njouendou, AJ; Pionnier, N; Quirynen, L; Sjoberg, HT; Steven, A; Taylor, MJ; Tayong, DB; Tekle, F; Turner, JD; Wanji, S; Ward, SA | 1 |
Geary, TG; Mackenzie, CD; Silber, SA | 1 |
Amaechi, AA; Chimechefulam, L; Colebunders, R; Eriama-Joseph, AI; Ezenwa, CI; Ezike, MN; Ikpeama, C; Nwachukwu, O; Nwanjor, SO; Nwazor, EO; Nwoke, BEB; Nwoke, MO; Nwokeji, MC; Ogomaka, AI; Okeke, J; Onuoha, BC; Osahor, K; Siewe, JNF; Ukaga, CN | 1 |
Cantey, PT; Sejvar, J | 1 |
Akonda, I; Colebunders, R; Couvreur, S; Hotterbeekx, A; Kabutako, B; Laudisoit, A; Menon, S; Mukendi, D; Ndibmun, CN; Rotsaert, A; Siewe, JNF; Tepage, F | 1 |
Bissek, AZ; Boullé, C; Boussinesq, M; Chesnais, CB; Colebunders, R; Dema, F; Kamgno, J; Lenou-Nanga, CG; Mengnjo, MK; Nana-Djeunga, HC; Njamnshi, AK; Siewe Fodjo, JN; Suykerbuyk, P | 1 |
Bernard, L; Byamukama, E; Eyamba, A; Griswold, E; Habomugisha, P; Katabarwa, MN; Khainza, A; Nwane, P; Richards, FO; Weiss, P | 1 |
Agbenyikey, L; Andoh, D; Ankrah, CB; Aseidu, P; Atta-Nyarko, RJ; Awuah, E; Conduah, B; Gyasi, SF; Nuhu, AR; Obeng-Ofori, D; Otabil, KB; Schallig, HDFH | 1 |
Dissak-Delon, FN; Ghogomu, SM; Godin, I; Humblet, PC; Kamga, GR; Kamgno, J; Robert, A; Souopgui, J | 1 |
Boussinesq, M; Fitzpatrick, C; Fletcher, DA; Kamgno, J; Klion, AD; Lenk, EJ; Moungui, HC; Nana-Djeunga, HC; Niamsi-Emalio, Y; Nutman, TB; Peultier, AMM; Pion, SD; Redekop, WK; Severens, JL; Stolk, WA | 1 |
Colebunders, R; Logora, MY; Mandro, M; Mmbando, BP; Mubiru, F; Njamnshi, AK; Siewe Fodjo, JN; Ukaga, C | 1 |
Boussinesq, M; Coffeng, LE; Pedrique, B; Pion, SDS; Remme, JH; Stolk, WA; Tekle, AH; Vinkeles Melchers, NVS; Wanji, S; Zouré, HGM | 1 |
Abhafule, G; Anyolito, A; Colebunders, R; Hotterbeekx, A; Lokonda, R; Mandro, M; Menon, S; Mukendi, D; Nakato, S; Nyisi, F; Siewe Fodjo, JN; Tepage, F; Wonya'rossi, D | 1 |
Basáñez, MG; Colebunders, R; Hopkins, A; Hotterbeekx, A; Kalinga, A; Lakwo, TL; Logora, MY; Siewe Fodjo, JN | 1 |
Agunyo, S; Bamuhiiga, J; Byamukama, E; Garms, R; Habomugisha, P; Katabarwa, M; Katamanywa, J; Lakwo, TL; Namanya, H; Oguttu, D; Richards, F; Rubaale, T; Tukesiga, E; Unnasch, T; Walsh, F | 1 |
Adeleke, MA; Arrendondo-Jiménez, JI; Guo, X; Lara-Ramírez, EE; Orozco-Algarra, ME; Pérez-Rodríguez, MA; Rodríguez-Pérez, MA | 1 |
Boussinesq, M; Kamgno, J; Nana-Djeunga, HC; Njiokou, F; Pion, SD; Prichard, RK; Tendongfor, N; Wanji, S | 1 |
Attah, SK; Ayeh-Kumi, PF; Nyarko, AK; Oppong, IV; Sittie, AA | 1 |
Arredondo-Jiménez, JI; Domínguez-Vázquez, A; Hassan, HK; Orozco-Algarra, ME; Prado-Velasco, FG; Rodríguez-Luna, IC; Rodríguez-Morales, KB; Rodríguez-Pérez, MA; Unnasch, TR | 1 |
Abiose, AO; Basáñez, MG; Boussinesq, M; Coffeng, LE; Cousens, S; Dadzie, KY; de Vlas, SJ; Fischer, PU; Murdoch, ME; O'Hanlon, S; Pion, SD; Remme, JH; Stolk, WA | 1 |
Basáñez, MG; Churcher, TS; Osei-Atweneboana, MY; Prichard, RK; Turner, HC; Walker, M | 1 |
Aziz, N; Deran, TC; Elmubark, WA; Hashim, K; Hassan, HK; Higazi, TB; Katabarwa, M; Mackenzie, CD; Mohamed, HA; Richards, F; Unnasch, TR; Zarroug, IM | 1 |
Agunyo, S; Byamukama, E; Dramuke, P; Habomugisha, P; Katabarwa, MN; Lakwo, T; Lwamafa, D; Oguttu, D; Onapa, A; Tukahebwa, EM; Tukesiga, E; Unnasch, TR; Unoba, D; Walsh, F | 1 |
Kuehn, BM | 1 |
Hoerauf, A; Slatko, BE; Taylor, MJ; Townson, S; Ward, SA | 1 |
Álvarez, CA; Ariza, Y; Duque, S; Fajardo, OS; Knudson, A; López, MC; Moncada, LI; Nicholls, RS; Reyes, P | 1 |
Asiedu, O; Basáñez, MG; Biritwum, NK; Churcher, TS; Osei-Atweneboana, MY; Tettevi, EJ; Turner, HC; Walker, M | 1 |
Boussinesq, M; Demanou, M; Kamgno, J; Kouam, MK; Pion, SD; Tchatchueng-Mbougua, JB | 1 |
Borges, R; Convit, J; Domínguez-Vázquez, A; Frontado, H; Grillet, ME; Olivero, V; Schuler, H | 1 |
Adjei, O; Arndts, K; Batsa, L; Debrah, AY; Hoerauf, A; Klarmann Schulz, U; Kwarteng, A; Layland, LE; Mand, S; Martin, C; Specht, S; Tamarozzi, F; Taylor, M | 1 |
Legesse, M; Medhin, G; Weldegebreal, F; Weldegebriel, Z | 2 |
Barzilai, A; Baum, S; Enk, CD; Greenberger, S; Pavlotsky, F; Schwartz, E; Solomon, M | 1 |
Abwaimo, F; Agunyo, S; Byamukama, E; Habomugisha, P; Katabarwa, M; Lakwo, T; Lwamafa, DW; Ndyomugyenyi, R; Ochieng, GO; Oguttu, D; Onapa, A; Richards, FO; Tukesiga, E; Unnasch, TR; Walsh, F | 1 |
Bopda, J; Bourguinat, C; Boussinesq, M; Kamgno, J; Kengne-Ouafo, JA; Nana-Djeunga, HC; Njiokou, F; Pion, SD; Prichard, RK; Wanji, S | 1 |
Gallé, D; Grésenguet, G; Kémata, B; Kobangué, L; Yaya, G | 1 |
Criollo, H; Guderian, R; Guevara, A; Hassan, HK; Lovato, R; Mackenzie, CD; Proaño, R; Unnasch, T | 1 |
Agba, AI; Banla, M; Gantin, RG; Helling-Giese, G; Heuschkel, C; Karabou, PK; Kére-Banla, A; Schulz-Key, H; Soboslay, PT; Tchalim, S | 1 |
Basáñez, MG; Biritwum, NK; Churcher, TS; Hopkins, A; Osei-Atweneboana, MY; Prichard, RK; Turner, HC; Walker, M | 1 |
Attah, SK; Awadzi, K; Kuesel, AC; Lazdins-Helds, J; Opoku, NO | 1 |
Enyong, PA; Noma, M; Nwoke, BE; Remme, JH; Tekle, AH; Zouré, HG | 1 |
Amazigo, UV; Diggle, PJ; Giorgi, E; Noma, M; Remme, JH; Tekle, AH; Zouré, HG | 1 |
Adamani, W; Alphonsus, K; Eigege, A; Evans, DS; Gonzales-Peralta, C; Mafuyai, H; Miri, E; Okoeguale, B; Pede, E; Richards, FO; Saka, Y; Umaru, J; Umbugadu, C | 1 |
Bakajika, DK; Hopkins, A; Katabarwa, MN; Lutumba, P; Makenga Bof, JC; Maketa, V; Mpunga, D; Murdoch, ME; Noma, MM; Ntumba, F; Tekle, AH; Zouré, H | 1 |
Bakker, R; Coffeng, LE; de Vlas, SJ; Habbema, D; Hoerauf, A; Hopkins, AD; Stolk, WA | 1 |
Berry, DM; Kabole, I; Mrisho, M; Schmidt, E; York, KJ | 1 |
Adjei, O; Badu, K; Baffour-Awuah, S; Biritwum, NK; Debrah, AY; Gankpala, L; Garms, R; Kruppa, TF; Nagel, M; Owusu-Dabo, E; Post, RJ | 1 |
Ang, KH; Arkin, M; Bell, A; Bidlow, CM; Bulman, CA; Chen, S; Cho-Ngwa, F; Debnath, A; Franklin, C; Gut, J; Knudsen, GM; Lim, KC; Lustigman, S; Marcellino, C; McKerrow, JH; Rascón, AA; Sakanari, JA; Samje, M; Supakorndej, N; Supakorndej, P; Suzuki, B; Tricoche, N; Williams, D; Wilson, C; Wolfe, AR | 1 |
Adedokun, SA; Adefioye, OA; Adeleke, MA; Adeyeba, OA; Akindele, AA; Akinleye, CA; Bolaji, OS; Ojo, JF; Ojurongbe, O; Oyedeji, MO | 1 |
Fischer, PU; Gilbert, R; Kouakou, IM; Lloyd, MM; Meite, A; Taha, NT; Weil, GJ | 1 |
Bonono, CR; Evina, CD; Nsangou, M; Tadenfok, CN; Vouking, MZ; Yondo, D | 1 |
Adzemye, BF; Chounna, PW; Datchoua-Poutcheu, FR; Enyong, P; Esum, ME; Eyong, JE; Jato, I; Kah, E; Kengne-Ouafo, JA; Taylor, DW; Tendongfor, N; Wanji, S | 1 |
Attah, SK; Awadzi, K; Basáñez, MG; Kuesel, AC; Opoku, NO; Turner, HC; Walker, M | 1 |
Endale, A; Erko, B; Legesse, M; Weldegebreal, F | 1 |
Basañez, MG; Biritwum, NK; Boakye, DA; Cheke, RA; Lamberton, PH; Osei-Atweneboana, MY; Post, RJ; Tetteh-Kumah, A; Tirados, I; Walker, M; Wilson, MD; Winskill, P | 1 |
Abdon, MW; Bienvenu, YA; Eric, MS; Francoise, MK; Luboya, ON; Philippe, CM | 1 |
Bhardwaj, RD; Chen, T; deMello, DE; Feiz-Erfan, I; Moon, K; Theodore, N | 1 |
Adjei, O; Batsa, L; Boakye, D; Büttner, M; Debrah, AY; Dubben, B; Fimmers, R; Hoerauf, A; Klarmann-Schulz, U; Kwarteng, A; Mackenzie, CD; Mand, S; Marfo-Debrekyei, Y; Osei-Atweneboana, M; Ricchiuto, A; Specht, S | 1 |
Evans, DS; Richards, FO; Unnasch, TR | 1 |
Dana, D; Debalke, S; Getahun, K; Kassahun, W; Mekonnen, Z; Suleman, S; Yewhalaw, D | 1 |
Arinaitwe, A; Byamukama, E; Eyamba, A; Habomugisha, P; Katabarwa, MN; Khainza, A; Musigire, J; Nwane, P; Tushemereirwe, R | 1 |
Cupp, EW; Domínguez-Vázquez, A; Fernández-Santos, NA; González-Roldán, JF; Hassan, HK; Kuri-Morales, PA; Orozco-Algarra, ME; Prado-Velasco, FG; Real-Najarro, O; Richards, FO; Rodríguez-Atanacio, JA; Rodríguez-Morales, KB; Rodríguez-Pérez, MA; Unnasch, TR | 1 |
Basáñez, MG; Lustigman, S; Taylor, DW; Turner, HC; Walker, M | 1 |
Hopkins, AD | 2 |
Kim, YE; Sicuri, E; Tediosi, F | 1 |
Amazigo, UV; Bakoné, L; Coffeng, LE; de Vlas, SJ; Krotneva, SP; Noma, M; Stolk, WA; Zouré, HG | 1 |
Tadenfok, CN; Tamo, VC; Vouking, MZ | 1 |
Basáñez, MG; Coffeng, LE; de Vlas, SJ; Stolk, WA; Walker, M | 1 |
Crovella Valdez, CG; Cupp, E; de Cabrera, RM; de Leon, O; Diaz Espinoza, CE; Domínguez, A; Eberhard, M; Hassan, HK; Klein, R; Monroy, ZM; Morales, AL; Richards, F; Rios, D; Rizzo, N; Sauerbrey, M; Unnasch, TR; Zea-Flores, G | 1 |
Albonico, M; Anselmi, M; Bisoffi, Z; Buonfrate, D; Gobbo, M; Guevara Espinoza, A; Marquez, M; Martin Moreira, J; Montresor, A; Prandi, R; Racines Orbe, M | 1 |
Abong, RA; Adzemye, BF; Chounna, PW; Datchoua-Poutcheu, FR; Enyong, P; Esum, ME; Eyong, JE; Jato, I; Kengne-Ouafo, JA; Taylor, DW; Wanji, S | 1 |
Alho, AM; Annoscia, G; Coelho, A; Cruz, L; de Carvalho, LM; Giannelli, A; Lia, RP; Mansinho, M; Martinho, F; Otranto, D | 1 |
Abegunde, AT; Ahuja, RM; Okafor, NJ | 1 |
Basañez, MG; Borges, D; Botto, C; Camacho, O; Coronel, P; Cortez, J; Escalona, M; Flores, J; Frontado, H; Graterol, B; Grillet, ME; Guerra, F; Margeli, H; Morales, AL; Noya-Alarcón, O; Ríos, D; Rodriguez, MA; Tovar, Y; Unnasch, TR; Villamizar, NJ; Vivas-Martínez, S | 1 |
Endeshaw, T; Katabarwa, MN; Richards, FO; Seid, T; Shafi, O; Tadesse, Z; Taye, A | 1 |
Achukwi, MD; Eisenbarth, A; Renz, A | 1 |
El-Bahnasawy, MM; Morsy, AT; Morsy, TA | 1 |
Iyioku, UU; Mnaemeka, AM; Okpara, EM; Udoh, UV | 1 |
Belay, T; Samuel, A; Taha, M; Yehalaw, D; Zemene, E; Zeynudin, A | 1 |
Cripe, M; Fan, B; Halaharvi, D; Meyer, H | 1 |
Abatih, EN; Colebunders, R; Kabeya, J; Komba, M; Laudisoit, A; Levick, B; Mambandu, G; Mandro, M; Mokili, JL; Musinya, G; Rood, E; Tepage, F | 1 |
Begon, M; Colebunders, R; Hoerauf, A; Laudisoit, A; Levick, B; Mambandu, G; Mandro, M; Mokili, JL; Mucinya, G; Pfarr, K; Reiter-Owona, I; Tepage, F | 1 |
Byamukama, E; Garms, R; Habomugisha, P; Katabarwa, MN; Katamanywa, J; Khainza, A; Lakwo, T; Nahabwe, C; Ngabirano, M; Oguttu, D; Richards, FO; Tukahebwa, E; Tukesiga, E; Unnasch, TR | 1 |
Attah, SK; Basáñez, MG; Bottomley, C; Isham, V; Kuesel, AC; Lustigman, S; Opoku, NO; Vivas-Martínez, S; Walker, M | 1 |
Abdul-Ghani, R; Beier, JC; Mahdy, MAK | 1 |
Cama, V; Crovella, CG; de León, O; Díaz Espinoza, CE; Klein, RE; Mendizábal-Cabrera, R; Morales, AL; Morales, Z; Richards, FO; Rizzo, N; Sauerbrey, M | 1 |
Boussinesq, M; Coffeng, LE; Noma, M; Remme, JH; Stolk, WA; Tekle, AH; Zouré, HG | 1 |
Awad, HA; Aziz, N; ElMubark, WA; ElNojomi, NA; Hashim, K; Hassan, HK; Higazi, TB; Katabarwa, M; Mackenzie, CD; Richards, F; Salih, KA; Shumo, ZA; Unnasch, TR; Zarroug, IM | 1 |
Ayiseh, RB; Cho-Ngwa, F; Mbah, GE | 1 |
Bakajika, D; Biholong, B; Boakye, D; Elhassan, E; Oye, J; Schmidt, E; Senyonjo, L; Tekle, A | 1 |
Aparicio, P; Benito, A; Gárate, T; Hernández-González, A; Herrador, Z; Moya, L; Nguema, J; Nguema, R; Perteguer, MJ | 1 |
Boussinesq, M; Chesnais, CB; Paguélé, M; Pion, SD; Takougang, I | 1 |
Caumes, É; Khonsari, RH; Monsel, G; Thellier, M | 1 |
Biholong, BD; Boussinesq, M; Dissak-Delon, FN; Kamga, GR; Kamgno, J; Mbigha-Ghogomu, S; Nana-Djeunga, HC; Robert, A; Souopgui, J; Zoure, HG | 1 |
Drabo, F; Kafando, CM; Koala, L; Nikiema, A; Paré, AB; Post, RJ; Traoré, S | 1 |
Badara Ly, A; Cama, VA; Cantey, PT; Cohn, D; Diawara, L; Direny, A; Dubray, C; Fall, M; Feeser, KR; Fox, LM; Kabore, A; Ndiaye, D; Seck, AF; Sy, N; Wilson, NO | 1 |
Begumisa, S; Byamukama, E; Garms, R; Habomugisha, P; Katabarwa, M; Katamanywa, J; Lakwo, T; Oguttu, D; Onapa, AW; Richards, F; Tukahebwa, EM; Tukesiga, E; Unnasch, TR; Wamani, J | 1 |
Fischer, PU; Jacobson, JA; King, CL; Weil, GJ | 1 |
Cheke, RA | 1 |
Basáñez, MG; Botto, C; Cortez, J; Escalona, M; Frontado, HL; Grillet, ME; Villamizar, NJ | 1 |
Ekobo, S; Eyamba, A; Habomugisha, P; Kamgno, J; Katabarwa, M; Kuete, T; Lakwo, T; Ndyomugyenyi, R; Ntep, M; Onapa, A; Richards, FO; Salifou, M | 1 |
Domínguez-Vázquez, A; Hassan, HK; Hernández-Hernández, R; Lizarazo-Ortega, C; Lutzow-Steiner, MA; Richards, F; Rodríguez-Pérez, MA; Sauerbrey, M; Segura-Cabrera, A; Unnasch, TR | 1 |
Etya'ale, DE; Kocur, I; Resnikoff, S; Ukety, TO | 1 |
Colatrella, B | 1 |
Boatin, B | 1 |
Amazigo, U | 1 |
Yaméogo, L | 1 |
Sauerbrey, M | 1 |
Bangoura, O | 1 |
Haddad, D | 1 |
Thylefors, B | 1 |
Boussinesq, M | 3 |
Baker, SK; Bush, S; Cross, C; Haddad, D; Hopkins, AD; Richards, FO; Thylefors, B | 1 |
Catú, E; Cruz-Ortiz, N; Domínguez, A; Gonzalez, RJ; Lindblade, KA; Oliva, O; Richards, FO; Richards, J; Rizzo, N; Sauerbrey, M; Zea-Flores, G | 1 |
Stingl, P | 2 |
Kilima, SP; Kisinza, WN; Kisoka, WJ; Magesa, SM; Mutalemwa, PP; Njau, J; Nkya, T; Tenu, F | 1 |
Adejai, ET; Adeoye, GO; Akinsanya, B; Atalabi, T; Braide, E; Ibidapo, CA; Okeke, P; Otubanjo, OA | 1 |
Katamanywa, J; Ndyomugyenyi, R; Tukesiga, E | 1 |
Adewale, B; Mafe, MA; Oyerinde, JP | 1 |
Adejai, EO; Adeoye, GO; Akinsanya, B; Braide, E; Ibidapo, CA; Okeke, P; Okwuzu, J; Otubanjo, AO | 1 |
Banic, DM; Calvão-Brito, RH; da Costa Alves, M; de Lima Pinheiro, LR; Maia-Herzog, M; Marchon-Silva, V; Schuertez, JC; Têva, A | 1 |
Brattig, NW | 1 |
Badji, A; Bissan, Y; Diawara, L; Doumbia, K; Goita, SF; Konaté, L; Mounkoro, K; Remme, JH; Sarr, MD; Seck, AF; Toé, L; Tourée, S; Traoré, MO | 1 |
Arana, B; Castro, J; Catú, E; Cruz-Ortiz, N; Gonzalez, RJ; Klein, RE; Lindblade, KA; Morales, AL; Richards, FO; Richards, J; Richards, M; Sauerbrey, M; Zea-Flores, G | 1 |
Crainey, JL; Post, RJ; Wilson, MD | 1 |
Amah, G; Emukah, E; Enyinnaya, U; Miri, E; Onyenama, J; Rakers, LJ; Richards, F; Ukairo, N | 1 |
Boussinesq, M; Kaiser, C; Pion, S | 1 |
Freeland, RD | 1 |
Duerr, HP; Eichner, M | 1 |
Agunyo, S; Eyamba, A; Habomugisha, P; Katabarwa, M; Mentou, C | 1 |
Agunyo, S; Byenume, F; Habomugisha, P; Katabarwa, MN; Kwebiiha, S; Male, B; McFarland, D; McKelvey, AC; Ogweng, N | 1 |
Andze, GO; Baldiagaï, J; Chouaibou, M; Enyong, P; Eyamba, A; Katabarwa, MN; Kuété, T; Madi, K; Richards, F; Yaya, S; Yougouda, A | 1 |
Büttner, DW; Hoerauf, A; Kaifi, JT; Korten, S | 1 |
Enyong, P; Esum, M; Faragher, B; Ford, L; Hoerauf, A; Johnston, KL; Langley, RS; Mand, S; Specht, S; Taylor, MJ; Tendongfor, N; Turner, JD; Wanji, S | 1 |
Boussinesq, M; Grout, L; Kamgno, J; Nana-Djeunga, H; Pion, SD | 1 |
Amazigo, U; Leak, S; Noma, M; Remme, JH; Tekle, AH; Wanji, S; Zoure, H | 1 |
Butters, MP; da Silva, IM; Deus, KM; Foy, BD; Gray, M; Hongyu, T; Kobylinski, KC; Sylla, M | 1 |
Arredondo-Jiménez, JI; Domínguez-Vázquez, A; Morales-Castro, AL; Orozco-Algarra, ME; Peña-Flores, GP; Rendón, VG; Richards, F; Rodríguez-Pérez, MA; Unnasch, TR; Vásquez-Rodríguez, MA | 1 |
Domínguez-Vázquez, A; Morales-Castro, AL; Orozco-Algarra, ME; Peña-Flores, GP; Prado-Velasco, G; Richards, F; Rodríguez-Pérez, MA; Unnasch, TR | 1 |
Bourguinat, C; Boussinesq, M; Geary, TG; Kamgno, J; Mackenzie, CD; Prichard, RK | 1 |
Kilima, S; Kisinza, WN; Kisoka, WJ; Magesa, SM; Mutalemwa, P; Njau, J; Nkya, T; Tenu, F | 1 |
Bockarie, M; Hoerauf, A; Taylor, MJ | 1 |
Cupp, EW; Richards, F; Sauerbrey, M | 1 |
Emukah, E; Gutman, J; Miri, ES; Obasi, A; Okoro, C; Okpala, N; Richards, FO | 1 |
Eneanya, CI; Mbanefo, EC; Nwaorgu, OC; Ogolo, BA; Oguoma, VM; Otiji, MO | 1 |
Hopkins, A; Ogoussan, KT | 1 |
Barreto, ML; Chico, ME; Cooper, PJ; Endara, P; Erazo, S; Lovato, R; Moncayo, AL; Oviedo, G; Quinzo, I; Rodrigues, LC; Rodriguez, A; Vaca, M | 1 |
Chapman, PL; Foy, BD; Gray, M; Kobylinski, KC; Rasgon, JL; Sarr, MD; Sylla, M | 1 |
Duerr, HP; Eichner, M; Raddatz, G | 1 |
Crump, A; Ōmura, S | 2 |
Amuyunzu-Nyamongo, M; Kabali, AT; Leak, S; Manianga, C; Okeibunor, JC; Onyeneho, NG; Tchounkeu, YF | 1 |
Attah, SK; Awadzi, K; Boakye, DA; Gyapong, JO; Osei-Atweneboana, MY; Prichard, RK | 1 |
Bush, S; Hopkins, AD | 1 |
Amazigo, UV; Bissek, AC; Boussinesq, M; Braide, EI; Hagan, M; Murdoch, IE; Murdoch, ME; Noma, MM; Ogbuagu, K; Ozoh, GA; Sékétéli, A; Shamad, M | 1 |
Geary, TG; Mackenzie, CD | 1 |
Aborigo, R; Adjuik, M; Akweongo, P; Amankwa, J; Anto, F; Anyorigiya, T; Asoala, V; Bimi, L; Hodgson, A; Oduro, A | 1 |
Debrah, AY; Hoerauf, A; Mand, S; Pfarr, K; Specht, S | 1 |
Abiose, AO; Amazigo, UV; Brieger, WR; Elhassan, E; Ndyomugyenyi, R; Okeibunor, JC; Wanji, S | 2 |
Carrilero, B; Iborra, MA; Segovia, M | 1 |
Hopkins, A | 1 |
Abanobi, OC; Chukwuocha, UM; Onwuiiliri, CO; Opara, KC | 1 |
Homeida, MM; Hopkins, AD; Lawrence, JC; Mackenzie, CD | 1 |
Andze, GO; Baldiagaï, J; Enyong, P; Eyamba, A; Katabarwa, MN; Madi, TK; Nwane, P; Richards, FO; Yaya, S; Yougouda, A | 1 |
Assob, JC; Kamga, HL; Nde Fon, P; Njem, PK; Njunda, AL; Shey, DN | 1 |
Banla, M; Gantin, RG; Helling-Giese, G; Heuschkel, C; Karabou, PK; Lechner, CJ; Portillo, J; Sarnecka, A; Schulz-Key, H; Seeger, T; Soboslay, PT | 1 |
Abiose, A; Amazigo, UV; Bush, S; Cousens, S; Elhassan, E; Isiyaku, S; Noma, M; Remme, JH; Tekle, AH | 1 |
Bissek, AC; Boussinesq, M; Coffeng, LE; de Vlas, SJ; Enyong, P; Fobi, G; Habbema, JD; Nlatté, BO; Noma, M; Olinga, JM; Ozoh, G; Stolk, WA; Zouré, HG | 1 |
Amazigo, UV; Amuyunzu-Nyamongo, M; Kabali, AT; Manianga, C; Onyeneho, NG; Tchounkeu, YF; Wanji, S | 1 |
Crump, A; Morel, CM; Omura, S | 1 |
Bourguinat, C; Boussinesq, M; Gardon, J; Kamgno, J; Nana-Djeunga, H; Njiokou, F; Pion, SD; Prichard, RK | 1 |
Nsofor, I; Tolhurst, R; Xie, Z | 1 |
Abladam, E; Ajonina-Ekoti, I; Djafsia, B; Liebau, E; Lüersen, K; Ndjonka, D | 1 |
Adeleke, MA; Adeyi, AO; Agbeyangi, O; Bankole, S; Gazama, J; Ikenga, M; Jayeola, OA; Kagni, A; Kosoko, TO; Lawniye, F; Mafiana, CF; Oluwole, AS; Sam-Wobo, SO; Toé, L; Yameogo, L | 1 |
Banda, HT; Bloch, P; de Sousa, A; Jemu, S; Makaula, P; Mangani, C; Mbera, GB; Muula, AS; Nkhono, E | 1 |
Badji, A; Bissan, Y; Diawara, L; Doumbia, K; Goita, SF; Konate, L; Mounkoro, K; Remme, JH; Sarr, MD; Seck, AF; Toe, L; Toure, S; Traore, MO | 1 |
Deb, RM; Mohammed, KA; Molyneux, DH; Stanton, MC | 1 |
Bishop, HS; Cantey, PT; Chundu, K; Eberhard, ML; Feiz-Erfan, I; Hobohm, D; Mathison, BA; Ostovar, GA | 1 |
Agblewonu, KB; Amazigo, UV; Bundy, DA; Coffeng, LE; de Vlas, SJ; Fobi, G; Habbema, D; Murdoch, ME; Noma, M; Richardus, JH; Stolk, WA; Veerman, JL; Zouré, HG | 1 |
Hougard, JM; Philippon, B; Yameogo, L | 1 |
Chima, R; Okonkwo, P; Onwujekwe, O; Shu, E | 1 |
de Graeff, PA; de Vries-Hospers, HG; Kampinga, GA; Rulo, HF; Sprenger, HG | 1 |
Ali, MM; Baraka, OZ; Homeida, MM; Kheir, MM; Mackenzie, CD; Mukhtar, MM | 1 |
Awadzi, K; Cooper, PJ; Guderian, RH; Irani, AM; Nutman, TB; Schwartz, LB | 1 |
Boussinesq, M; Duke, BO; Gardo, J; Kamgno, J; Marty, AM; Peett, DL; Pion, SD | 1 |
Aripko, B; Eka, BL; Enyong, P; Kale, O; Lamlenn, SB; Meli, J; Meremikwu, M; Remme, JH; Takougang, I; Wandji, S; Yenshu, EV | 1 |
Burnham, G | 3 |
AbdelRahman, SI; Ali, MM; Baraka, OZ; Homeida, MM; Mackenzie, CD; Sulaiman, SM; Williams, JF | 1 |
Collins, R; Guevara, AG; Katholi, CR; Lilley, BG; López, A; Rumbea, J; Unnasch, TR; Vieira, JC; Vieira, N | 1 |
Chandenier, J; Gaxotte, P; Richard-Lenoble, D | 1 |
Fagenro-Beyioku, AF; Oyibo, WA | 1 |
Adjei, O; Büttner, DW; Büttner, M; Hoerauf, A; Mand, S; Marfo-Debrekyei, Y; Taylor, M; Volkmann, L | 1 |
BenEzra, D; Enk, CD; Gardlo, K; Ruzicka, T | 1 |
Ridley, RG | 1 |
Addy, ET; Ardrey, AE; Attah, SK; Awadzi, K; Duke, BO; Edwards, G; Opoku, NO; Quartey, BT | 1 |
Bergmann, S; Brattig, NW; Büttner, DW; Fischer, P; Hammerschmidt, S; Jolodar, A | 1 |
Fagbenro-Beyioku, AF; Oyibo, WA | 3 |
Meredith, SE; Twum-Danso, NA | 1 |
Basáñez, MG; Botto, C; Carabin, H; Escalona, M; Joseph, L; Marshall, C; Vivas-Martínez, S | 1 |
Asuzu, MC; Kale, OO; Osungbade, KO | 1 |
Bansal, I; Brar, I; del Rio, M; Maeda, K; Skarf, B | 1 |
Bradley, M; Hoerauf, A; Kyelem, D; Molyneux, DH; Taylor, MJ | 1 |
Kabatereine, N; Ndyomugyenyi, R | 1 |
Bamhuhiiga, J; Büttner, DW; Kipp, W; Rubaale, T | 1 |
Basáñez, MG; Carabin, H; Gyorkos, T; Joseph, L; Marshall, C | 1 |
Bella Hiag, LA; Bengono, G; Fobi, G; McMoli, TE; Moussala, M; Ongolo Zogo, P | 1 |
Domínguez-Vázquez, A; Lilley, BG; Lizarazo-Ortega, C; Mendoza-Herrera, A; Reyes-Villanueva, F; Rodríguez-Pérez, MA; Segura-Arenas, R; Unnasch, TR | 1 |
Elston, DM; Okulicz, JF; Schwartz, RA; Stibich, AS | 1 |
Boakye, B; Lazdins-Helds, JK; Remme, JH | 1 |
Twum-Danso, NA | 1 |
Remme, JH | 1 |
Collins, K | 1 |
Peters, DH; Phillips, T | 1 |
Burnham, G; Rehwinkel, JA; Waters, HR | 1 |
Burnham, G; Mebrahtu, T | 1 |
Beeche, A; Tielsch, JM | 1 |
Addy, ET; Ahmed, K; Ardrey, AE; Attah, SK; Awadzi, K; Boakye, DA; Boatin, BA; Edwards, G; Lazdins-Helds, JK; Opoku, NO; Osei-Atweneboana, MY; Quartey, BT; Soumbey-Alley, EW | 1 |
Ndyomugyenyi, R; Nuwaha, F; Okware, J | 2 |
Amadiegwu, S; Amazigo, U; Ekeanyanwu, J; Emukah, EC; Korve, K; Miri, ES; Obijuru, C; Onyenama, J; Osuji, N; Osuoha, E; Richards, FO | 1 |
Boussinesq, M; Duke, BO; Gardon, J; Gardon-Wendel, N; Kamgno, J | 1 |
Brenya, R; Garms, R; Kruppa, TF; Kutin, K | 1 |
Addy, ET; Ahmed, K; Attah, SK; Awadzi, K; Boakye, DA; Boatin, BA; Edwards, G; Lazdins-Helds, JK; Opoku, NO; Quartey, BT | 1 |
Ardelli, BF; Prichard, RK | 2 |
Boussinesq, M; Clément, MC; Pion, SD | 1 |
Amazigo, UV; Benton, B; Bump, J; Maduka, C; Nnoruka, E; Sékétéli, A | 1 |
Büttner, DW; Garms, R; Ndyomugyenyi, R; Tukesiga, E | 1 |
Gbeleou, SC; Ogungbemi, MK; Okeibunor, JC; Oyene, U; Remme, JH; Sama, M | 1 |
Gilbert, J; Makepeace, BL; Nfon, CK; Njongmeta, LM; Tanya, VN; Trees, AJ | 1 |
Addy, ET; Ardrey, AE; Attah, SK; Awadzi, K; Edwards, G; Favager, S; Opoku, NO; Quartey, BT; Yamuah, LK | 1 |
Cunningham, BB; Leake, JA; Newbury, RO; Pong, AL; Scher, CA | 1 |
Dozie, I; Nwoke, B; Onwuliri, C | 1 |
Adewale, B; Appelt, B; Bamgbose, A; Idowu, ET; Mafe, MA | 1 |
Amazigo, U; Emukah, EC; Maduka, CU; Miri, ES; Nweke, LN; Richards, FO | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Pion, DS | 1 |
Castro, J; Cupp, EW; Cupp, MS; Dominguez, A; Duke, BO; Eversole, RR; Guzmán, JR; Mackenzie, CD; Mendez-Galvan, J; Richards, F; Sauerbrey, M; Vieira, JC | 1 |
de-la-Rosa, JL; Gómez-Priego, A; Mendoza, R | 1 |
Basáñez, MG; Brackenboro, L; Collins, RC; Porter, CH; Vieira, JC | 1 |
Aimard-Favennec, L; Boussinesq, M; Duke, BO; Fobi, G; Gardon, J; Gardon-Wendel, N; Kamgno, J; Lafleur, C | 1 |
Crump, A; Otoguro, K | 1 |
Lalobo, O; Ndyomugyenyi, R; Semiyaga, NB | 1 |
Duke, BO | 2 |
Eng, JK; Prichard, RK | 1 |
Bamhuhiiga, J; Kabagambe, G; Kipp, W; Rubaale, T | 1 |
Gebre-Michael, T; Malone, JB; McNally, K | 1 |
Ekwe, A; Fagbemi, OB; Okenu, DM; Opara, KN | 1 |
Boatin, B; Bonkoungou, M; Kyelem, D; Medlock, J; Molyneux, DH; Sanou, S | 1 |
Bourguinat, C; Boussinesq, M; Duke, BO; Gardon, J; Gardon-Wendel, N; Kamgno, J; Pion, SD; Prichard, RK | 1 |
Banla, M; Fendt, J; Hamm, DM; Helling-Giese, G; Heuschkel, C; Schulz-Key, H; Soboslay, PT; Wolf, H | 1 |
Ardelli, BF; Guerriero, SB; Prichard, RK | 2 |
Abiose, A; Adekeye, O; Amazigo, UV; Mohamed, NA; Ogungbemi, MK; Okeibunor, JC; Onwujekwe, OE | 1 |
Cupp, EW; Cupp, MS | 1 |
Aquino, SL; Branda, JA; Felsenstein, D; Morgan, JG; Ryan, ET | 1 |
Enyong, P; Fobi, G; Kayembé, D; Louango, E; Noma, M; Sékétéli, A; Traoré, S; Yaméogo, L | 1 |
Lakwo, TL; Ndyomugyenyi, R; Onapa, AW; Twebaze, C | 1 |
Berg, A; Ellingsen, CL | 1 |
Boatin, BA; Richards, FO | 1 |
Hassan, HK; Katholi, CR; Rodríguez-Pérez, MA; Unnasch, TR | 1 |
Basáñez, MG; Boussinesq, M; Filipe, JA; Gardon, J; Kamgno, J; Pion, SD | 1 |
Abellana, R; Ardevol, MM; Ascaso, C; de Jiménez Anta, MT; Duran, E; Echeverria, MA; Escaramis, G; Mas, J; Nguema, R; Nkogo, PR; Sánchez, MJ; Sima, A; Untoria, MD | 1 |
Pincock, S | 1 |
Gasarasi, DB; Lakwo, TL | 1 |
Bani-Sadr, F; Chakvetadze, C; Develoux, M; Le Breton, C; Pialoux, G | 1 |
Awadzi, K; Beech, RN; Blackhall, WJ; Bourguinat, C; Eng, JK; Galazzo, D; Lubega, GW; Osei-Atweneboana, MY; Prichard, RK; Unnasch, TR | 1 |
Galvani, AP; Poolman, EM | 1 |
Amazigo, U; Boatin, B | 1 |
Udall, DN | 1 |
Atting, IA; Fagbemi, BO; Okenu, DM; Opara, KN; Oyene, UE | 1 |
Abiose, AO; Amazigo, UV; Brieger, WR; Elhassan, E; Kisoka, W; Ndyomugyenyi, R; Okeibunor, JC; Wanji, S | 1 |
Agossou, A; Banla, M; Hamm, DM; Heuschkel, C; Mai, CS; Schulz-Key, H; Soboslay, PT | 1 |
Amazigo, U; Bump, J; Matovu, V; Okeibunor, J; Seketeli, A; Zouré, H | 1 |
Boussinesq, M; Dimomfu, BL; Lubeji, DK; Noma, M; Sékétéli, A | 1 |
Gaulier, A; Niamba, P; Taïeb, A | 1 |
Cooper, PJ; Guderian, RH; Guzmán, JR; López, AA; Lovato, R; Mancero, T; Proaño, R; Rivera, J; Vieira, JC | 1 |
Habomugisha, P; Lakwo, T; Male, B; Ndyomugyenyi, R | 1 |
Boussinesq, M; Kamgno, J; Pion, SD; Tejiokem, MC; Thylefors, B; Twum-Danso, NA | 1 |
Brown, H | 1 |
Alemnji, GA; Ashuntantang, G; Asonganyi, T; Ebong, CE | 1 |
Ameh, GI; Anosike, JC; Dozie, IN; Nwoke, BE; Nwosu, DC; Nzechukwu, CT; Udujih, OS; Ukaga, CN | 1 |
Amazigo, U; Barryson, A; Engels, D; Remme, JH; Yameogo, L | 1 |
Cupp, E; Eberhard, M; Lammie, P; Richards, F | 1 |
Amann, J; Arana, B; Blanco, C; Domínguez, A; Eberhard, M; Guarner, J; Klein, R; Lopez, B; Maguire, JH; Mendoza, C; Punkosdy, G; Richards, FO | 1 |
Bourguinat, C; Boussinesq, M; Duke, BO; Gardon, J; Kamgno, J; Pion, SD; Prichard, RK | 1 |
Abiose, A; Grepin, K; Hodgkin, C; Molyneux, DH; Philippon, B; Reich, MR; Remme, JH; Thylefors, B; Traore, M | 1 |
Lustigman, S; McCarter, JP | 1 |
Adjei, O; Albers, A; Bandi, C; Batsa, L; Brattig, N; Büttner, DW; Büttner, M; Debrah, AY; Fimmers, R; Hoerauf, A; Konadu, P; Larbi, J; Mand, S; Marfo-Debrekyei, Y; Pfarr, K; Specht, S; Taylor, MJ | 1 |
Omura, S | 1 |
Kabula, B; Kalinga, AK; Maegga, BT; Malley, KD; Mweya, CN; Ruhiso, MH | 1 |
Akpan, EA; Amazigo, U; Emukah, EC; Enyinnaya, U; Hopkins, DR; Katabarwa, MN; Miri, ES; Okoronkwo, C; Olaniran, NS; Rakers, L; Richards, FO; Stanley, A | 1 |
Domínguez-Vásquez, A; Hassan, HK; Lizarazo-Ortega, C; Lugo-Moreno, P; Méndez-Galván, J; Richards, F; Rodríguez-Pérez, MA; Sauerbrey, M; Unnasch, TR | 1 |
Büttner, DW; Heider, U; Hoerauf, A; Pfarr, KM; Schmetz, C | 1 |
Ardelli, BF; Bourguinat, C; Boussinesq, M; Duke, BO; Gardon, J; Kamgno, J; Pion, SD; Prichard, RK | 1 |
Biswas, G; Bradley, MH; Chitsulo, L; Engels, D; Gabrielli, AF; Haji, HJ; Mohammed, KA; Molyneux, DH; Mubila, L; Savioli, L | 1 |
Eigege, A; Jinadu, MY; Miri, E; Njepuome, AN; Ogbu Pearce, P; Pede, E; Umaru, J | 1 |
Adejai, EO; Adeoye, GO; Akinsanya, B; Atalabi, T; Braide, EI; Ibidapo, CA; Okwuzu, J; Otubanjo, AO | 1 |
Fagbemi, BO; Opara, KN | 1 |
Alleman, MM; Thylefors, B; Twum-Danso, NA | 1 |
Basáñez, MG; Boakes, E; Boussinesq, M; Churcher, TS; Filipe, JA; Pion, SD | 1 |
Aziz, MA; Diallo, S; Diop, IM; Lariviere, M; Porta, M | 1 |
Rougemont, A | 1 |
Aziz, MA; Diallo, S; Diop, IM; Gaxotte, P; Lariviere, M; Porta, IM | 1 |
Aziz, MA; Cenac, J; Coulaud, JP; Deluol, AM; Gaxotte, P; Gervais, MC; Lariviere, M | 1 |
Awadzi, K; Aziz, MA; Dadzie, KY; Gilles, HM; Haddock, DR; Schulz-Key, H | 1 |
Taylor, HR | 3 |
Goodwin, LG | 1 |
Aziz, MA; Badiane, S; Diallo, S; Diop-Mar, I; Larivière, M; Ndiaye, MR; Ndir, O; Porta, M | 1 |
Devaney, E; Howells, RE | 1 |
Copeman, DB; Forsyth, KP; Mitchell, GF | 1 |
Donham, JC; Herd, RP | 1 |
Aziz, A; Cenac, J; Coulaud, JP; Deluol, AM; Gaxotte, P; Gervais, MC; Larivière, M | 1 |
Klei, TR; Ochoa, R; Torbert, BJ | 1 |
DiPietro, JA; Lock, TF; McPherron, TA; Todd, KS | 1 |
Boussinesq, M; Chippaux, JP; Ernould, JC; Prod'hon, J; Quillevere, D | 2 |
Achu-Kwi, D; Edwards, G; Renz, A; Trees, AJ; Wahl, G | 1 |
Buttner, DW; Fischer, P; Kabwa, P; Kipp, W | 1 |
Hills, E; Mwetta, E | 1 |
Burnham, G; Courtright, P; Johnston, K | 1 |
Akpoboua, A; Back, C; Bissan, Y; Coulibaly, Y; Doucouré, K; Guillet, P; Hougard, JM; Poudiougo, P; Sesay, I; Sib, AP | 1 |
Agoua, H; Akpoboua, LK; Alley, ES; Bissan, Y; Boatin, BA; Guillet, P; Quillévéré, D; Samba, EM; Sékétéli, A | 1 |
Margeli-Perez, HM; Rivas-Alcala, AR; Rodriguez, MH; Rodriguez-Perez, MA | 1 |
Alley, ES; Boatin, BA; Bonneux, L; De Vlas, SJ; Habbema, JD; Plaisier, AP; Remme, H; Van Oortmarssen, GJ | 1 |
Campbell, WC; Ottesen, EA | 1 |
Behnke, JM; Gilbert, FS; McNicholas, AM; Park, JR; Pritchard, DI; Wakelin, D | 1 |
Beek, WM; Keukens, HJ; Kijlstra, A; Njoo, FL; Oosting, J; Stilma, JS; van Wilgenburg, H | 1 |
Awadzi, K; Büttner, DW; Coventry, PA; Edwards, G; Hero, M; Opoku, NO; Orme, ML; Prime, MA | 1 |
Gonzalez-Peralta, C; Lujan-Trangay, A; Nutman, TB; Steel, C; Zea-Flores, G | 2 |
de Vries, PJ; Kingma, WP; Wetsteyn, JC | 1 |
Bonow, I; Büttner, DW; Darge, K; Knab, J; Tischendorf, FW; Wildenburg, G | 1 |
Porter, JC; Whitworth, JA | 1 |
Breyer, S; Graninger, W; Wenisch, C; Wiesinger, E; Winkler, S | 1 |
Hack, CE; Kijlstra, A; Luyendijk, L; Njoo, FL; Oosting, J; Stilma, JS | 1 |
Abiose, A; Alexander, ND; Babalola, OE; Cassels-Brown, A; Cousens, SN; Evans, J; Ibrahim, UF; Jones, BR; Murdoch, I; Nuhu, I | 1 |
Mabey, D | 1 |
Van Damme, W | 1 |
Chavasse, DC; Downham, MD; Kläger, S; Post, RJ; Whitworth, JA | 1 |
Bamuhiga, J; Binta-Kahwa, J; Büttner, DW; Fischer, P; Kiefer, A; Kipp, W | 1 |
Banla, M; Blanke, CH; Dreweck, CM; Helling, G; Heuschkel, C; Hoffmann, WH; Lüder, CG; Michaelis, I; Pritze, S; Soboslay, PT | 1 |
Hack, CE; Kijlstra, A; Njoo, FL; Oosting, J; Stilma, JS | 1 |
Akpala, C; Nwagbo, D; Nwakoby, B; Okonkwo, PO | 1 |
Chavasse, DC; Davies, JB; Post, RJ; Whitworth, JA | 1 |
Boussinesq, M; Chippaux, JP; Enyong, P; Prod'hon, J; Prud'hom, JM; Quillevere, D | 1 |
Boussinesq, M; Chippaux, JP; Prod'hon, J; Quillévéré, D | 1 |
Abiose, A; Alexander, ND; Cousens, SN; Jones, BR; Yahaya, H | 1 |
Dinga, JS; Enyong, PA; Fobi, G; Ngosso, A; Somo, RM | 1 |
Abiose, A; Edgeworth, JD; Jones, BR | 1 |
Klotz, U; Ofoegbu, E; Ogbuokiri, JE; Okonkwo, PO | 1 |
Bulto, T; Kebede, A; Taticheff, S; Tilahun, D; Workneh, W | 1 |
Belling, GA; Kijlstra, A; Njoo, FL; Oosting, J; Stilma, JS; Vetter, JC | 1 |
Addy, ET; Awadzi, K; Opoku, NO; Quartey, BT | 1 |
Chandrashekar, R; Taylor, HR; Van Swinderen, B; Weil, GJ | 1 |
Abanobi, OC; Anosike, JC | 3 |
Boussinesq, M; Chippaux, JP; Ducorps, M; Gardon, J; Gardon-Wendel, N; Ndong, W; Ranque, S; Schneider, D | 1 |
Chippaux, JP; Ernould, JC; Gardon, J; Gardon-Wendel, N | 1 |
Akuffo, H; Britton, S; Engström, K; Lavebratt, C; Maasho, K | 1 |
Queguiner, P | 1 |
Resnikoff, S | 1 |
Cline, BL; Hewlett, BS; Kollo, B | 1 |
Downham, MD; Lahai, G; Maude, GH; Whitworth, JA | 1 |
Gbakima, AA | 1 |
Gonzales-Peralta, C; Jallah, E; Miri, E; Richards, F | 1 |
Amédée-Manesme, O; Juillet, Y | 1 |
Essomba, RO; Godin, C; Ngoumou, P | 1 |
Büttner, DW; Darge, K | 1 |
Addy, ET; Awadzi, K; Büttner, DW; Opoku, NO; Plenge-Bönig, A | 1 |
Baraka, OZ; Geary, TG; Homeida, MM; Mahmoud, BM; Marschke, CK; Williams, JF | 1 |
Kijlstra, A; Ronday, MJ; Rothova, A; Stilma, JS; Van der Lelij, A; Wienesen, M | 1 |
Büttner, DW; Eggert, P; Erttmann, KD; Gallin, MY | 1 |
Downham, MD; Kläger, SL; Whitworth, JA | 1 |
Tagboto, SK; Townson, S | 1 |
Pearson, CA | 1 |
Lopes, C; Van Laethem, Y | 1 |
Cooper, PJ; Espinel, I; Griffin, GE; Guderian, RH; Nutman, TB; Prakash, D; Remick, DG; Taylor, DW | 1 |
Downham, MD; Maude, GH; Whitworth, JA | 1 |
Ajuwon, AJ; Brieger, WR; Okunade, A; Oladepo, O; Oshiname, FO | 1 |
Nightingale, SL | 1 |
Akuffo, HO; Eriksson, T; Guzmán, G; Lavebratt, C; Ljungström, I; Thors, C | 1 |
Diarrassouba, S; Riviere, F; Traore, S | 1 |
Davies, JB; López-Martinez, LA; Luján, R; Morales-Hernández, BE; Paniagua-Alvarez, AJ; Sherlock, K | 1 |
Bianco, AE; Butcher, GA; Folkard, SG; Taylor, MJ | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J | 1 |
Addy, ET; Attah, SK; Awadzi, K; Duke, BO; Kshirsagar, NA; Nyame, PK; Opoku, NO | 1 |
Akogun, OB; Kelly, MG | 1 |
Alley, ES; Boatin, BA; Habbema, JD; Plaisier, AP; van Oortmarssen, GJ | 1 |
Achu-Kwi, D; Bronsvoort, BM; Cross, HF; Renz, A; Trees, AJ; Wahl, G | 1 |
Newell, ED | 1 |
Anselmi, M; Calvopiña, HM; Cooper, PJ; Espinel, M; Guderian, RH; Mancero, T; Proaño, R; Rivadeneira, G; Vieira, JC | 1 |
Boussinesq, M; Gardon, J | 1 |
Büttner, DW; Darge, K; Knab, J | 1 |
Bulman, GM; Mancebo, OA; Verdi, JH | 1 |
Ogbodo, SO; Okonkwo, PO; Shu, EN | 1 |
François, R; Moussa, S; Soumana, D; Soungalo, T | 1 |
Bricaire, F; Caumes, E; Danis, M; Datry, A; Gentilini, M; Nozais, JP | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Ngoumou, P | 1 |
Boussinesq, M; Godin, C; Louis, FJ | 1 |
Duke, BO; Mutabazi, D | 1 |
Awadzi, K | 1 |
Ndyomugyenyi, R | 2 |
Büttner, DW; Darge, K; Korten, S; Wildenburg, G | 1 |
Davies, JB; Kroon, CC; López-Martínez, LA; Luján, R; Oskam, L; Paniagua-Alvarez, AJ; Schoone, GJ | 1 |
Brieger, WR; Oshiname, FO; Ososanya, OO | 1 |
Alvarez, E; Baldwin, W; Bauler, B; Bayona, M; Beltrán, F; Blanks, J; Brandling-Bennett, D; Cedillos, R; Collins, R; Heisler, M; Jacox, M; Klein, R; Richards, F; Zea Flores, G | 1 |
Fagbenro-Beyiku, AF; Oyibo, WA | 1 |
Basáñez, MG; Collins, RC; Reyes-Villanueva, F; Rodríguez, MH; Rodríguez-Pérez, MA | 1 |
Akpala, CO; Nwagbo, D; Okonkwo, PO; Onwujekwe, OE; Shu, EN | 1 |
Newell, E; Vyungimana, F | 1 |
Büttner, DW; Korten, S; Mainuka, P; Wildenburg, G | 1 |
Amazigo, U; Boatin, BA; Dadzie, KY; Etya'alé, DE; Noma, M; Sékétéli, A | 1 |
Benton, B | 1 |
Alley, ES; Boatin, BA; Dadzie, KY; Dembélé, N; Toé, L; Weiss, N | 1 |
Akpoboua, LK; Alley, ES; Boatin, BA; Dadzie, KY; Dembélé, N; Hougard, JM; Sékétéli, A; Yaméogo, L | 1 |
Dadzie, KY | 1 |
Dull, HB; Meredith, SE | 1 |
Etya'alé, DE | 1 |
Martin-Tellaeche, A; Mendez-Galvan, J; Ramirez-Hernandez, J; Santos-Preciado, JI | 1 |
Miri, ES | 1 |
Baraka, OZ; Homeida, MM; Khier, MM; Mukhtar, MM | 1 |
Eneanya, CI; Ogbuagu, KF | 1 |
Cross, C | 1 |
Espinel, M | 1 |
Fettig, CT | 1 |
Godin, C | 1 |
Jiya, JJ | 1 |
Nyiama, T | 1 |
Okwero, P | 1 |
Bronsvoort, M; Renz, A; Tanya, VN; Trees, AJ; Wood, VL | 1 |
Awedoba, AK; Brieger, WR; Burnham, GM; Eneanya, CI; Hagan, M; Kale, OO; Noma, M; Ogbuagu, KF; Okello, DO; Ososanya, OO; Ovuga, EB; Remme, JH | 1 |
Awadzi, K; Cooper, PJ; Nutman, TB; Ottesen, EA; Remick, D | 1 |
Bronsvoort, M; Renz, A; Tanya, V; Tchakouté, VL; Trees, AJ | 1 |
Katabarwa, M; Mutabazi, D; Richards, F | 2 |
Boussinesq, M; Hougard, JM | 2 |
Flores, GZ; Flores, RZ; Gonzáles-Peralta, C; Klein, RE; Ramírez, JC; Richards, FO; Roman, SG | 1 |
Abiose, A; Alexander, ND; Jones, BR; Seed, P; Thomas, W; Whitworth, JA | 1 |
Bamuhiiga, J; Burnham, G; Büttner, DW; Kipp, W; Weis, P | 1 |
Takeuchi, T | 1 |
Bradley, JE; Danis-Lozano, R; Rodríguez, MH; Rodríguez-Pérez, MA | 1 |
Basáñez, MG; Boussinesq, M | 1 |
Katabarwa, MN; Mutabazi, D | 2 |
Ebrahim, GJ | 1 |
Brattig, NW; Burchard, GD; Kruppa, T; Kubica, T; Tischendorf, FW | 1 |
Okonkwo, PO; Onwujekwe, OE; Shu, EN | 2 |
Katabarwa, M; Nakileza, B; Onapa, AW | 1 |
Okonkwo, P; Onwujekwe, O; Shu, E | 1 |
Okonkwo, PO; Onwujekwe, EO; Shu, EN | 1 |
Gérôme, P; Hernandez, E; Lanternier, G; Le Guyadec, T; Le Vagueresse, R; Maccari, F | 1 |
Bradley, JE; Danis-Lozano, R; Rodríguez, MH; Rodríguez-Pérez, MA; Unnasch, TR | 1 |
Akogun, MK; Akogun, OB; Audu, Z | 1 |
Lokili, P; Okonkwo, PO; Onwujekwe, EO; Shu, EN | 1 |
Nwadike, KI; Okonkwo, PO; Onwujekwe, EO; Shu, EN; Ugwu, OC | 1 |
Beck, LA; Cooper, PJ; Deyampert, NM; Espinel, I; Guderian, RH; Hartnell, A; Jose, PJ; Nutman, TB; Paredes, W | 1 |
Burov, E; Telang, GH; Turner, SE; Vernick, W | 1 |
Krah, CK | 1 |
Habomugisha, P; Katabarwa, M; Richards, F | 1 |
Carlier, C; Chovet, M; Mariko, S; Queguiner, P | 1 |
Chijioke, CP | 1 |
Katabarwa, NM; Mutabazi, D; Richards, FO | 1 |
Connor, SJ; Dunne, M; Molyneux, DH; Obsomer, V; Thomson, MC | 1 |
Grant, W | 1 |
Basáñez, MG; Botto, C; Curtis, CF; García, M; Villegas, L; Vivas-Martínez, S | 1 |
Henry, NL; Klion, AD; Law, M; Nutman, TB | 1 |
Awolola, SO; Chandrashekar, R; Ogunrinade, AF; Rotimi, O | 1 |
Boussinesq, M; Gardon, J; Kamgno, J | 1 |
Adelakun, AO; Akogun, MK; Akogun, OB; Akoh, JI; Audu, Z; Kale, OO; Remme, H; Weiss, MG | 1 |
Brieger, WR; Kale, OO; Ososanya, OO | 1 |
Katabarwa, MN; Richards, FO | 1 |
Adjei, O; Büttner, DW; Fleischer, B; Hoerauf, A; Mand, S | 1 |
Taylor, M | 1 |
Agunyo, S; Habomugisha, P; Katabarwa, MN; Ndyomugyenyi, R | 1 |
Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Pion, SD | 1 |
Albert, MR; Klion, A; Turner, ML | 1 |
Bonow, I; Ekale, D; Fischer, A; Renz, A; Seidenfaden, R; Tanya, V | 1 |
Okonkwo, PO; Shu, EN | 1 |
Boussinesq, M; Chippaux, JP | 1 |
Ndum, C; Okonkwo, P; Onwuameze, O; Onwujekwe, O; Shu, E | 1 |
Alley, WS; Boatin, BA; Borsboom, GJ; Habbema, JD; Lazdins, J; Nagelkerke, NJ; Plaisier, AP; Remme, JH; van Oortmarssen, GJ | 1 |
Boatin, B; Richards, FO; Sauerbrey, M; Sékétéli, A | 1 |
Adeniyi, JD; Brieger, WR; Oke, GA; Oshiname, FO; Otusanya, SA | 1 |
Awadzi, K; Keiser, PB; Nutman, TB; Ottesen, EA; Reynolds, SM; Taylor, MJ | 1 |
Dozie, IN; Nwoke, BE; Ukaga, CC | 1 |
Verburg, GP | 1 |
al Kohlani, A; al Qubati, Y; Gaxotte, P; Pisella, PJ; Richard-Lenoble, D; Toe, L | 1 |
Ndyomugyenyi, R; Remme, J | 1 |
Habomugisha, P; Katabarwa, MN; Richards, FO | 1 |
Bertocchi, I; Hopkins, AD; Kennedy, MH; Meredith, SE | 1 |
Alley, ES; Boatin, BA; Habbema, JD; Nagelkerke, NJ; Plaisier, AP; van Oortmarssen, G; Winnen, M | 1 |
Chavasse, DC; Lemoh, PA; Post, RJ; Whitworth, JA | 1 |
Bain, O; Balaton, A; Diarrassouba, S; Traoré, S; Vuong, PN; Wanji, S | 1 |
Burnham, G; Kamugisha, J; Kipp, W | 1 |
Nwoke, BE | 1 |
Collins, RC; Cupp, EW; Gonzales-Peralta, C; Ochoa, JO; Porter, CH | 1 |
Castro, J; Collins, RC; Cupp, EW; Cupp, MS; Gonzales-Peralta, C; Richards, FO; Zea-Flores, G | 1 |
Castro, J; Collins, RC; Cupp, EW; Cupp, MS; Gonzales-Peralta, C; Ochoa, JO; Zea-Flores, G | 1 |
Banla, M; Dreweck, CM; Görgen, H; Heuschkel, C; Hoffmann, WH; Lüder, CG; Schulz-Key, H; Soboslay, PT | 1 |
Castro, J; Cupp, EW; Duke, BO; Munoz, B; Zea-Flores, G | 3 |
Brotman, B; Dreweck, CM; Greene, BM; Schulz-Key, H; Soboslay, PT; Taylor, HR; Weiss, N | 1 |
Bissan, Y; Dembele, D; Doumbo, O; Keita, M; Kodio, B; Pichard, E; Ranque, P; Sacko, D; Sangare, M; Soula, G | 1 |
Downham, MD; Luty, AJ; Morgan, D; Taylor, DW; Whitworth, JA | 1 |
Greene, BM | 2 |
Anselmi, M; Cooper, PJ; Guderian, RH; Sempertegui, R | 1 |
Bryan, RT; Spencer, HC; Stokes, SL | 1 |
Luty, AJ; Maude, GH; Whitworth, JA | 1 |
Clissold, SP; Goa, KL; McTavish, D | 1 |
Campbell, WC | 1 |
Behrendsen, J; Büttner, DW; Darge, K; Lucius, R; Monson, MH | 1 |
Duke, BO; Muñoz, B; Zea-Flores, G | 1 |
Awissi, D; Banla, M; Heuschkel, C; Schulz-Key, H | 1 |
Marshall, E | 1 |
Duke, BO; Greene, BM; Muñoz, B; Pacqué, MC; Taylor, HR | 1 |
Glover, M; Leigh, I; Murdoch, M | 1 |
Elkassaby, MH | 1 |
Black, ME; Bryceson, AD; Dow, C; Godfrey-Faussett, P | 1 |
Greene, BM; Muñoz, B; Pacqué, M; Taylor, HR | 3 |
Dadzie, KY; De Sole, G; Giese, J; Remme, J | 1 |
Dukuly, Z; Greene, BM; Muñoz, B; Pacqué, M; Taylor, HR; White, AT | 1 |
Pond, B | 1 |
Bryceson, AD; Davidson, RN; Godfrey-Faussett, P | 1 |
Foose, J; Greene, BM; Muñoz, B; Pacqué, M; Poetschke, G; Taylor, HR | 1 |
Dukuly, ZD; Greene, BM; Muñoz, B; Pacqué, M; Taylor, HR; White, AT | 1 |
Dukuly, ZD; Elmets, C; Greene, BM; Muñoz, B; Pacqué, M; Taylor, HR; White, AT | 1 |
Bratthauer, GL; Doumbo, O; Duke, BO; Soula, G; Zea-Flores, G | 1 |
Flores, GZ; Flores, RZ; Gonzales-Peralta, C; Klein, RE; Ramírez, JC; Richards, F | 1 |
Mogg, TD; Pollitt, CC; Thompson, H; Willmore, JP | 1 |
Awadzi, K; Dadzie, KY; De Sole, G; Remme, J | 1 |
Toufic, N | 1 |
Ali, BH; Bashir, AA | 1 |
Brown, KR; Neu, DC | 1 |
Alley, ES; Baker, RH; Dadzie, KY; De Sole, G; Habbema, JD; Plaisier, AP; Remme, J; Samba, EM; van Oortmarssen, GJ | 1 |
Chavasse, DC; Davies, JB | 1 |
Awadzi, K; Breckenridge, A; Edwards, G; Orme, M | 1 |
Childs, JE; Fryauff, DJ; Greene, BM; Munoz, BE; Pacque, MC; Taylor, HR; Trpis, M; Williams, PN | 1 |
Samba, EM | 2 |
Barbe, RF; Rothova, A; Stilma, JS; van der Lelij, G; Wilson, WR | 1 |
Davies, JB | 1 |
Schulz-Key, H | 1 |
Habbema, JD; Plaisier, AP; Remme, J; van Oortmarssen, GJ | 1 |
Dull, HB | 1 |
Jürgens, S; Schulz-Key, H | 1 |
Junghanss, T; Weiss, N | 1 |
Abeloos, J; Aziz, M; Bamba, M; Beauvais, B; Bossebceuf, C; Derouin, F; Ferly-Therizol, M; Garin, JF; Larivière, M; Sarfati, C | 1 |
Abeloos, J; Aziz, M; Bamba, M; Basset, D; Beauvais, B; Derouin, F; Ferly-Therizol, M; Garin, JF; Larivière, M; Sarfati, C | 1 |
Abeloos, J; Aziz, M; Beauvais, B; Derouin, F; Ferly-Therizol, M; Garin, JF; Kouakou, P; Larivière, M; Peignot, C; Sarfati, C | 1 |
Barbe, RF; Rothova, A; Stilma, JS; van der Lelij, A; Wilson, WR | 1 |
Duke, BO; Richards, FO; Zea Flores, R | 1 |
Adams, MA; Alley, ES; Avissey, HS; Baker, RH; Dadzie, KY; De Sole, G; Remme, J; Walsh, JF | 1 |
Awadzi, K; Ba, O; Dadzie, KY; De Sole, G; Giese, J; Karam, M; Keita, FM; Opoku, NO; Remme, J | 1 |
Accorsi, S; Alley, ES; Awadzi, K; Ba, O; Dadzie, KY; De Sole, G; Giese, J; Karam, M; Keita, FM; Remme, J | 1 |
Dukuly, Z; Greene, BM; Keyvan-Larijani, E; Munoz, B; Pacque, MC; Taylor, HR; Williams, PN | 1 |
Dukuly, Z; Greene, BM; Keyvan-Larijani, E; Newland, HS; Semba, RD; Taylor, HR; White, A | 1 |
Greene, BM; Taylor, HR | 1 |
Awadzi, K; Dadzie, KY; Gilles, HM; Kläger, S | 1 |
Collins, RC; Cupp, EW; Ochoa, AO; Ramberg, FR; Zea, G | 1 |
Chandenier, J; Gaxotte, P; Kombila, M; Richard-Lenoble, D | 1 |
Bories, C; Gayral, P; Loiseau, P | 1 |
Otterlei, O | 1 |
Winter, FC | 1 |
Basset, A; Basset, D; Bouree, P; Lariviere, M | 1 |
Bain, O; Hébrard, G; Lardeux, F; Prod'hon, J; Prud'hom, JM | 1 |
Aziz, M; Basset, D; Beauvais, B; Derouin, F; Gaxotte, P; Ginoux, J; Lariviere, M; Schulz-Key, H; Vingtain, P; Weimann, D | 1 |
Ali, HM; Bagi, IA; Bennett, JL; el Sheikh, H; Ghalib, HW; Homeida, MM; Ismail, A; Sulieman, S; Williams, J; Yousif, MA | 1 |
Maude, GH; Morgan, D; Taylor, DW; Whitworth, JA | 1 |
Aziz, MA; D'Anna, SA; Greene, BM; Keyvan-Larijani, E; Newland, HS; Taylor, HR; White, AT; Williams, PN | 1 |
Bissan, Y; Coulibaly, SM; Ginoux, J; Pichard, E; Ranque, P; Thillaye, B; Vingtain, P | 1 |
Awadzi, K; Breckenridge, AM; Edwards, G; Orme, M | 1 |
Dietz, K; Mössinger, J; Schulz-Key, H | 1 |
Comte, P; Le Bras, M; Vérin, P | 1 |
Albiez, EJ; Büttner, DW; Greene, BM; Kaiser, A; Newland, HS; Ranque, P; Taylor, HR; Walter, G; White, AT | 1 |
Aziz, MA; Gaxotte, P; Kombila, M; Nguiri, C; Pappayliou, ES; Richard-Lenoble, D; Rupp, EA | 1 |
Kumar, D; Raisinghani, PM | 1 |
Chapman, MR; Foil, CS; Foil, LD; French, DD; Klei, TM; McClure, JJ; Miller, RI | 1 |
Albiez, EJ; Büttner, DW; Greene, BM; Kaiser, A; Newland, HS; Taylor, HR; White, AT | 1 |
Basset, A; Basset, D; Beauvais, B; Derouin, F; Larivière, M; Sarfati, C | 1 |
Aziz, MA; Badiane, S; Diallo, JS; Diallo, S; Diop-Mar, I; Gaxotte, P; Lariviere, M; N'Dir, O; Py, D; Schulz-Key, H | 1 |
Aziz, MA; D'Anna, SA; Erttmann, KD; Greene, BM; Keyvan-Larijani, E; Nara, A; Newland, HS; Taylor, HR; White, AT; Williams, PN | 1 |
Donnelly, JJ; Haldar, JP; Hill, DE; Khatami, M; Lok, JB; Rockey, JH; Xi, MS | 1 |
Brotman, B; Cupp, EW; Greene, BM; Newland, HS; Soboslay, PT; Taylor, HR; Trpis, M | 1 |
Drudge, JH; Lyons, ET; Tolliver, SC | 1 |
Connelly, C; Dobinson, A; Muller, R; Townson, S | 1 |
Kaminski, ZC; Kapila, R; Lambert, WC; Maso, MJ; Schwartz, RA; Wiltz, H | 1 |
Aziz, MA; Dukuly, ZD; Gallin, MY; Greene, BM; Keyvan-Larijani, E; Newland, HS; Taylor, HR; White, AT; Williams, PN | 1 |
Bianco, AE; Doenhoff, MJ; Muller, RL; Nwachukwu, MA; Townson, S | 1 |
Aziz, MA; Cupp, EW; D'Anna, SA; Greene, BM; Keyvan-Larijani, E; Murphy, RP; Newland, HS; Taylor, HR; White, AT | 1 |
Badiane, S; Diallo, JS; Diallo, S; Diop Mar, I; Ndir, O | 1 |
Awadzi, K; Aziz, MA; Dadzie, KY; Fulford, AJ; Gilles, HM; Schulz-Key, H | 1 |
Awadzi, K; Aziz, MA; Bird, AC; Dadzie, KY; Gilles, HM; Schulz-Key, H | 1 |
Albiez, EJ; Erttmann, KD; Greene, BM; Newland, HS; Soboslay, PT; Taylor, HR; White, AT; Williams, PN | 1 |
Walsh, J | 2 |
Nyerges, AE | 1 |
Aziz, MA; Bernardo, MJ; Collins, RC; Cupp, EW; Greene, BM; Kiszewski, AE; Taylor, HR | 1 |
Holdsworth, PA; Kelly, WR; Meacham, CS; Pollitt, CC; Sheahan, B | 1 |
Awadzi, K; Aziz, MA; Dadzie, KY; Gilles, HM; Haddock, DR; Shulz-Key, H | 1 |
Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT | 1 |
Keyvan-Larijani, E; Newland, HS; Taylor, HR | 1 |
Bell, D | 1 |
79 review(s) available for dextrothyroxine and Onchocerciasis
Article | Year |
---|---|
Vector control and entomological capacity for onchocerciasis elimination.
Topics: Humans; Ivermectin; Loiasis; Mass Drug Administration; Onchocerciasis | 2022 |
A call for loiasis to be added to the WHO list of neglected tropical diseases.
Topics: Animals; Ivermectin; Loa; Loiasis; Neglected Diseases; Onchocerciasis; World Health Organization | 2022 |
Forging Ahead the Repositioning of Multitargeted Drug Ivermectin.
Topics: COVID-19; Drug Repositioning; Humans; Ivermectin; Onchocerciasis; SARS-CoV-2 | 2023 |
Onchocerciasis-associated epilepsy: an update and future perspectives.
Topics: Animals; Child; Epilepsy; Humans; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Seizures | 2023 |
PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile.
Topics: Administration, Oral; Animals; Child; Female; Humans; Ivermectin; Male; Micelles; Models, Biological; Onchocerciasis | 2023 |
Onchocerciasis (river blindness): larva-induced eczema (onchodermatitis) from an important oculocutaneous tropical disease spilling over into North America and Europe.
Topics: Animals; Eczema; Europe; Ivermectin; Larva; North America; Onchocerciasis; Onchocerciasis, Ocular | 2020 |
Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control.
Topics: Africa, Eastern; Africa, Western; Cote d'Ivoire; Epilepsy; Humans; Ivermectin; Onchocerciasis; Prevalence | 2020 |
Mapping the burden of onchocercal skin disease.
Topics: Adult; Animals; Humans; Ivermectin; Male; Neglected Diseases; Nigeria; Onchocerciasis; Prevalence | 2021 |
Moxidectin: an oral treatment for human onchocerciasis.
Topics: Administration, Oral; Animals; Anthelmintics; Disease Eradication; Humans; Ivermectin; Macrolides; Mass Drug Administration; Onchocerciasis | 2020 |
Onchocerciasis control in Ghana (1974-2016).
Topics: Animals; Communicable Disease Control; Ghana; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prevalence | 2021 |
Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
Topics: Africa South of the Sahara; Community Health Services; Community Health Workers; Elephantiasis, Filarial; Female; Humans; Ivermectin; Mass Drug Administration; Neglected Diseases; Onchocerciasis | 2021 |
Broadening the range of use cases for ivermectin - a review of the evidence.
Topics: Animals; Antiparasitic Agents; Humans; Ivermectin; Malaria; Neglected Diseases; Onchocerciasis; Scabies | 2022 |
Review of Ethiopian Onchocerciasis Elimination Programme.
Topics: Animals; Community Health Services; Disease Eradication; Endemic Diseases; Ethiopia; Filaricides; Humans; Ivermectin; Onchocerciasis | 2017 |
Application of optimal control to the onchocerciasis transmission model with treatment.
Topics: Antiparasitic Agents; Epidemics; Ghana; Humans; Ivermectin; Models, Theoretical; Onchocerciasis | 2018 |
Diagnostics for onchocerciasis in the era of elimination.
Topics: Africa; Animals; Antiparasitic Agents; Disease Eradication; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2018 |
Review on medicinal plants and natural compounds as anti-Onchocerca agents.
Topics: Acacia; Africa; Anacardium; Animals; Anthelmintics; Euphorbia; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Plant Extracts; Plants, Medicinal; Tannins | 2018 |
Neurological manifestations in Onchocerca volvulus infection: A review.
Topics: Africa; Africa South of the Sahara; Animals; Epilepsy; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2019 |
Flubendazole as a macrofilaricide: History and background.
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Gastrointestinal Diseases; Humans; Ivermectin; Mebendazole; Microfilariae; Onchocerca volvulus; Onchocerciasis; Wuchereria bancrofti | 2019 |
Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
Topics: Animals; Anti-Bacterial Agents; Brugia malayi; Child; Doxycycline; Drug Discovery; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Onchocerca volvulus; Onchocerciasis; Pregnancy; Symbiosis; Wolbachia | 2014 |
[Systematic review on the contribution of women community distributors in the fight against onchocerciasis sub-Saharan Africa].
Topics: Africa South of the Sahara; Antiparasitic Agents; Community Health Services; Community Health Workers; Delivery of Health Care; Female; Humans; Ivermectin; Male; Onchocerciasis; Patient Acceptance of Health Care | 2014 |
Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.
Topics: Africa South of the Sahara; Antiparasitic Agents; Community Health Services; Community Health Workers; Female; Humans; Ivermectin; Male; Onchocerciasis; Program Development; Sex Factors | 2015 |
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Topics: Doxycycline; Drug Therapy, Combination; Filaricides; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Randomized Controlled Trials as Topic; Vision Disorders | 2016 |
Onchocerciasis in Yemen: Time to take action against a neglected tropical parasitic disease.
Topics: Animals; Humans; Ivermectin; Microfilariae; Neglected Diseases; Onchocerciasis; Simuliidae; Yemen | 2016 |
Factors affecting onchocerciasis transmission: lessons for infection control.
Topics: Africa; Albendazole; Animals; Anthelmintics; Central America; Doxycycline; Humans; Insect Vectors; Insecticides; Ivermectin; Macrolides; Onchocerca volvulus; Onchocerciasis; Simuliidae; South America | 2017 |
Onchocerciasis control: biological research is still needed.
Topics: Animals; Drug Resistance; Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Treatment Outcome; Vaccination | 2008 |
Onchocerciasis: developments in diagnosis, treatment and control.
Topics: Antiparasitic Agents; Communicable Disease Control; Global Health; Humans; Ivermectin; Onchocerciasis | 2009 |
Onchodermatitis.
Topics: Africa; Animals; Anti-Bacterial Agents; Dermatitis; Doxycycline; Filaricides; Humans; Insect Control; Ivermectin; Latin America; Macrolides; Onchocerciasis; Skin Diseases, Parasitic | 2010 |
Lymphatic filariasis and onchocerciasis.
Topics: Africa South of the Sahara; Age Factors; Albendazole; Animals; Anti-Bacterial Agents; Antinematodal Agents; Blindness; Culicidae; Dermatitis; Dermatologic Agents; Diethylcarbamazine; Doxycycline; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Gram-Negative Bacterial Infections; Granuloma; Humans; India; Ivermectin; Lymphadenitis; Lymphangitis; Lymphedema; Macrolides; Onchocerciasis; Prevalence; Symbiosis; Wolbachia | 2010 |
Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Topics: Africa; Americas; Animals; Filaricides; Follow-Up Studies; Humans; Ivermectin; Mali; Microfilariae; Onchocerca volvulus; Onchocerciasis; Senegal; Treatment Outcome | 2011 |
Ivermectin, 'wonder drug' from Japan: the human use perspective.
Topics: Antiparasitic Agents; Drug Resistance; Humans; Ivermectin; Japan; Onchocerciasis; Treatment Outcome | 2011 |
Filariasis in Africa--treatment challenges and prospects.
Topics: Africa; Albendazole; Animals; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Symbiosis; Wolbachia; Wuchereria bancrofti | 2011 |
Elimination of onchocerciasis from Africa: possible?
Topics: Africa; Animals; Anthelmintics; Drug Resistance; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Simuliidae | 2012 |
The onchocerciasis chronicle: from the beginning to the end?
Topics: Animals; Delivery of Health Care; Disease Eradication; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Insect Control; Ivermectin; Onchocerca; Onchocerciasis; Simuliidae | 2012 |
Zoonotic Onchocerca lupi infection in a 22-month-old child in Arizona: first report in the United States and a review of the literature.
Topics: Animals; Anthelmintics; Arizona; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Humans; Infant; Ivermectin; Onchocerca; Onchocerciasis; United States; Zoonoses | 2013 |
Onchocerciasis in West Africa after 2002: a challenge to take up.
Topics: Africa, Western; Animals; Anthelmintics; Eye Infections, Parasitic; Forecasting; Goals; Government Programs; Humans; Insect Control; Insect Vectors; International Cooperation; Ivermectin; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Program Evaluation; Simuliidae; Skin Diseases, Parasitic; World Health Organization | 2002 |
Ivermectin and filariasis.
Topics: Child; Drug Administration Schedule; Female; Filaricides; Humans; Ivermectin; Onchocerciasis; Pregnancy | 2003 |
Mass drug treatment for lymphatic filariasis and onchocerciasis.
Topics: Africa; Albendazole; Animals; Drug Evaluation, Preclinical; Drug Resistance; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; Ivermectin; Onchocerciasis | 2003 |
Bayesian statistics for parasitologists.
Topics: Animals; Anthelmintics; Bayes Theorem; Epidemiologic Studies; Humans; Ivermectin; Onchocerciasis; Parasitology; Prevalence; Strongyloidiasis | 2004 |
Mass treatment of onchocerciasis with ivermectin: should people with epilepsy and/or growth-retardation syndromes be excluded?
Topics: Africa; Animals; Anthelmintics; Contraindications; Developing Countries; Endemic Diseases; Epilepsy; Growth Disorders; Humans; Incidence; Ivermectin; Onchocerciasis; Prevalence | 2004 |
Research for control: the onchocerciasis experience.
Topics: Africa; Animals; Biomedical Research; Cost of Illness; Disease Vectors; Endemic Diseases; Filaricides; Humans; Ivermectin; Loiasis; Models, Biological; Onchocerca; Onchocerciasis; Prevalence | 2004 |
Economic evaluation of Mectizan distribution.
Topics: Cost-Benefit Analysis; Developing Countries; Filaricides; Gift Giving; Health Care Costs; Humans; International Cooperation; Ivermectin; Onchocerciasis | 2004 |
The delivery of ivermectin (Mectizan).
Topics: Developing Countries; Filaricides; Humans; International Cooperation; Ivermectin; Onchocerciasis; Program Evaluation | 2004 |
Impact of ivermectin on illness and disability associated with onchocerciasis.
Topics: Developing Countries; Filaricides; Humans; International Cooperation; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Public Health | 2004 |
The life and times of ivermectin - a success story.
Topics: Africa; Americas; Animals; Anthelmintics; Community Networks; Costs and Cost Analysis; Elephantiasis, Filarial; Humans; Ivermectin; Life Cycle Stages; Onchocerca volvulus; Onchocerciasis; Streptomyces | 2004 |
[Onchocerciasis].
Topics: Adult; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Doxycycline; Female; Filaricides; Humans; Ivermectin; Male; Mice; Onchocerciasis; Onchocerciasis, Ocular; World Health Organization | 2004 |
[Ivermectin].
Topics: Animals; Anthelmintics; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2005 |
Control of onchocerciasis.
Topics: Africa; Americas; Animals; Community Health Services; Drug Resistance; Filaricides; Geography; Humans; Insect Control; Insect Vectors; Ivermectin; Loiasis; National Health Programs; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Simuliidae | 2006 |
Recent updates on onchocerciasis: diagnosis and treatment.
Topics: Animals; Antibodies, Helminth; Antiparasitic Agents; DNA, Helminth; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis | 2007 |
Ivermectin: 25 years and still going strong.
Topics: Animals; Antiparasitic Agents; Filaricides; Humans; Ivermectin; Onchocerciasis | 2008 |
Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
Topics: Antiparasitic Agents; Drug Industry; Female; Filaricides; Gift Giving; Humans; Ivermectin; Male; Onchocerciasis; Program Evaluation; Public Health | 2008 |
Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Filaricides; Humans; Ivermectin; Male; Mathematics; Middle Aged; Onchocerca volvulus; Onchocerciasis; Randomized Controlled Trials as Topic; Skin; Treatment Outcome | 2008 |
Recent advances in research on filariasis. Chemotherapy.
Topics: Animals; Anti-Inflammatory Agents; Arsenicals; Benzimidazoles; Diethylcarbamazine; Drug Evaluation, Preclinical; Filariasis; Filaricides; Filarioidea; Humans; Ivermectin; Lactones; Onchocerciasis; Suramin | 1984 |
Ivermectin in human medicine.
Topics: Animals; Ectoparasitic Infestations; Filariasis; Humans; Intestinal Diseases, Parasitic; Ivermectin; Nematode Infections; Onchocerciasis | 1994 |
[Short review of pathophysiology and therapeutic possibilities in onchocerciasis with reference to a case report].
Topics: Adult; Animals; Antibodies, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Eosinophilia; Humans; Immunoglobulin E; Ivermectin; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; T-Lymphocytes | 1994 |
Treatment of onchocerciasis.
Topics: Animals; Antinematodal Agents; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 1996 |
Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
Topics: Adolescent; Adult; Africa, Central; Aged; Animals; Child; Child, Preschool; Contraindications; Endemic Diseases; Filaricides; Humans; Ivermectin; Loiasis; Microfilariae; Middle Aged; Onchocerciasis; Prevalence; Topography, Medical | 1997 |
[Human onchocerciasis in Africa].
Topics: Africa; Africa, Western; Animals; DNA Probes; DNA, Helminth; Endemic Diseases; Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Simuliidae; Skin Diseases, Parasitic; Socioeconomic Factors | 1997 |
Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana.
Topics: Albendazole; Animals; Filaricides; Humans; Ivermectin; Mebendazole; Onchocerca volvulus; Onchocerciasis; Piperazines | 1997 |
Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
Topics: Africa; Filaricides; Health Care Costs; Health Services; Humans; Ivermectin; Onchocerciasis | 1998 |
Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview.
Topics: Africa; Cost-Benefit Analysis; Filaricides; Health Care Costs; Humans; Ivermectin; Onchocerciasis; Program Evaluation | 1998 |
Diagnostics in onchocerciasis: future challenges.
Topics: Animals; Antigens, Helminth; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Microfilariae; Onchocerciasis; Parasitology; Polymerase Chain Reaction | 1998 |
The impact of Mectizan on the transmission of onchocerciasis.
Topics: Africa, Western; Animals; Filaricides; Guatemala; Humans; Insect Vectors; Ivermectin; Onchocerca; Onchocerciasis; Simuliidae | 1998 |
The Mectizan Donation Programme--a 10-year report.
Topics: Filaricides; Humans; International Agencies; Ivermectin; Onchocerciasis; Program Evaluation | 1998 |
Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
Topics: Africa; Filaricides; Humans; International Agencies; International Cooperation; Ivermectin; Onchocerciasis; Program Evaluation | 1998 |
[The campaign against onchocerciasis in Africa: update].
Topics: Africa; Animals; Antinematodal Agents; Disease Vectors; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 1998 |
[Onchocerciasis].
Topics: Animals; Antiparasitic Agents; Diagnosis, Differential; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prognosis; Skin Diseases, Parasitic | 1999 |
[The campaign against onchocerciasis: a success?].
Topics: Africa; Disease Vectors; Filaricides; Humans; Ivermectin; Onchocerciasis | 1999 |
Musculo-skeletal pain (MSP) in onchocerciasis: a potential in the rapid low cost epidemiological survey and in the assessment of impact of ivermectin treatment on a community.
Topics: Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Pain | 1992 |
Modern medicine versus an ancient scourge: progress toward control of onchocerciasis.
Topics: Animals; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Simuliidae | 1992 |
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.
Topics: Animals; Humans; Ivermectin; Onchocerciasis | 1991 |
Ivermectin as an antiparasitic agent for use in humans.
Topics: Animals; Filariasis; Humans; Intestinal Diseases, Parasitic; Ivermectin; Nematode Infections; Onchocerciasis | 1991 |
Reactions to ivermectin treatment in onchocerciasis patients.
Topics: Acute-Phase Reaction; Animals; Asthma; Clinical Trials as Topic; Humans; Hypotension, Orthostatic; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis | 1990 |
Ivermectin in human filariasis: a mini-review.
Topics: Animals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Filariasis; Humans; Ivermectin; Onchocerciasis | 1990 |
Ivermectin--clinical trials and treatment schedules in onchocerciasis.
Topics: Animals; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Ivermectin; Onchocerca; Onchocerciasis; Skin | 1990 |
Large scale ivermectin distribution and its epidemiological consequences.
Topics: Africa, Western; Animals; Clinical Trials as Topic; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis | 1990 |
Clinical pharmacokinetics of drugs against onchocerciasis.
Topics: Anthelmintics; Benzimidazoles; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Onchocerciasis; Suramin; Trichlorfon | 1990 |
Human onchocerciasis--an overview of the disease.
Topics: Africa; Animals; Humans; Insect Vectors; Insecticides; Ivermectin; Microfilariae; Onchocerciasis; Simuliidae | 1990 |
The status of ivermectin in the treatment of human onchocerciasis.
Topics: Clinical Trials as Topic; Humans; Ivermectin; Onchocerciasis | 1989 |
Drug treatment of onchocerciasis.
Topics: Diethylcarbamazine; Humans; Ivermectin; Levamisole; Onchocerciasis; Suramin | 1988 |
107 trial(s) available for dextrothyroxine and Onchocerciasis
Article | Year |
---|---|
'Slash and clear' vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages.
Topics: Child; Epilepsy; Humans; Incidence; Ivermectin; Onchocerciasis; Randomized Controlled Trials as Topic; Seroepidemiologic Studies | 2021 |
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
Topics: Administration, Oral; Adolescent; Adult; Animals; Female; Humans; Ivermectin; Macrolides; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Simuliidae; Young Adult | 2022 |
Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
Topics: Albendazole; Animals; Cross-Sectional Studies; Elephantiasis, Filarial; Helminthiasis; Humans; Ivermectin; Liberia; Mass Drug Administration; Onchocerciasis; Praziquantel; Prevalence; Soil; Wuchereria bancrofti | 2022 |
Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.
Topics: Animals; Democratic Republic of the Congo; Ghana; Humans; Intestinal Volvulus; Ivermectin; Liberia; Macrolides; Microfilariae; Onchocerciasis | 2022 |
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Onchocerciasis; Pilot Projects | 2023 |
Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial.
Topics: Albendazole; Animals; Female; Ghana; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2020 |
Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
Topics: Adolescent; Adult; Anticonvulsants; Antiparasitic Agents; Democratic Republic of the Congo; Drug Therapy, Combination; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerciasis; Young Adult | 2020 |
Efficacy of Moxidectin Versus Ivermectin Against Strongyloides stercoralis Infections: A Randomized, Controlled Noninferiority Trial.
Topics: Adult; Animals; Antinematodal Agents; Coinfection; Equivalence Trials as Topic; Female; Humans; Ivermectin; Lost to Follow-Up; Macrolides; Male; Onchocerciasis; Opisthorchis; Single-Blind Method; Strongyloides stercoralis; Strongyloidiasis | 2017 |
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Topics: Adolescent; Animals; Anthelmintics; Democratic Republic of the Congo; Double-Blind Method; Endemic Diseases; Female; Ghana; Humans; Ivermectin; Liberia; Macrolides; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; Parasite Load; Skin | 2018 |
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
Topics: Adult; Aged; Antiparasitic Agents; Cohort Studies; Double-Blind Method; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Placebos; Treatment Outcome; Visual Acuity | 2014 |
A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
Topics: Adolescent; Adult; Animals; Anthelmintics; Blood Pressure; Double-Blind Method; Exanthema; Female; Ghana; Humans; Ivermectin; Macrolides; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Pruritus; Skin; Young Adult | 2014 |
Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Double-Blind Method; Doxycycline; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Placebos; Treatment Outcome; Wolbachia; Young Adult | 2015 |
Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Topics: Adolescent; Adult; Animals; Double-Blind Method; Doxycycline; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Placebos; Treatment Outcome; Young Adult | 2010 |
Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Child, Preschool; Drug Resistance; Female; Filaricides; Host-Pathogen Interactions; Humans; Ivermectin; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; Sex Factors; Skin; Treatment Outcome; Young Adult | 2011 |
Community-directed interventions for priority health problems in Africa: results of a multicountry study.
Topics: Africa; Antimalarials; Antiparasitic Agents; Antitubercular Agents; Community Health Services; Community Participation; Costs and Cost Analysis; Dietary Supplements; Directly Observed Therapy; Health Priorities; Humans; Insecticide-Treated Bednets; Ivermectin; Malaria, Falciparum; Onchocerciasis; Vitamin A | 2010 |
Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis.
Topics: Animals; Antigens, Helminth; Antinematodal Agents; Cohort Studies; Filaricides; Humans; Immunocompetence; Ivermectin; Leukocytes, Mononuclear; Lymphocyte Activation; Microfilariae; Onchocerca volvulus; Onchocerciasis; Pruritus; Recurrence; Sudan; Treatment Outcome | 2002 |
Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment.
Topics: Adult; Aging; Animals; Anthelmintics; Cameroon; Female; Humans; Ivermectin; Male; Middle Aged; Neoplasms; Odds Ratio; Onchocerca volvulus; Onchocerciasis; Prevalence | 2002 |
Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms.
Topics: Animals; Anti-Bacterial Agents; Doxycycline; Female; Follow-Up Studies; Humans; Immunohistochemistry; Ivermectin; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Spermatogenesis; Spermatozoa; Treatment Outcome; Wolbachia | 2003 |
The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Topics: Administration, Oral; Adult; Albendazole; Animals; Anthelmintics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis | 2003 |
Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
Topics: Adolescent; Adult; Animals; Anthelmintics; Double-Blind Method; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Risk Factors | 2004 |
Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal.
Topics: Animals; Cattle; Cattle Diseases; Disease Susceptibility; Drug Administration Schedule; Filaricides; Ivermectin; Microfilariae; Onchocerciasis; Prospective Studies | 2004 |
The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Topics: Adolescent; Adult; Albendazole; Animals; Anticestodal Agents; Antinematodal Agents; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Ivermectin; Levamisole; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Treatment Outcome | 2004 |
A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.
Topics: Adolescent; Adult; Anterior Chamber; Anthelmintics; Cameroon; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Treatment Outcome; Vision Disorders; Visual Acuity | 2005 |
Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Topics: Administration, Oral; Animals; Anthelmintics; Cameroon; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Ovarian Neoplasms; Sex Factors | 2005 |
A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients.
Topics: Adolescent; Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Drug Resistance; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Molecular Sequence Data; Onchocerca volvulus; Onchocerciasis; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Tubulin | 2005 |
Chemokines in onchocerciasis patients after a single dose of ivermectin.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Chemokines; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Skin | 2005 |
Non-adherence to community directed treatment with ivermectin for onchocerciasis control in Rungwe district, southwest Tanzania.
Topics: Adult; Aged; Antiparasitic Agents; Community Health Services; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Ivermectin; Male; Middle Aged; Onchocerciasis; Patient Compliance; Patient Education as Topic; Risk Assessment; Risk Factors; Tanzania | 2006 |
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Topics: Adult; Africa; Animals; Antiparasitic Agents; Double-Blind Method; Female; Humans; Ivermectin; Loiasis; Male; Middle Aged; Onchocerciasis; Treatment Outcome | 2007 |
No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin.
Topics: Adolescent; Adult; Animals; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Rifampin; Wolbachia | 2007 |
Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.
Topics: Adult; Animals; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combination; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Wolbachia | 2008 |
P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus.
Topics: Animals; Antiparasitic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Base Sequence; Cameroon; Drug Resistance; Female; Gene Frequency; Genetic Markers; Genotype; Helminth Proteins; Humans; Ivermectin; Linkage Disequilibrium; Male; Molecular Sequence Data; Onchocerca volvulus; Onchocerciasis; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2008 |
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Helminthiasis; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Praziquantel; Tanzania; Young Adult | 2008 |
Efficacy and tolerance of ivermectin in human onchocerciasis.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Double-Blind Method; Humans; Ivermectin; Lactones; Male; Onchocerciasis; Random Allocation | 1982 |
Ivermectin in onchocerciasis.
Topics: Anthelmintics; Clinical Trials as Topic; Double-Blind Method; Humans; Ivermectin; Lactones; Male; Onchocerciasis | 1982 |
Ivermectin in onchocerciasis.
Topics: Anthelmintics; Filaricides; Humans; Ivermectin; Lactones; Onchocerciasis | 1984 |
Ivermectin in onchocerciasis.
Topics: Adolescent; Adult; Diethylcarbamazine; Humans; Ivermectin; Lactones; Male; Middle Aged; Onchocerciasis | 1984 |
[Clinical trial of Ivermectime in the treatment of human onchorcercosis].
Topics: Adult; Clinical Trials as Topic; Drug Tolerance; Humans; Ivermectin; Lactones; Male; Onchocerca; Onchocerciasis; Pruritus | 1984 |
Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
Topics: Africa; Animals; Cattle; Cattle Diseases; Drug Evaluation, Preclinical; Female; Filaricides; Follow-Up Studies; Ivermectin; Male; Onchocerca; Onchocerciasis; Skin; Suramin; Thiazoles; Time Factors; Uterus | 1995 |
Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Child; Child, Preschool; Double-Blind Method; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Skin; Skin Diseases, Parasitic | 1995 |
Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Skin; Tanzania; Treatment Outcome | 1994 |
Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa.
Topics: Adult; Africa, Western; Animals; Cohort Studies; Communicable Disease Control; Ghana; Humans; Ivermectin; Mathematics; Models, Biological; Onchocerca; Onchocerciasis; Skin | 1995 |
Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone.
Topics: Adult; Analysis of Variance; Child; Demography; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Ivermectin; Male; Onchocerciasis; Parasite Egg Count; Placebos; Prevalence; Probability; Sex Factors; Sierra Leone | 1994 |
The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics.
Topics: Adolescent; Adult; Albendazole; Animals; Biological Availability; Cross-Over Studies; Drug Interactions; Female; Food-Drug Interactions; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis | 1994 |
Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis.
Topics: Adult; Animals; Antigens, Helminth; Cytokines; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-10; Interleukin-5; Interleukins; Ivermectin; Leukocytes, Mononuclear; Male; Onchocerca; Onchocerciasis; Skin; Time Factors; Tumor Necrosis Factor-alpha | 1994 |
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
Topics: Adolescent; Adult; Aged; Animals; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Optic Nerve Diseases; Regression Analysis | 1993 |
Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin.
Topics: Animals; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fertilization; Humans; Insemination; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Oogenesis; Spermatozoa | 1993 |
Ivermectin dose assessment without weighing scales.
Topics: Adult; Body Height; Body Weight; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Ivermectin; Male; Onchocerciasis | 1993 |
A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments.
Topics: Animals; Cameroon; Eye; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Prevalence; Skin | 1993 |
An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus.
Topics: Animals; Antigens, CD; Calcium-Binding Proteins; Calgranulin A; Calgranulin B; Eosinophils; Female; Humans; Immunohistochemistry; Immunophenotyping; Ivermectin; Leukocytes; Macrophages; Male; Nigeria; Onchocerca volvulus; Onchocerciasis | 1993 |
The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
Topics: Animals; Anthelmintics; Dose-Response Relationship, Drug; Double-Blind Method; Fluorescein Angiography; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prognosis; Skin | 1995 |
A community trial of ivermectin for onchocerciasis in Sierra Leone: compliance and parasitological profiles after three and a half years of intervention.
Topics: Adolescent; Adult; Antinematodal Agents; Child; Female; Filaricides; Follow-Up Studies; Humans; Ivermectin; Male; Onchocerciasis; Patient Compliance; Recurrence; Sierra Leone; Treatment Outcome | 1996 |
The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Double-Blind Method; Drug Therapy, Combination; Eye; Follow-Up Studies; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Skin Diseases, Parasitic | 1995 |
Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin.
Topics: Adult; Animals; Dose-Response Relationship, Drug; Female; Fertility; Humans; Ivermectin; Longitudinal Studies; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis | 1996 |
Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Child; Cross-Sectional Studies; Dermatitis; Double-Blind Method; Female; Follow-Up Studies; Humans; Ivermectin; Male; Onchocerca; Onchocerciasis; Prevalence; Pruritus; Sierra Leone | 1996 |
Outcome of two patient education methods on recruitment and compliance with ivermectin in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Aged; Antinematodal Agents; Child; Female; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Patient Compliance; Patient Dropouts; Patient Education as Topic | 1996 |
The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Topics: Adolescent; Adult; Animals; Dizziness; Double-Blind Method; Drug Therapy, Combination; Eye Diseases; Filaricides; Ghana; Humans; Inflammation; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Piperazines; Pruritus; Skin | 1997 |
Comparative efficacy of moxidectin 2% equine oral gel and ivermectin 2% equine oral paste against Onchocerca cervicalis (Railliet and Henry, 1910) microfilariae in horses with naturally acquired infections in Formosa (Argentina).
Topics: Administration, Oral; Animals; Anthelmintics; Anti-Bacterial Agents; Argentina; Female; Gels; Horse Diseases; Horses; Ivermectin; Macrolides; Male; Ointments; Onchocerca; Onchocerciasis; Skin | 1997 |
An improved dosing schedule for ivermectin as a microfilaricidal agent against onchocerciasis.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Drug Administration Schedule; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis | 1997 |
Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana.
Topics: Albendazole; Animals; Filaricides; Humans; Ivermectin; Mebendazole; Onchocerca volvulus; Onchocerciasis; Piperazines | 1997 |
A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
Topics: Africa; Antiparasitic Agents; Dermatitis; Double-Blind Method; Filaricides; Humans; Ivermectin; Onchocerciasis; Pruritus; Rural Health | 1998 |
The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
Topics: Adult; Antiparasitic Agents; Double-Blind Method; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; Prevalence; Pruritus; Rural Population; Severity of Illness Index; Skin Diseases, Parasitic; Uganda | 1998 |
Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin.
Topics: Agranulocytosis; Animals; Anthelmintics; Cell Degranulation; Dose-Response Relationship, Drug; Double-Blind Method; Eosinophils; Ghana; Humans; Interleukin-5; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Placebos | 1999 |
Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
Topics: Animals; Cattle; Cattle Diseases; Female; Filaricides; Ivermectin; Onchocerca; Onchocerciasis; Prospective Studies | 1999 |
Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Topics: Adult; Child; Community Participation; Endemic Diseases; Filaricides; Health Education; Humans; Ivermectin; Male; Mass Screening; Nigeria; Onchocerciasis; Physical Examination; Program Evaluation; Rural Health; Teaching; Time Factors | 1999 |
Development of reactive onchocercal skin lesions during a placebo-controlled trial with ivermectin among persons without lesions at baseline.
Topics: Adult; Antinematodal Agents; Antiparasitic Agents; Double-Blind Method; Female; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; Prevalence; Skin Diseases, Parasitic | 2001 |
A controlled prospective trial of the prophylactic effect of a single dose of ivermectin against Onchocerca volvulus.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Child; Child, Preschool; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis | 2001 |
The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Double-Blind Method; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Sex Factors; Sierra Leone | 1992 |
Effects of three-month doses of ivermectin on adult Onchocerca volvulus.
Topics: Adolescent; Adult; Animals; Embryo, Nonmammalian; Guatemala; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Time Factors | 1992 |
[Tolerance of ivermectin treatment of rural communities infected by savannah onchocerciasis in Mali].
Topics: Humans; Ivermectin; Mali; Onchocerciasis; Rural Population | 1992 |
Immunological studies on onchocerciasis in Sierra Leone. 2. Cell-mediated immune responses after repeated treatment with ivermectin.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Child, Preschool; Double-Blind Method; Humans; Immunity, Cellular; Ivermectin; Lymphocyte Activation; Microfilariae; Onchocerca; Onchocerciasis; Sierra Leone; Skin; Tuberculin | 1992 |
[Ivermectin in the treatment of onchocerciasis: feasibility, compliance and efficacy of a mass treatment].
Topics: Adolescent; Adult; Double-Blind Method; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Patient Compliance | 1991 |
Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin.
Topics: Adult; Body Weight; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis | 1991 |
Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus.
Topics: Animals; Drug Administration Schedule; Female; Guatemala; Humans; Ivermectin; Male; Onchocerca; Onchocerciasis | 1991 |
Lack of adverse reactions in ivermectin treatment of onchocerciasis.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Ivermectin; Onchocerciasis; Product Surveillance, Postmarketing | 1990 |
A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.
Topics: Adolescent; Adult; Animals; Anterior Chamber; Cornea; Dose-Response Relationship, Drug; Humans; Ivermectin; Microfilariae; Onchocerciasis; Onchocerciasis, Ocular; Skin | 1991 |
Improvement in severe onchocercal skin disease after a single dose of ivermectin.
Topics: Adolescent; Adult; Aged; Antiparasitic Agents; Female; Follow-Up Studies; Humans; Ivermectin; Liberia; Male; Middle Aged; Onchocerciasis; Skin Diseases, Parasitic | 1991 |
Efficacy of avermectin B1 given orally against equine intestinal strongyles and Onchocera microfilaria.
Topics: Administration, Oral; Animals; Anthelmintics; Antiparasitic Agents; Feces; Female; Fenbendazole; Horse Diseases; Horses; Intestinal Diseases, Parasitic; Ivermectin; Male; Microfilariae; Ointments; Onchocerca; Onchocerciasis; Parasite Egg Count; Skin Diseases, Parasitic; Strongyle Infections, Equine | 1990 |
Reactions to ivermectin treatment in onchocerciasis patients.
Topics: Acute-Phase Reaction; Animals; Asthma; Clinical Trials as Topic; Humans; Hypotension, Orthostatic; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis | 1990 |
Ivermectin--clinical trials and treatment schedules in onchocerciasis.
Topics: Animals; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Ivermectin; Onchocerca; Onchocerciasis; Skin | 1990 |
Large scale ivermectin distribution and its epidemiological consequences.
Topics: Africa, Western; Animals; Clinical Trials as Topic; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis | 1990 |
The effect of ivermectin on the uptake and development of O. volvulus microfilariae in S. damnosum s.l.
Topics: Animals; Humans; Insect Vectors; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Randomized Controlled Trials as Topic; Simuliidae | 1990 |
Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus.
Topics: Animals; Chi-Square Distribution; Drug Administration Schedule; Female; Guatemala; Humans; Ivermectin; Male; Microfilariae; Onchocerca; Onchocerciasis; Parasite Egg Count | 1990 |
Effect of ivermectin on the vertical distribution of Onchocerca volvulus microfilariae in the skin.
Topics: Animals; Biopsy; Double-Blind Method; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Skin | 1990 |
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg].
Topics: Adult; Clinical Trials as Topic; Cote d'Ivoire; Double-Blind Method; Humans; Ivermectin; Male; Onchocerciasis; Placebos; Random Allocation | 1989 |
Ivermectin treatment of patients with severe ocular onchocerciasis.
Topics: Adolescent; Adult; Animals; Anterior Chamber; Anterior Eye Segment; Clinical Trials as Topic; Cornea; Double-Blind Method; Eye; Eye Diseases; Humans; Ivermectin; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Random Allocation; Skin; Visual Acuity | 1989 |
The status of ivermectin in the treatment of human onchocerciasis.
Topics: Clinical Trials as Topic; Humans; Ivermectin; Onchocerciasis | 1989 |
The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
Topics: Adolescent; Adult; Animals; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Ghana; Humans; Hypotension, Orthostatic; Insect Control; Insect Vectors; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Simuliidae; Skin | 1989 |
Ivermectin treatment of onchocerciasis.
Topics: Animals; Clinical Trials as Topic; Colony Count, Microbial; Double-Blind Method; Female; Humans; Ivermectin; Male; Microfilariae; Onchocerciasis; Time Factors | 1989 |
[Effects of diethylcarbamazine and ivermectin on the mobilization of microfilariae of Onchocerca volvulus].
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Filarioidea; Humans; Ivermectin; Mali; Microfilariae; Onchocerciasis; Placebos | 1989 |
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.
Topics: Adolescent; Adult; Aged; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Filaricides; Humans; Ivermectin; Keratitis; Lactones; Male; Middle Aged; Onchocerca; Onchocerciasis; Random Allocation; Skin | 1985 |
Community-based treatment with ivermectin.
Topics: Community Health Services; Humans; Ivermectin; Onchocerciasis; Sierra Leone | 1988 |
Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.
Topics: Adolescent; Adult; Animals; Child; Clinical Trials as Topic; Double-Blind Method; Eye; Eye Diseases; Female; Fundus Oculi; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Random Allocation; Skin; Visual Acuity | 1988 |
[Ivermectin and human onchocerciasis. A study of 234 onchocerciasis patients in the Republic of Mali].
Topics: Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Humans; Ivermectin; Keratitis; Male; Mali; Onchocerciasis; Random Allocation; Recurrence; Skin | 1988 |
Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
Topics: Analysis of Variance; Animals; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Regression Analysis; Skin | 1988 |
Histological examination of onchocercomata after therapy with ivermectin.
Topics: Animals; Female; Humans; Ivermectin; Liberia; Male; Mali; Microfilariae; Onchocerca; Onchocerciasis; Time Factors | 1988 |
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Topics: Adult; Animals; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Skin; Skin Diseases, Parasitic; Urine | 1988 |
[Ivermectin in the treatment and prevention of human onchocerciasis].
Topics: Administration, Oral; Animals; Clinical Trials as Topic; Double-Blind Method; Eye Diseases; Female; Humans; Ivermectin; Male; Onchocerca; Onchocerciasis | 1987 |
A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Pruritus; Skin | 1986 |
Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis.
Topics: Clinical Trials as Topic; Eye Diseases; Female; Humans; Ivermectin; Male; Onchocerca; Onchocerciasis; Random Allocation; Skin; Vision, Ocular | 1987 |
Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye; Eye Diseases; Humans; Ivermectin; Lactones; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Random Allocation; Retina; Time Factors | 1986 |
[Senegalese experience with the efficacy of ivermectin (MK 933) in the treatment of human onchocerciasis (double-blind comparative study with diethylcarbamazine citrate) (DEC.C)].
Topics: Adolescent; Adult; Anthelmintics; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Lactones; Male; Middle Aged; Onchocerciasis | 1986 |
The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Skin; Time Factors | 1986 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Time Factors | 1987 |
Ivermectin effect on microfilariae of Onchocerca volvulus after a single oral dose in humans.
Topics: Animals; Dose-Response Relationship, Drug; Humans; Ivermectin; Microfilariae; Movement; Onchocerca; Onchocerciasis | 1987 |
The effects of ivermectin on transmission of Onchocerca volvulus.
Topics: Humans; Insect Vectors; Ivermectin; Lactones; Onchocerca; Onchocerciasis; Simuliidae | 1986 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Filaricides; Humans; Ivermectin; Lactones; Male; Middle Aged; Onchocerciasis; Random Allocation; Skin; Skin Diseases, Parasitic; Time Factors | 1985 |
An ocular reaction index for use in the study of onchocerciasis.
Topics: Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Blind Method; Eye; Humans; Ivermectin; Lactones; Male; Onchocerca; Onchocerciasis | 1985 |
643 other study(ies) available for dextrothyroxine and Onchocerciasis
Article | Year |
---|---|
Knowledge/perception and attitude/practices of populations of two first-line communities of the Centre Region of Cameroon regarding onchocerciasis and black fly nuisance and bio-ecology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Cross-Sectional Studies; Endemic Diseases; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Logistic Models; Male; Middle Aged; Onchocerciasis; Perception; Public Health; Seasons; Simuliidae; Surveys and Questionnaires; Young Adult | 2021 |
Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum.
Topics: Animals; Cameroon; Female; Humans; Insect Control; Insect Vectors; Insecticides; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Rural Health; Seasons; Simuliidae | 2021 |
Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
Topics: Animals; Cameroon; Cross-Sectional Studies; Endemic Diseases; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis; Prevalence | 2022 |
A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Topics: Adult; Animals; Anthelmintics; Cohort Studies; Eye; Female; Ghana; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Skin | 2021 |
Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
Topics: Animals; Cameroon; Child; Female; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Pregnancy; Prevalence | 2022 |
Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
Topics: Animals; Antibodies, Helminth; Antiparasitic Agents; Coinfection; Female; Humans; Ivermectin; Loa; Loiasis; Male; Mass Drug Administration; Models, Statistical; Onchocerca; Onchocerciasis | 2022 |
Impact of ivermectin mass drug administration on burden of soil-transmitted helminths in onchocerciasis control and elimination programs, Yeki district, southwest Ethiopia.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Cross-Sectional Studies; Ethiopia; Feces; Female; Helminthiasis; Helminths; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Prevalence; Sex Characteristics; Soil; Young Adult | 2022 |
Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping.
Topics: Costs and Cost Analysis; Disease Eradication; Feasibility Studies; Humans; Ivermectin; Onchocerciasis | 2022 |
Black flies and Onchocerciasis: Knowledge, attitude and practices among inhabitants of Alabameta, Osun State, Southwestern, Nigeria.
Topics: Animals; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Nigeria; Onchocerciasis; Simuliidae | 2022 |
High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination.
Topics: Albendazole; Animals; Child; Child, Preschool; Cross-Sectional Studies; Female; Helminthiasis; Humans; Ivermectin; Male; Mebendazole; Onchocerciasis; Soil | 2022 |
Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
Topics: Animals; Cameroon; Child; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Prevalence; Seroepidemiologic Studies | 2022 |
Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Topics: Aged; Animals; Cytokines; Humans; Immunoglobulin G; Interleukin-10; Intestinal Volvulus; Ivermectin; Microfilariae; Mitogens; Onchocerca; Onchocerca volvulus; Onchocerciasis; Parasites; Simuliidae; Togo | 2022 |
Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
Topics: Albendazole; Child; Child, Preschool; Elephantiasis, Filarial; Humans; Ivermectin; Nigeria; Onchocerciasis; Prevalence | 2022 |
The preparatory phase for ground larviciding implementation for chocerciasis control in the Meme River Basin in South West Cameroon: the COUNTDOWN Consortium alternative strategy implementation trial.
Topics: Animals; Brachyura; Cameroon; Ivermectin; Larva; Onchocerciasis; Rivers; Simuliidae; Temefos | 2022 |
Geospatial modeling of pre-intervention nodule prevalence of Onchocerca volvulus in Ethiopia as an aid to onchocerciasis elimination.
Topics: Animals; Bayes Theorem; Ethiopia; Humans; Intestinal Volvulus; Ivermectin; Onchocerca; Onchocerca volvulus; Onchocerciasis; Prevalence; Retrospective Studies | 2022 |
Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia.
Topics: Adolescent; Adult; Cross-Sectional Studies; Ethiopia; Female; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Surveys and Questionnaires; Young Adult | 2022 |
Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions.
Topics: Animals; Female; Ivermectin; Mass Drug Administration; Onchocerca volvulus; Onchocerciasis; Prevalence; Seroepidemiologic Studies; World Health Organization | 2022 |
The prevalence of onchocerciasis in Africa and Yemen, 2000-2018: a geospatial analysis.
Topics: Bayes Theorem; Ghana; Humans; Ivermectin; Nigeria; Onchocerciasis; Prevalence; Yemen | 2022 |
Status of Onchocerca volvulus (Spirurida: Onchocercidae) Transmission and Effect of Climatic Variables on the Vector Population Dynamics After Two Decades of Ivermectin-based Preventive Chemotherapy in the Mbam Valley (Centre Region, Cameroon).
Topics: Animals; Cameroon; Female; Humans; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Population Dynamics; Simuliidae; Spirurida | 2022 |
The interruption of transmission of onchocerciasis in Kaduna, Kebbi and Zamfara states, Nigeria: another milestone achievement.
Topics: Animals; Child; Child, Preschool; Humans; Immunoglobulins; Immunosorbents; Ivermectin; Nigeria; Onchocerciasis; Simuliidae | 2022 |
Ivermectin mass drug administration for onchocerciasis elimination: can it reduce the prevalence of scabies in Ethiopia?
Topics: Cross-Sectional Studies; Ethiopia; Humans; Ivermectin; Mass Drug Administration; Onchocerciasis; Prevalence; Scabies | 2022 |
Prevalence of epilepsy in Ndom Health District (Littoral Region, Cameroon) after long-term ivermectin-based preventive chemotherapy for the control of onchocerciasis.
Topics: Adult; Cameroon; Cross-Sectional Studies; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerciasis; Prevalence; Young Adult | 2022 |
Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin.
Topics: Adult; Cross-Sectional Studies; Humans; Ivermectin; Mass Drug Administration; Nigeria; Onchocerciasis; Prevalence | 2022 |
Onchocerciasis in the Ntui Health District of Cameroon: epidemiological, entomological and parasitological findings in relation to elimination prospects.
Topics: Adult; Animals; Cameroon; Child; Female; Humans; Intestinal Volvulus; Ivermectin; Male; Microfilariae; Onchocerciasis; Simuliidae | 2022 |
Two Nigerian States (Plateau and Nasarawa) Have Eliminated Transmission of Human Onchocerciasis-A Report of Post-Ivermectin Mass Drug Administration Surveillance.
Topics: Animals; Humans; Insect Vectors; Ivermectin; Mass Drug Administration; Onchocerca volvulus; Onchocerciasis; Simuliidae | 2023 |
Evaluating the impact of alternative intervention strategies in accelerating onchocerciasis elimination in an area of persistent transmission in the West Region of Cameroon.
Topics: Animals; Cameroon; Doxycycline; Humans; Ivermectin; Microfilariae; Onchocerciasis; Temefos | 2022 |
Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis.
Topics: Animals; Humans; Ivermectin; Loa; Microfilariae; Onchocerciasis; Retrospective Studies | 2023 |
Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery.
Topics: Animals; Cattle; Filaricides; Gerbillinae; Humans; Ivermectin; Loa; Loiasis; Mice; Microfilariae; Models, Animal; Onchocerciasis | 2023 |
Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.
Topics: Animals; Epilepsy; Follow-Up Studies; Humans; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Prevalence; Tanzania; Treatment Outcome | 2022 |
A new key-player for onchocerciasis elimination.
Topics: Animals; Disease Eradication; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular | 2023 |
Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon.
Topics: Adult; Cameroon; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerciasis; Prevalence | 2023 |
Factors influencing community acceptability of mass drug administration for the elimination of onchocerciasis in the Asante Akim South Municipal, Ghana.
Topics: Adult; Cross-Sectional Studies; Female; Ghana; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerciasis | 2023 |
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin.
Topics: Adult; Animals; Female; Humans; Insect Bites and Stings; Insect Vectors; Ivermectin; Mass Drug Administration; Nigeria; Onchocerciasis; Simuliidae | 2023 |
Acceptability of test and treat with doxycycline against Onchocerciasis in an area of persistent transmission in Massangam Health District, Cameroon.
Topics: Cameroon; Doxycycline; Female; Humans; Ivermectin; Male; Onchocerciasis; Pregnancy; Prevalence | 2023 |
Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
Topics: Adult; Animals; COVID-19; Cross-Sectional Studies; Female; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Onchocerciasis; Pandemics; Prevalence | 2023 |
Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report.
Topics: Adult; Anthelmintics; Cameroon; Female; Humans; Ivermectin; Nervous System Diseases; Onchocerciasis; Young Adult | 2023 |
Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening model.
Topics: Animals; Cricetinae; Female; Filaricides; Gerbillinae; Ivermectin; Onchocerca; Onchocerciasis | 2023 |
Disease perception, impacts and coping strategies for onchocerciasis in Southeast Nigeria: a qualitative study among patients and program managers.
Topics: Adaptation, Psychological; Humans; Ivermectin; Nigeria; Onchocerciasis; Perception | 2023 |
Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
Topics: Adolescent; Animals; Blindness; Child; Child, Preschool; Epilepsy; Female; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Simuliidae; South Sudan | 2023 |
Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon.
Topics: Animals; Biological Factors; Endemic Diseases; Gabon; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerciasis | 2023 |
Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study.
Topics: Adolescent; Antiparasitic Agents; Child; Epilepsy; Humans; Incidence; Ivermectin; Nodding Syndrome; Onchocerciasis; Prevalence; Prospective Studies; Tanzania | 2023 |
Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
Topics: Cameroon; Child; Child, Preschool; Doxycycline; Female; Humans; Ivermectin; Mass Drug Administration; Onchocerciasis; Pregnancy; Prevalence | 2023 |
Enhancing onchocerciasis elimination program management: A biological approach to deciding when to begin Stop Mass Drug Administration activities.
Topics: Cost-Effectiveness Analysis; Health Facilities; Humans; Ivermectin; Mass Drug Administration; Onchocerciasis | 2023 |
Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study.
Topics: Adolescent; Adult; Child; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Nodding Syndrome; Onchocerciasis; Prevalence; Prospective Studies; South Sudan; Young Adult | 2023 |
Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of Cameroon.
Topics: Aged; Animals; Cameroon; COVID-19; Female; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Onchocerciasis; Pandemics; Prevalence | 2023 |
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin.
Topics: Adult; Animals; Cross-Sectional Studies; Epilepsy; Female; Ghana; Humans; Intestinal Volvulus; Ivermectin; Male; Mass Drug Administration; Microfilariae; Onchocerciasis; Prevalence; Seroepidemiologic Studies | 2023 |
Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
Topics: Africa; Humans; Ivermectin; Mass Drug Administration; Neglected Diseases; Onchocerciasis | 2023 |
Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cross-Sectional Studies; Female; Ghana; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Neglected Diseases; Onchocerciasis; Prevalence; Seroepidemiologic Studies; Young Adult | 2023 |
Cost of implementing a doxycycline test-and-treat strategy for onchocerciasis elimination among settled and semi-nomadic groups in Cameroon.
Topics: Cameroon; Doxycycline; Humans; Ivermectin; Onchocerciasis; Public Health | 2023 |
Potential mitigating role of ivermectin on the spread of Chlamydia trachomatis by Musca sorbens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Elephantiasis, Filarial; Humans; Ivermectin; Muscidae; Onchocerciasis; Trachoma | 2023 |
Real-Time Polymerase Chain Reaction Method for the Detection of Onchocerca volvulus in Post-Elimination Surveillance of Onchocerciasis in Ecuador.
Topics: Adult; Animals; Ecuador; Humans; Intestinal Volvulus; Ivermectin; Onchocerca; Onchocerca volvulus; Onchocerciasis; Real-Time Polymerase Chain Reaction; Simuliidae | 2023 |
Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
Topics: Animals; Child; Child, Preschool; Cross-Sectional Studies; Humans; Ivermectin; Mali; Mass Drug Administration; Onchocerciasis; Seroepidemiologic Studies; Simuliidae | 2023 |
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study.
Topics: Adult; Cross-Sectional Studies; Female; Ghana; Humans; Ivermectin; Male; Medication Adherence; Onchocerciasis; Persistent Infection | 2023 |
Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis.
Topics: Adult; Child; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis; Prevalence; Strongyloidiasis | 2024 |
Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo.
Topics: Adult; Community Medicine; Democratic Republic of the Congo; Female; Filaricides; Humans; Ivermectin; Male; Onchocerciasis; Retrospective Studies | 2019 |
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Topics: Animals; Anopheles; Humans; Ivermectin; Malaria; Mass Drug Administration; Onchocerciasis; Simuliidae | 2019 |
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Topics: Adolescent; Adult; Animals; Cameroon; Child; Cohort Studies; Endemic Diseases; Female; Humans; Ivermectin; Loa; Loiasis; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Young Adult | 2020 |
Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes.
Topics: Child; Humans; Infant; Ivermectin; Onchocerciasis; Scabies | 2020 |
Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Topics: Animals; Anthelmintics; Cameroon; Disease Eradication; Doxycycline; Feasibility Studies; Health Plan Implementation; Humans; Insecticides; Ivermectin; Loiasis; Onchocerca; Onchocerciasis; Patient Acceptance of Health Care; Prevalence; Public Health; Simuliidae; Temefos; World Health Organization | 2019 |
Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
Topics: Adult; Albendazole; Censuses; Chemoprevention; Elephantiasis, Filarial; Female; Filaricides; Helminthiasis; Humans; Ivermectin; Male; Mass Drug Administration; Neglected Diseases; Onchocerciasis; Sierra Leone; Surveys and Questionnaires | 2019 |
Untreated villages and factors associated with the absence of Community-Directed Treatment with Ivermectin (CDTI) in DRC.
Topics: Antiparasitic Agents; Attitude to Health; Community Health Services; Democratic Republic of the Congo; Endemic Diseases; Humans; Ivermectin; Onchocerciasis; Retrospective Studies; Rural Health | 2018 |
Post-elimination surveillance in formerly onchocerciasis endemic focus in Southern Mexico.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Disease Eradication; DNA, Helminth; Female; Humans; Infant; Ivermectin; Male; Mass Drug Administration; Mexico; Middle Aged; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Population Surveillance; Skin; Young Adult | 2020 |
The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.
Topics: Animals; Child; Child, Preschool; Emigration and Immigration; Ethiopia; Female; Humans; Ivermectin; Male; Mass Drug Administration; Onchocerca volvulus; Onchocerciasis; Simuliidae; Sudan | 2020 |
The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.
Topics: Albendazole; Anthelmintics; Drug Combinations; Humans; Ivermectin; Mass Drug Administration; Nigeria; Onchocerciasis; Retrospective Studies | 2020 |
Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria.
Topics: Elephantiasis, Filarial; Humans; Ivermectin; Mass Drug Administration; Nigeria; Onchocerciasis | 2020 |
Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.
Topics: Adolescent; Animals; Antiparasitic Agents; Child; Endemic Diseases; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Nodding Syndrome; Onchocerca volvulus; Onchocerciasis; Prevalence; Uganda; Young Adult | 2020 |
Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Elephantiasis, Filarial; Humans; Ivermectin; Mali; Middle Aged; Onchocerciasis; Seroepidemiologic Studies; Young Adult | 2021 |
Onchocerciasis dynamics: modelling the effects of treatment, education and vector control.
Topics: Animals; Basic Reproduction Number; Computer Simulation; Disease Vectors; Health Education; Insecticides; Ivermectin; Models, Biological; Numerical Analysis, Computer-Assisted; Onchocerciasis; Public Health; Reproducibility of Results | 2020 |
Biting rates and relative abundance of Simulium flies under different climatic conditions in an onchocerciasis endemic community in Ghana.
Topics: Animals; Antiparasitic Agents; Disease Vectors; Ghana; Humans; Insect Bites and Stings; Insect Vectors; Ivermectin; Neglected Diseases; Onchocerciasis; Rain; Seasons; Simuliidae; Temperature | 2020 |
Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.
Topics: Adolescent; Adult; Animals; Anthelmintics; Cameroon; Chemoprevention; Cohort Studies; Drug Administration Schedule; Humans; Ivermectin; Larva; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Randomized Controlled Trials as Topic; Young Adult | 2020 |
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle.
Topics: Animals; Antiparasitic Agents; Cameroon; Cattle; Cattle Diseases; Delayed-Action Preparations; Female; Injections; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Skin; Treatment Outcome | 2020 |
Designing antifilarial drug trials using clinical trial simulators.
Topics: Clinical Trial Protocols as Topic; Clinical Trials as Topic; Computer Simulation; Drug Evaluation; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Models, Biological; Onchocerciasis | 2020 |
Elimination of
Topics: Animals; Antiparasitic Agents; Brachyura; Disease Eradication; Humans; Ivermectin; Onchocerciasis; Simuliidae; Temefos; Uganda | 2020 |
Prevalence of onchocerciasis, attitudes and practices and the treatment coverage after 15 years of mass drug administration with ivermectin in the Tombel Health District, Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparasitic Agents; Cameroon; Child; Child, Preschool; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Young Adult | 2020 |
Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
Topics: Adolescent; Adult; Cross-Sectional Studies; Endemic Diseases; Ethiopia; Female; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Morbidity; Onchocerciasis; Prevalence; Program Evaluation; Young Adult | 2020 |
Prevalence of onchocerciasis after seven years of continuous community-directed treatment with ivermectin in the Ntui health district, Centre region, Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Child; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Young Adult | 2020 |
Assessing Hypoendemic Onchocerciasis in
Topics: Adult; Antibodies, Helminth; Antiparasitic Agents; Child; Child, Preschool; Disease Eradication; Endemic Diseases; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ivermectin; Local Government; Loiasis; Male; Mass Drug Administration; Middle Aged; Nigeria; Onchocerciasis; Prevalence | 2020 |
Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Albendazole; Ancylostomatoidea; Animals; Child; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Elephantiasis, Filarial; Female; Hookworm Infections; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Prevalence; Young Adult | 2020 |
Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulati
Topics: Adolescent; Animals; Antiparasitic Agents; Biopsy; Cameroon; Child; Child, Preschool; Female; Humans; Ivermectin; Male; Mass Drug Administration; Microscopy; Onchocerca volvulus; Onchocerciasis; Real-Time Polymerase Chain Reaction; Skin; Young Adult | 2020 |
Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Cameroon; Child; Child, Preschool; Cross-Sectional Studies; Endemic Diseases; Female; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Young Adult | 2020 |
Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
Topics: Animals; Feasibility Studies; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis; Prevalence | 2021 |
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
Topics: Adult; Cameroon; Child; Cross-Sectional Studies; Humans; Ivermectin; Mass Drug Administration; Onchocerciasis | 2021 |
The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
Topics: Animals; Antiparasitic Agents; Cameroon; Female; Humans; Insect Bites and Stings; Insect Vectors; Ivermectin; Lysosomal-Associated Membrane Protein 3; Mass Drug Administration; Onchocerca; Onchocerciasis; Real-Time Polymerase Chain Reaction; Rivers; Seasons; Simuliidae | 2021 |
What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
Topics: Communicable Disease Control; COVID-19; Disease Eradication; Filaricides; Humans; Ivermectin; Mass Drug Administration; Models, Theoretical; Neglected Diseases; Onchocerciasis; Pandemics; Prevalence; SARS-CoV-2 | 2021 |
Progress towards onchocerciasis elimination in Côte d'Ivoire: A geospatial modelling study.
Topics: Animals; Cote d'Ivoire; Humans; Ivermectin; Mass Drug Administration; Microfilariae; Onchocerciasis; Prevalence | 2021 |
Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
Topics: Animals; Benzimidazoles; Depsipeptides; Filaricides; Humans; Ivermectin; Larva; Leukocytes, Mononuclear; Macrolides; Onchocerca volvulus; Onchocerciasis | 2021 |
Status of Onchocerca volvulus infection and transmission by blackflies after 15 years of ivermectin distribution at Adani, Nigeria.
Topics: Animals; Female; Humans; Insect Bites and Stings; Insect Vectors; Ivermectin; Mass Drug Administration; Nigeria; Onchocerca volvulus; Onchocerciasis; Seasons; Simuliidae | 2020 |
In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epilepsy in Cameroon - A mixed methods study.
Topics: Adult; Cameroon; Cross-Sectional Studies; Epilepsy; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Socioeconomic Factors; Surveys and Questionnaires | 2021 |
The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Burkina Faso; Child; Child, Preschool; Drug Resistance; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Parasite Load; Parasitic Sensitivity Tests; Recurrence; Young Adult | 2021 |
COVID-19: The Ivermectin African Enigma.
Topics: Africa; Antiparasitic Agents; COVID-19; Humans; Ivermectin; Onchocerciasis | 2020 |
Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
Topics: Animals; Cameroon; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerciasis; Skin | 2021 |
Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making.
Topics: Africa; Decision Making; Humans; Ivermectin; Mass Drug Administration; Onchocerciasis | 2021 |
The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.
Topics: Animals; Antiparasitic Agents; Communicable Disease Control; Disease Eradication; Humans; Insect Bites and Stings; Ivermectin; Mass Drug Administration; Onchocerca; Onchocerciasis; Simuliidae | 2021 |
The World Health Organization road map for neglected tropical diseases 2021-2030: implications for onchocerciasis elimination programs.
Topics: Disease Eradication; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; South Sudan; World Health Organization | 2021 |
Eliminating onchocerciasis within the Meme River Basin of Cameroon: A social-ecological approach to understanding everyday realities and health systems.
Topics: Adolescent; Adult; Anthelmintics; Cameroon; Data Collection; Diethylcarbamazine; Disease Eradication; Ecosystem; Environmental Exposure; Female; Health Care Costs; Humans; Interviews as Topic; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Patient Acceptance of Health Care; Rivers; Socioeconomic Factors; Young Adult | 2021 |
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
Topics: Adolescent; Adult; Africa; Animals; Anthelmintics; Child; Child, Preschool; Eye Diseases; Female; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerca; Onchocerciasis; Skin Diseases; Young Adult | 2021 |
Single-Nucleotide Polymorphism Associates' β-Tubulin Isotype-1 Gene in Onchocerca volvulus Populations in Ivermectin-Treated Communities in Taraba State, Nigeria.
Topics: Animals; Humans; Ivermectin; Microfilariae; Nigeria; Onchocerca; Onchocerca volvulus; Onchocerciasis; Polymorphism, Single Nucleotide; Tubulin | 2022 |
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
Topics: Africa; Disease Eradication; Environment; Forecasting; Humans; Ivermectin; Mass Drug Administration; Onchocerciasis; ROC Curve | 2021 |
Skin snips have no role in programmatic evaluations for onchocerciasis elimination: a reply to Bottomley et al.
Topics: Drug Monitoring; Filaricides; Ivermectin; Mass Drug Administration; Onchocerciasis; Skin | 2017 |
Recognising the role of community-directed treatment and of women in the fight against NTDs.
Topics: Africa; Community Health Services; Female; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Professional Role; Tropical Medicine; Women | 2017 |
Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Nigeria; Onchocerciasis; Patient Compliance; Prevalence; Skin; Treatment Outcome; Young Adult | 2017 |
High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Antiparasitic Agents; Case-Control Studies; Child; Child, Preschool; Democratic Republic of the Congo; Demography; Endemic Diseases; Epilepsy; Family Characteristics; Female; Humans; Infant; Infant, Newborn; Ivermectin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Onchocerciasis; Prevalence; Prospective Studies; Risk Factors; Young Adult | 2017 |
Evaluation of Onchocerciasis Transmission in Tanzania: Preliminary Rapid Field Results in the Tukuyu Focus, 2015.
Topics: Adolescent; Anthelmintics; Child; Child, Preschool; Female; Humans; Infant; Ivermectin; Male; Onchocerciasis; Serologic Tests; Tanzania; Time Factors; Young Adult | 2017 |
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.
Topics: Animals; Antiparasitic Agents; Cameroon; Drug Resistance; Female; Gene Expression Profiling; Genetic Drift; Genetic Variation; Genotype; Ghana; High-Throughput Nucleotide Sequencing; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Quantitative Trait Loci | 2017 |
Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Topics: Adolescent; Adult; Animals; Cameroon; Child; Cross-Sectional Studies; Disease Eradication; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Public Health; Surveys and Questionnaires; Young Adult | 2017 |
Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Community Health Services; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Hygiene; Ivermectin; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Onchocerciasis; Program Evaluation; Simuliidae; Young Adult | 2017 |
Global programme to eliminate lymphatic filariasis: progress report, 2016.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Global Health; Humans; Ivermectin; Loiasis; Neglected Diseases; Onchocerciasis; Program Evaluation | 2017 |
Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela.
Topics: Animals; Antiparasitic Agents; Disease Eradication; Disease Vectors; Humans; Indians, South American; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Program Evaluation; Time Factors; Venezuela | 2017 |
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Blood; Cameroon; Child; Elephantiasis, Filarial; Endemic Diseases; Female; Humans; Ivermectin; Loa; Logistic Models; Loiasis; Male; Microfilariae; Microscopy, Video; Middle Aged; Onchocerciasis | 2017 |
Mass Administration of Ivermectin in Areas Where Loa loa Is Endemic.
Topics: Animals; Filaricides; Humans; Ivermectin; Loa; Mass Drug Administration; Onchocerciasis | 2017 |
Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
Topics: Cameroon; Community Health Services; Community Health Workers; Cross-Sectional Studies; Female; Filaricides; Humans; Ivermectin; Male; Onchocerciasis; Program Evaluation; Retrospective Studies; Surveys and Questionnaires | 2017 |
For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
Topics: Africa; Antiparasitic Agents; Disease Eradication; Drug Industry; Elephantiasis, Filarial; Global Health; Humans; Ivermectin; Latin America; Onchocerciasis | 2018 |
Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ivermectin; Loa; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Scabies; Strongyloides stercoralis | 2018 |
The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
Topics: Adolescent; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Elephantiasis, Filarial; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Uganda; Wuchereria bancrofti | 2017 |
Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Child; Child, Preschool; Cross-Sectional Studies; Elephantiasis, Filarial; Equatorial Guinea; Female; Geographic Mapping; Humans; Infection Control; Ivermectin; Male; Mansonella; Mansonelliasis; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Reproducibility of Results; Sensitivity and Specificity; Skin; Young Adult | 2018 |
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Topics: Africa South of the Sahara; Albendazole; Animals; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Onchocerca; Onchocerciasis; Wuchereria bancrofti | 2018 |
The blackfly vectors and transmission of Onchocerca volvulus in Mahenge, south eastern Tanzania.
Topics: Adult; Animals; Breeding; Female; Humans; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Rivers; Simuliidae; Tanzania | 2018 |
Progress toward elimination of onchocerciasis in the Americas.
Topics: Antiparasitic Agents; Disease Eradication; Humans; Ivermectin; Onchocerciasis; South America; United States | 2018 |
After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight.
Topics: Adult; Animals; Antiparasitic Agents; Disease Eradication; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Uganda | 2018 |
The role of the NGDO Coordination Group for the Elimination of Onchocerciasis.
Topics: Animals; Antiparasitic Agents; Disease Eradication; Humans; Internationality; Ivermectin; Onchocerciasis | 2018 |
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Topics: Africa, Central; Animals; Antiparasitic Agents; Cameroon; Disease Eradication; Elephantiasis, Filarial; Humans; Ivermectin; Loiasis; Onchocerciasis | 2018 |
Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
Topics: Africa; Animals; Antiparasitic Agents; Disease Eradication; Geographic Mapping; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; World Health Organization | 2018 |
Onchocerciasis in Yemen: moving forward towards an elimination program.
Topics: Adult; Antiparasitic Agents; Disease Eradication; Humans; Ivermectin; Onchocerciasis; Yemen | 2018 |
Alternative treatment strategies to accelerate the elimination of onchocerciasis.
Topics: Animals; Anthelmintics; Disease Eradication; Humans; Insect Control; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prevalence | 2018 |
Treating Onchocerciasis in Regions in Which Loa loa Is Endemic.
Topics: Animals; Endemic Diseases; Humans; Ivermectin; Loa; Onchocerciasis | 2018 |
Treating Onchocerciasis in Regions in Which Loa loa Is Endemic.
Topics: Animals; Endemic Diseases; Humans; Ivermectin; Loa; Onchocerciasis | 2018 |
Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antibodies, Helminth; Child; Child, Preschool; Cross-Sectional Studies; Endemic Diseases; Female; Humans; Immunoglobulin G; Infant; Infant, Newborn; Insect Vectors; Ivermectin; Male; Middle Aged; Multivariate Analysis; Onchocerca volvulus; Onchocerciasis; Seroepidemiologic Studies; Simuliidae; Yemen; Young Adult | 2018 |
Rethinking the serological threshold for onchocerciasis elimination.
Topics: Animals; Antibodies, Helminth; Disease Eradication; Humans; Ivermectin; Mass Drug Administration; Onchocerca volvulus; Onchocerciasis; Sample Size; World Health Organization | 2018 |
Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
Topics: Adult; Antiparasitic Agents; Child; Cross-Sectional Studies; Endemic Diseases; Epilepsy; Humans; Incidence; Ivermectin; Onchocerciasis; Prevalence; Public Health; Tanzania; Young Adult | 2018 |
Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Female; Filaricides; Humans; Infant; Ivermectin; Male; Mass Drug Administration; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Sierra Leone | 2018 |
Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
Topics: Animals; Antibodies, Helminth; Colombia; Disease Eradication; Disease Transmission, Infectious; Epidemiological Monitoring; Health Policy; Humans; Ivermectin; Mass Drug Administration; Onchocerca volvulus; Onchocerciasis; Simuliidae | 2018 |
Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa.
Topics: Animals; Burkina Faso; Cameroon; Cote d'Ivoire; Disease Eradication; Ghana; Humans; Insect Bites and Stings; Insect Control; Insect Vectors; Insecticides; Ivermectin; Models, Theoretical; Onchocerciasis; Population Dynamics; Simuliidae | 2018 |
How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
Topics: Animals; Antiparasitic Agents; Disease Eradication; Female; Humans; Insect Vectors; Insecticides; Ivermectin; Male; Mass Drug Administration; Microfilariae; Models, Theoretical; Onchocerciasis; Prevalence; Simuliidae | 2018 |
Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
Topics: Adolescent; Adult; Cameroon; Child; Community Health Services; Community Health Workers; Cross-Sectional Studies; Female; Filaricides; Humans; Ivermectin; Male; Medication Adherence; Middle Aged; Onchocerciasis; Young Adult | 2018 |
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Topics: Adolescent; Adult; Animals; Child; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Population; Tanzania; Young Adult | 2018 |
Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Topics: Adult; Animals; Antiparasitic Agents; Female; Forests; Ghana; Humans; Insect Vectors; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Simuliidae; Surveys and Questionnaires | 2018 |
Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Child; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Local Government; Male; Mass Drug Administration; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2018 |
Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Topics: Africa; Animals; Disease Eradication; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Public Health | 2018 |
Operational Performance of the
Topics: Animals; Antibodies, Helminth; Child; Disease Eradication; Enzyme-Linked Immunosorbent Assay; Global Health; Humans; Ivermectin; Mass Drug Administration; Onchocerca volvulus; Onchocerciasis; Seroepidemiologic Studies; Time Factors | 2018 |
Diagnosing risk factors alongside mass drug administration using serial diagnostic tests-which test first?
Topics: Algorithms; Animals; Coinfection; Cost-Benefit Analysis; Decision Making; Diagnostic Tests, Routine; Female; Humans; Ivermectin; Loa; Loiasis; Mass Drug Administration; Microfilariae; Onchocerca; Onchocerciasis; Population Health; Pregnancy; Prevalence; Risk Factors | 2018 |
Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
Topics: Adolescent; Animals; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; Infant; Ivermectin; Male; Mass Drug Administration; Onchocerca; Onchocerciasis; Prevalence; Rural Population; Sarcoptes scabiei; Scabies; Tanzania; Wuchereria bancrofti | 2018 |
Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.
Topics: Animals; Community Participation; Humans; Insect Control; Insect Vectors; Ivermectin; Mass Drug Administration; Neglected Diseases; Onchocerca volvulus; Onchocerciasis; Simuliidae; Time Factors; Uganda | 2018 |
Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report.
Topics: Aged; Antiparasitic Agents; Cameroon; Drug Eruptions; Humans; Ivermectin; Male; Onchocerciasis | 2018 |
Onchocerciasis-Associated Epilepsy with Head Nodding Seizures-Nodding Syndrome: A Case Series of 15 Patients from Western Uganda, 1994.
Topics: Adolescent; Antiparasitic Agents; Child; Child, Preschool; Cohort Studies; Disease Eradication; Female; Humans; Ivermectin; Male; Nodding Syndrome; Onchocerciasis; Prevalence; Research Design; Uganda | 2018 |
Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Child; Cross-Sectional Studies; Elephantiasis, Filarial; Female; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Prevalence; Treatment Outcome; Young Adult | 2018 |
The foundations for a global elimination programme for onchocerciasis.
Topics: Animals; Cameroon; Filaricides; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2018 |
Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.
Topics: Adult; Animals; Antigens, Helminth; Antiparasitic Agents; Computational Biology; Cross-Sectional Studies; Endemic Diseases; Epidemiological Monitoring; Escherichia coli; Female; Humans; Immunity, Humoral; Immunoglobulin E; Immunoglobulin G; Ivermectin; Male; Neglected Diseases; Onchocerca volvulus; Onchocerciasis; Protein Domains; Recombinant Proteins; Young Adult | 2018 |
Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cote d'Ivoire; Disease Transmission, Infectious; Elephantiasis, Filarial; Endemic Diseases; Epidemiologic Studies; Female; Filaricides; Humans; Insect Control; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Young Adult | 2018 |
Continuous and pulsed epidemiological models for onchocerciasis with implications for eradication strategy.
Topics: Africa South of the Sahara; Animals; Computer Simulation; Drug Administration Schedule; Endemic Diseases; Filaricides; Humans; Insect Vectors; Ivermectin; Mathematical Concepts; Microfilariae; Models, Biological; Nonlinear Dynamics; Onchocerca; Onchocerciasis; Simuliidae; Software | 2018 |
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Topics: Adolescent; Antiparasitic Agents; Child; Child, Preschool; Endemic Diseases; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Nodding Syndrome; Onchocerciasis; Prevalence; Public Health; South Sudan | 2018 |
High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey.
Topics: Adolescent; Adult; Antiparasitic Agents; Child; Child, Preschool; Endemic Diseases; Epilepsy; Female; Geography, Medical; Humans; Incidence; Infant; Infant, Newborn; Ivermectin; Male; Onchocerciasis; Prevalence; Risk Factors; Rivers; South Sudan; Young Adult | 2018 |
Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Topics: Adolescent; Adult; Antiparasitic Agents; Cameroon; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Retrospective Studies; Rivers; Young Adult | 2018 |
Entomological assessment of the transmission following recrudescence of onchocerciasis in the Comoé Valley, Burkina Faso.
Topics: Animals; Burkina Faso; Communicable Disease Control; Disease Transmission, Infectious; Humans; Insect Vectors; Insecticides; Ivermectin; Larva; Onchocerca volvulus; Onchocerciasis; Prevalence; Recurrence; Simuliidae | 2019 |
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models.
Topics: Administration, Oral; Animals; Brugia malayi; Disease Models, Animal; Filaricides; Ivermectin; Male; Mebendazole; Mice; Mice, Inbred BALB C; Mice, SCID; Microfilariae; Onchocerca; Onchocerciasis; Parasite Load | 2019 |
Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparasitic Agents; Child; Child, Preschool; Cross-Sectional Studies; Epilepsy; Female; Humans; Infant; Infant, Newborn; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Young Adult | 2019 |
Onchocerciasis associated epilepsy-A question of causality.
Topics: Democratic Republic of the Congo; Epilepsy; Humans; Ivermectin; Onchocerciasis; Prevalence | 2019 |
High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Case-Control Studies; Child; Child, Preschool; Democratic Republic of the Congo; Epilepsy; Female; Focus Groups; Humans; Immunoglobulin G; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Population; Seizures; Young Adult | 2019 |
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
Topics: Adolescent; Adult; Antinematodal Agents; Cameroon; Child; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Mass Drug Administration; Onchocerciasis; Prevalence; Young Adult | 2019 |
Comparison of Reported and Survey-Based Coverage in Onchocerciasis Programs over a Period of 8 Years in Cameroon and Uganda.
Topics: Adult; Cameroon; Endemic Diseases; Female; Filaricides; Geography; Humans; Ivermectin; Male; Mass Drug Administration; Onchocerciasis; Surveys and Questionnaires; Uganda | 2019 |
Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Blindness; Cross-Sectional Studies; Endemic Diseases; Female; Ghana; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Middle Aged; Onchocerciasis; Prevalence | 2019 |
Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders' views.
Topics: Africa South of the Sahara; Animals; Antiparasitic Agents; Cameroon; Community Health Services; Community Health Workers; Cost of Illness; Evaluation Studies as Topic; Female; Filaricides; Focus Groups; Health Plan Implementation; Humans; Infection Control; Ivermectin; Male; Onchocerciasis; Program Evaluation; Stakeholder Participation; Surveys and Questionnaires | 2019 |
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
Topics: Animals; Cameroon; Costs and Cost Analysis; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis | 2020 |
Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa.
Topics: Africa; Child; Child, Preschool; Endemic Diseases; Female; Humans; Ivermectin; Male; Observation; Onchocerciasis; Surveys and Questionnaires | 2020 |
Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
Topics: Africa; Animals; Coinfection; Humans; Ivermectin; Loa; Loiasis; Onchocerciasis | 2020 |
Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Child; Child, Preschool; Cross-Sectional Studies; Democratic Republic of the Congo; Endemic Diseases; Epilepsy; Female; Humans; Infant; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Qualitative Research; Randomized Controlled Trials as Topic; Seizures; Severity of Illness Index; Young Adult | 2019 |
From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Topics: Antiparasitic Agents; Blindness; Cost of Illness; Disease Eradication; Epilepsy; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Onchocerciasis, Ocular; Rivers | 2019 |
The disappearance of onchocerciasis from the Itwara focus, western Uganda after elimination of the vector Simulium neavei and 19 years of annual ivermectin treatments.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Child; Child, Preschool; Disease Eradication; Disease Vectors; Humans; Infant; Insecticides; Ivermectin; Onchocerca; Onchocerciasis; Simuliidae; Skin; Temefos; Uganda | 2013 |
Time series analysis of onchocerciasis data from Mexico: a trend towards elimination.
Topics: Anthelmintics; Disease Eradication; Endemic Diseases; Humans; Incidence; Ivermectin; Mexico; Onchocerciasis; Prevalence | 2013 |
Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
Topics: Adult; Aged; Animals; Anthelmintics; Cameroon; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Parasite Load; Skin | 2013 |
Extracts of Euphorbia hirta Linn. (Euphorbiaceae) and Rauvolfia vomitoria Afzel (Apocynaceae) demonstrate activities against Onchocerca volvulus microfilariae in vitro.
Topics: Animals; Antinematodal Agents; Cell Line; Drug Resistance; Euphorbia; Haplorhini; Ivermectin; Kidney; Microfilariae; Onchocerca volvulus; Onchocerciasis; Phytotherapy; Plant Extracts; Rauwolfia | 2013 |
Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México.
Topics: Animals; Anthelmintics; Child; Child, Preschool; DNA, Helminth; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Ivermectin; Male; Mexico; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Simuliidae | 2013 |
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae.
Topics: Adolescent; Adult; Africa; Animals; Antiparasitic Agents; Child; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Skin; Young Adult | 2013 |
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
Topics: Antiparasitic Agents; Female; Humans; Ivermectin; Male; Models, Theoretical; Onchocerciasis; Treatment Outcome | 2013 |
Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan.
Topics: Animals; Antigens, Helminth; Antiparasitic Agents; Child; Disease Eradication; Enzyme-Linked Immunosorbent Assay; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Prevalence; Seroepidemiologic Studies; Simuliidae; Sudan | 2013 |
Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin.
Topics: Adult; Animals; Antiparasitic Agents; Brachyura; Child; Drug Administration Schedule; Humans; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Simuliidae; Uganda | 2013 |
Scientists celebrate successes, new tools in fight against human parasitic worms.
Topics: Africa; Antiparasitic Agents; Blindness; Elephantiasis, Filarial; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Skin Diseases; Sudan | 2013 |
[The effect of ivermectin on geohelminth frequency (i.e. as used in the onchocerciasis control program in Colombia)].
Topics: Adolescent; Adult; Aged; Antiparasitic Agents; Child; Child, Preschool; Colombia; Female; Humans; Infant; Ivermectin; Longitudinal Studies; Male; Middle Aged; National Health Programs; Onchocerciasis; Program Evaluation; Young Adult | 2012 |
The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
Topics: Antiparasitic Agents; Costs and Cost Analysis; Drug Therapy; Ghana; Humans; Ivermectin; Onchocerciasis; Time Factors | 2013 |
Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Cameroon; Diptera; Female; Humans; Insecticides; Ivermectin; Larva; Loa; Loiasis; Male; Middle Aged; Onchocerciasis; Parasite Load; Young Adult | 2013 |
African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2013.
Topics: Africa; Community Health Workers; Community Networks; Endemic Diseases; Filaricides; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular | 2013 |
Interruption of Onchocerca volvulus transmission in Northern Venezuela.
Topics: Adolescent; Animals; Anthelmintics; Child; Child, Preschool; Communicable Disease Control; Female; Head; Humans; Infant; Infant, Newborn; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Simuliidae; Venezuela | 2013 |
Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antiparasitic Agents; Cohort Studies; Cytokines; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca; Onchocerciasis; Parasite Load; Young Adult | 2014 |
Assessment of community's knowledge, attitude and practice about onchocerciasis and community directed treatment with Ivermectin in Quara District, north western Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cross-Sectional Studies; Demography; Endemic Diseases; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Onchocerca; Onchocerciasis; Residence Characteristics; Young Adult | 2014 |
Late-onset onchocercal skin disease among Ethiopian immigrants.
Topics: Adolescent; Adult; Antiparasitic Agents; Child; Dermatitis, Atopic; Emigrants and Immigrants; Ethiopia; Female; Humans; Israel; Ivermectin; Male; Middle Aged; Onchocerciasis; Pruritus; Retrospective Studies; Young Adult | 2014 |
Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted.
Topics: Adolescent; Animals; Antibodies, Helminth; Antiparasitic Agents; Brachyura; Child; Child, Preschool; Humans; Infant; Insect Vectors; Ivermectin; Larva; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; Prevalence; Simuliidae; Uganda | 2014 |
Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
Topics: Adult; Animals; Anthelmintics; Cameroon; Embryonic Development; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Reproduction | 2014 |
[Elimination or control of the onchocerciasis in Africa? Case of Gami village in Central African Republic].
Topics: Adolescent; Adult; Africa; Antiparasitic Agents; Central African Republic; Child; Child, Preschool; Cities; Communicable Disease Control; Cross-Sectional Studies; Disease Eradication; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Rivers; Young Adult | 2014 |
Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
Topics: Adolescent; Animals; Antibodies, Helminth; Child; Child, Preschool; Ecuador; Filaricides; Humans; Infant; Infant, Newborn; Insect Vectors; Ivermectin; Onchocerciasis; Preventive Health Services; Simuliidae | 2014 |
Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Topics: Africa; Anthelmintics; Disease Eradication; Health Care Costs; Humans; Ivermectin; Neglected Diseases; Onchocerciasis | 2014 |
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
Topics: Africa; Animals; Diptera; Disease Vectors; Epidemiologic Methods; Filaricides; Humans; Ivermectin; Onchocerciasis | 2014 |
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
Topics: Africa; Animals; Diptera; Disease Vectors; Endemic Diseases; Epidemiologic Methods; Filaricides; Humans; Ivermectin; Onchocerciasis; Prevalence | 2014 |
Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antibodies; Antiparasitic Agents; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Seroepidemiologic Studies; Simuliidae; Young Adult | 2014 |
Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.
Topics: Antiparasitic Agents; Community Health Services; Democratic Republic of the Congo; Health Personnel; Humans; Ivermectin; Onchocerciasis; Retrospective Studies; Treatment Outcome | 2015 |
African Programme for Onchocerciasis Control: progress report, 2013-2014.
Topics: Africa; Antiparasitic Agents; Disease Eradication; Geographic Mapping; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Program Evaluation | 2014 |
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
Topics: Africa; Animals; Computer Simulation; Disease Eradication; Humans; Ivermectin; Models, Biological; Onchocerca volvulus; Onchocerciasis; Probability; Skin; Time Factors; Treatment Outcome | 2014 |
Factors affecting community participation in the CDTI program in Morogoro, Tanzania.
Topics: Adult; Antiparasitic Agents; Community Health Services; Female; Focus Groups; Health Care Surveys; Health Education; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Ivermectin; Male; Middle Aged; Needs Assessment; Onchocerciasis; Program Evaluation; Qualitative Research; Tanzania; Young Adult | 2015 |
Assessments of the transmission of Onchocerca volvulus by Simulium sanctipauli in the Upper Denkyira District, Ghana, and the intermittent disappearance of the vector.
Topics: Animals; Breeding; Female; Geography; Ghana; Humans; Insect Vectors; Insecticides; Ivermectin; Larva; Onchocerca volvulus; Onchocerciasis; Rivers; Simuliidae | 2015 |
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Auranofin; Brugia malayi; Cattle; Cell Line; Diethylcarbamazine; Drug Repositioning; Elephantiasis, Filarial; Female; Filaricides; Gerbillinae; Haplorhini; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerca volvulus; Onchocerciasis | 2015 |
Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Child, Preschool; Coinfection; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Nigeria; Onchocerca volvulus; Onchocerciasis; Prevalence; Public Health; Rainforest; Young Adult | 2015 |
Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes.
Topics: Adult; Animals; Cote d'Ivoire; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Prevalence; Real-Time Polymerase Chain Reaction; Skin | 2015 |
Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
Topics: Animals; Cameroon; Disease Transmission, Infectious; Feeding Behavior; Humans; Insecticides; Ivermectin; Onchocerca; Onchocerciasis; Prevalence; Rainforest; Simuliidae | 2015 |
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.
Topics: Africa South of the Sahara; Anthelmintics; Clinical Trials, Phase II as Topic; Health Care Costs; Humans; Ivermectin; Macrolides; Models, Biological; Models, Economic; Onchocerciasis; Patient Compliance; Population Surveillance | 2015 |
Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia.
Topics: Anthelmintics; Cross-Sectional Studies; Ethiopia; Ivermectin; Medication Adherence; Onchocerciasis; Patient Acceptance of Health Care; Random Allocation; Surveys and Questionnaires | 2015 |
Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.
Topics: Animals; DNA Primers; Epidemiological Monitoring; Filaricides; Ghana; Humans; Insect Vectors; Ivermectin; Larva; Onchocerca; Onchocerciasis; Population Dynamics; Seasons; Simuliidae | 2015 |
[Knowledge, attitudes and practices of the population of SAMBWA health area in relation to the treatment of onchocerciasis with ivermectin under community directives].
Topics: Adolescent; Adult; Aged; Community Networks; Democratic Republic of the Congo; Health Education; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Middle Aged; Onchocerciasis; Residence Characteristics; Young Adult | 2014 |
Case report of an epidural cervical Onchocerca lupi infection in a 13-year-old boy.
Topics: Adolescent; Arnold-Chiari Malformation; Cervical Vertebrae; Craniotomy; Doxycycline; Filaricides; Humans; Ivermectin; Laminectomy; Magnetic Resonance Imaging; Male; Onchocerciasis; Spinal Cord Compression | 2015 |
Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
Topics: Africa; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Disease Eradication; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2015 |
A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
Topics: Adolescent; Adult; Age Factors; Animals; Awareness; Cross-Sectional Studies; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Neglected Diseases; Onchocerca volvulus; Onchocerciasis; Prevalence; Residence Characteristics; Rural Population; Sex Factors; Socioeconomic Factors; Young Adult | 2015 |
Community-directed interventions are practical and effective in low-resource communities: experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004-2010.
Topics: Cameroon; Community Health Services; Community Health Workers; Community Participation; Decision Making; Family Characteristics; Filaricides; Humans; Ivermectin; Onchocerciasis; Uganda | 2016 |
Elimination of Onchocerciasis from Mexico.
Topics: Animals; Anthelmintics; Female; Humans; Insect Vectors; Ivermectin; Male; Mexico; Onchocerca volvulus; Onchocerciasis; Simuliidae | 2015 |
Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthelmintics; Child; Child, Preschool; Female; Humans; Infant; Ivermectin; Male; Middle Aged; Models, Biological; Onchocerciasis; Risk Factors; Sex Factors; Time Factors; Vaccination; Vaccines; Young Adult | 2015 |
From 'control to elimination': a strategic change to win the end game.
Topics: Africa; Communicable Disease Control; Disease Eradication; Humans; Ivermectin; Onchocerciasis | 2015 |
Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Topics: Africa South of the Sahara; Animals; Communicable Disease Control; Disease Eradication; Disease Transmission, Infectious; Epidemiological Monitoring; Filaricides; Health Care Costs; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Simuliidae | 2015 |
African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
Topics: Africa; Antiparasitic Agents; Disease Transmission, Infectious; Helminthiasis; Humans; Intestinal Diseases, Parasitic; Ivermectin; Onchocerciasis; Prevalence; Scabies | 2015 |
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
Topics: Africa; Disease Eradication; Drug Therapy; Filaricides; Ivermectin; Models, Theoretical; Onchocerciasis; Time Factors | 2015 |
Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico.
Topics: Antiparasitic Agents; Disease Eradication; Endemic Diseases; Guidelines as Topic; Humans; Ivermectin; Mexico; Onchocerciasis; World Health Organization | 2015 |
One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.
Topics: Animals; Child, Preschool; Disease Eradication; Eye; Female; Filaricides; Guatemala; Humans; Insect Control; Insect Vectors; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Simuliidae; Skin | 2015 |
Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Ascariasis; Child; Child, Preschool; Drug Therapy; Ecuador; Female; Hookworm Infections; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Retrospective Studies; Strongyloides stercoralis; Strongyloidiasis; Trichuriasis; Young Adult | 2015 |
African Programme for Onchocerciasis Control: progress report, 2014–2015.
Topics: Africa; Antinematodal Agents; Disease Eradication; Geographic Mapping; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Program Evaluation | 2015 |
Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
Topics: Animals; Anthelmintics; Cameroon; Humans; Ivermectin; Medication Adherence; Onchocerca volvulus; Onchocerciasis; Prevalence; Skin; Surveys and Questionnaires | 2015 |
Aberrant laryngeal location of Onchocerca lupi in a dog.
Topics: Animals; Antiparasitic Agents; Dog Diseases; Dogs; Female; Ivermectin; Laryngeal Diseases; Larynx; Onchocerca; Onchocerciasis; Portugal; Prednisolone | 2016 |
Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus.
Topics: Animals; Child, Preschool; Female; Geography; Humans; Infant; Insect Vectors; Insecticides; Ivermectin; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; Prevalence; Seasons; Simuliidae; Venezuela | 2016 |
Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Antiparasitic Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Utilization; Elephantiasis, Filarial; Endemic Diseases; Ethiopia; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Prevalence; Sex Distribution; Wuchereria bancrofti | 2015 |
Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
Topics: Animals; Anthelmintics; Cameroon; Cattle; Cattle Diseases; Humans; Insect Vectors; Insecticides; Ivermectin; Onchocerca volvulus; Onchocerciasis; Rivers; Rural Population; Simuliidae | 2016 |
THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?.
Topics: Adult; Africa South of the Sahara; Animals; Anthelmintics; Camelus; Female; Humans; Insect Vectors; Ivermectin; Neglected Diseases; Onchocerciasis; Simuliidae | 2015 |
DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
Topics: Antiparasitic Agents; Humans; Ivermectin; Nigeria; Onchocerciasis; Time Factors | 2015 |
Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cross-Sectional Studies; Ethiopia; Female; Humans; Infectious Disease Medicine; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Public Health; Skin; Surveys and Questionnaires; Young Adult | 2016 |
Onchocerciasis Presenting as a Breast Mass.
Topics: Aged; Antiparasitic Agents; Biopsy, Large-Core Needle; Breast Diseases; Doxycycline; Humans; Ivermectin; Male; Onchocerciasis; Ultrasonography, Mammary | 2016 |
Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Community Health Services; Endemic Diseases; Ethiopia; Female; Health Knowledge, Attitudes, Practice; Humans; Insect Vectors; Ivermectin; Logistic Models; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Public Health; Simuliidae; Young Adult | 2016 |
Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo.
Topics: Adolescent; Adult; Age Distribution; Animals; Child; Child, Preschool; Democratic Republic of the Congo; Endemic Diseases; Epilepsy; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Neglected Diseases; Onchocerca volvulus; Onchocerciasis; Prevalence; Risk Factors; Rivers; Simuliidae; Young Adult | 2016 |
Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Topics: Adolescent; Adult; Animals; Case-Control Studies; Child; Child, Preschool; Democratic Republic of the Congo; Epilepsy; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Risk Factors; Simuliidae; Young Adult | 2016 |
The Imaramagambo Onchocerciasis Focus in Southwestern Uganda: Interruption of Transmission After Disappearance of the Vector Simulium neavei and Its Associated Freshwater Crabs.
Topics: Adult; Animals; Anthelmintics; Brachyura; Disease Eradication; Epidemiological Monitoring; Fresh Water; Humans; Incidence; Insect Vectors; Ivermectin; Larva; Onchocerca volvulus; Onchocerciasis; Simuliidae; Uganda | 2016 |
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
Topics: Animals; Cameroon; Female; Ghana; Guatemala; Humans; Ivermectin; Neglected Diseases; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Sensitivity and Specificity; Skin; Venezuela | 2016 |
A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.
Topics: Adult; Antiparasitic Agents; Female; Guatemala; Health Education; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Ivermectin; Male; Onchocerciasis; Surveys and Questionnaires | 2016 |
Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Topics: Africa South of the Sahara; Animals; Bayes Theorem; Community Health Services; Filaricides; Ivermectin; Microfilariae; Monte Carlo Method; Onchocerca volvulus; Onchocerciasis; Prevalence | 2016 |
The First Confirmed Elimination of an Onchocerciasis Focus in Africa: Abu Hamed, Sudan.
Topics: Animals; Carrier Proteins; Child; Communicable Disease Control; DNA, Helminth; Helminth Proteins; Humans; Immunoglobulin G; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Simuliidae; Sudan | 2016 |
Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Topics: Animals; Cricetinae; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Ivermectin; Loa; Male; Mice; Mice, Inbred BALB C; Onchocerca; Onchocerciasis | 2016 |
Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Cameroon; Child; Child, Preschool; Community Health Services; Disease Eradication; Female; Filaricides; Humans; Ivermectin; Male; Medication Adherence; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Surveys and Questionnaires; Young Adult | 2016 |
Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Child; Child, Preschool; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Equatorial Guinea; Family Characteristics; Female; Humans; Immunoglobulin G; Insect Vectors; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Seroepidemiologic Studies; Simuliidae; Young Adult | 2016 |
Excess mortality associated with loiasis: a retrospective population-based cohort study.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Middle Aged; Onchocerciasis; Prevalence; Retrospective Studies | 2017 |
Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
Topics: Americas; Animals; Disease Eradication; Female; Filaricides; Guatemala; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Program Evaluation | 2016 |
Subcutaneous Nodules and Pruritus Years After Short Trips in Sub-Saharan Africa.
Topics: Adult; Africa South of the Sahara; Female; Humans; Ivermectin; Onchocerciasis; Pruritus; Skin Diseases; Travel | 2016 |
Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Cameroon; Child; Cross-Sectional Studies; Endemic Diseases; Female; Humans; Ivermectin; Male; Medication Adherence; Middle Aged; Onchocerca; Onchocerciasis; Parasite Load; Treatment Outcome; Young Adult | 2016 |
Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
Topics: Animals; Antiparasitic Agents; Burkina Faso; Disease Outbreaks; Elephantiasis, Filarial; Environment; Humans; Infection Control; Insect Vectors; Ivermectin; Microfilariae; Onchocerciasis; Prevalence; Recurrence | 2017 |
Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Helminth; Child; Child, Preschool; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Senegal; Treatment Outcome; Young Adult | 2016 |
Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding.
Topics: Animals; Antiparasitic Agents; Child; Humans; Insect Control; Insect Vectors; Insecticides; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Simuliidae; Temefos; Uganda | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis | 2017 |
Vector competence of Simulium oyapockense s.l. and S. incrustatum for Onchocerca volvulus: Implications for ivermectin-based control in the Amazonian focus of human onchocerciasis, a multi-vector-host system.
Topics: Animals; Antiparasitic Agents; Behavior, Animal; Feeding Behavior; Host-Parasite Interactions; Humans; Insect Vectors; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Simuliidae; Venezuela | 2008 |
After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Topics: Adolescent; Adult; Animals; Cameroon; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Endemic Diseases; Female; Filaricides; Humans; Infant; Ivermectin; Male; Onchocerciasis; Sentinel Surveillance; Treatment Outcome; Uganda | 2008 |
Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.
Topics: Animals; Drug Administration Schedule; Filaricides; Humans; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis; Skin | 2008 |
Vision 2020 - the right to sight.
Topics: Blindness; Delivery of Health Care; Developing Countries; Eye Diseases; Filaricides; Humans; International Agencies; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Trachoma | 2008 |
The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.
Topics: Developing Countries; Drug Industry; Filaricides; Gift Giving; Humans; International Cooperation; Ivermectin; Onchocerciasis; Program Evaluation | 2008 |
The Onchocerciasis Control Programme in West Africa (OCP).
Topics: Africa, Western; Animals; Developing Countries; Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Simuliidae | 2008 |
The African Programme for Onchocerciasis Control (APOC).
Topics: Africa; Community Health Services; Developing Countries; Filaricides; Humans; Ivermectin; Onchocerciasis | 2008 |
Special intervention zones.
Topics: Africa, Western; Animals; Developing Countries; Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Simuliidae | 2008 |
The Onchocerciasis Elimination Program for the Americas (OEPA).
Topics: Americas; Animals; Developing Countries; Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Pan American Health Organization; Simuliidae | 2008 |
The World Bank.
Topics: Africa; Animals; Delivery of Health Care; Developing Countries; Filaricides; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; United Nations | 2008 |
The NGDO Co-ordination Group for Onchocerciasis Control.
Topics: Africa; Community Health Services; Developing Countries; Filaricides; Humans; International Agencies; Ivermectin; Latin America; Onchocerciasis | 2008 |
The Mectizan Donation Program (MDP).
Topics: Africa; Americas; Community Health Services; Developing Countries; Drug Industry; Filaricides; Gift Giving; Humans; International Cooperation; Ivermectin; Onchocerciasis; Program Evaluation | 2008 |
African Programme for Onchocerciasis Control--report on task force meeting, July 2008.
Topics: Africa; Filaricides; Humans; Ivermectin; Onchocerciasis | 2008 |
Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control.
Topics: Animals; Antiparasitic Agents; Cooperative Behavior; Goals; Humans; Infection Control; Ivermectin; Onchocerca; Onchocerciasis; Primary Health Care; Socioeconomic Factors | 2008 |
Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
Topics: Animals; Anthelmintics; Child; Communicable Disease Control; Developing Countries; Female; Guatemala; Humans; Insect Vectors; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Simuliidae | 2009 |
Community directed interventions for malaria, tuberculosis and vitamin A in onchocerciasis endemic districts of Tanzania.
Topics: Adult; Antitubercular Agents; Child, Preschool; Community Networks; Dietary Supplements; Directly Observed Therapy; Endemic Diseases; Female; Humans; Infant; Insecticides; Ivermectin; Malaria; Male; Onchocerciasis; Pregnancy; Program Evaluation; Prospective Studies; Protective Clothing; Tanzania; Tuberculosis; Vitamin A; Vitamin A Deficiency; Young Adult | 2008 |
Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Endemic Diseases; Female; Humans; Ivermectin; Loiasis; Male; Middle Aged; National Health Programs; Nigeria; Onchocerciasis; Retrospective Studies; Young Adult | 2008 |
Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities.
Topics: Adolescent; Adult; Antimalarials; Child; Community Health Services; Female; Humans; Ivermectin; Malaria; Onchocerciasis; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Uganda; Young Adult | 2009 |
Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
Topics: Animals; Antiparasitic Agents; Breeding; Female; Humans; Insect Bites and Stings; Insect Vectors; Ivermectin; Nigeria; Onchocerca volvulus; Onchocerciasis; Simuliidae | 2008 |
Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.
Topics: Adolescent; Adult; Aged; Antinematodal Agents; Cross-Sectional Studies; Female; Humans; Incidence; Ivermectin; Loiasis; Male; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Rural Population; Young Adult | 2008 |
Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
Topics: Adolescent; Adult; Antiparasitic Agents; Brazil; Child; Child, Preschool; Female; Humans; Ivermectin; Longitudinal Studies; Male; Middle Aged; Onchocerciasis; Prevalence; Young Adult | 2009 |
Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.
Topics: Africa; Animals; Antiparasitic Agents; Female; Humans; Insect Control; Ivermectin; Onchocerciasis; Simuliidae | 2009 |
Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Topics: Adult; Animals; DNA, Helminth; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Longitudinal Studies; Male; Mali; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Prevalence; Senegal; Simuliidae; Young Adult | 2009 |
Exposure of seasonal migrant workers to Onchocerca volvulus on coffee plantations in Guatemala.
Topics: Adolescent; Adult; Agriculture; Animals; Anthelmintics; Coffee; Female; Guatemala; Humans; Ivermectin; Male; Occupational Exposure; Onchocerca volvulus; Onchocerciasis; Pilot Projects; Population Surveillance; Seasons; Transients and Migrants; Young Adult | 2009 |
An 18S ribosomal DNA barcode for the study of Isomermis lairdi, a parasite of the blackfly Simulium damnosum s.l.
Topics: Animals; Antiparasitic Agents; DNA, Ribosomal; Drug Resistance; Filaricides; Gene Amplification; Ghana; Humans; Ivermectin; Mermithoidea; Onchocerciasis; Phylogeny; Polymerase Chain Reaction; Predatory Behavior; RNA, Ribosomal, 18S; Simuliidae | 2009 |
Sustainability of ivermectin distribution programmes.
Topics: Africa; Antiparasitic Agents; Drug Costs; Financing, Government; Health Planning Support; Humans; Ivermectin; Onchocerciasis; Organizations; United Nations | 2009 |
Head nodding syndrome and river blindness: a parasitologic perspective.
Topics: Africa South of the Sahara; Animals; Antibodies, Helminth; Antiparasitic Agents; Cerebrospinal Fluid; Humans; Infant; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Spasms, Infantile; Syndrome | 2009 |
Picture this...Onchocerciasis.
Topics: Africa South of the Sahara; Animals; Filaricides; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Simuliidae | 2009 |
Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Topics: Africa; Animals; Communicable Disease Control; Endemic Diseases; Female; Filaricides; Humans; Insect Bites and Stings; Ivermectin; Models, Statistical; Onchocerca volvulus; Onchocerciasis | 2010 |
Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions--a comparison of Cameroon and Uganda experiences over a period of three years (2004-2006).
Topics: Cameroon; Community Health Services; Community Health Workers; Delivery of Health Care, Integrated; Drug Utilization; Filaricides; Humans; Ivermectin; Onchocerciasis; Uganda | 2010 |
African Programme for Onchocerciasis Control - report of the sixth meeting of National Task Forces, October 2009.
Topics: Africa; Filaricides; Humans; Ivermectin; Onchocerciasis | 2010 |
Traditional kinship system enhanced classic community-directed treatment with ivermectin (CDTI) for onchocerciasis control in Uganda.
Topics: Adult; Antiparasitic Agents; Community Health Services; Decision Making; Delivery of Health Care; Family Characteristics; Female; Health Education; Humans; Interpersonal Relations; Ivermectin; Male; Onchocerciasis; Program Evaluation; Rural Health Services; Surveys and Questionnaires; Uganda | 2010 |
Does onchocerciasis transmission take place in hypoendemic areas? a study from the North Region of Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antinematodal Agents; Cameroon; Child; Developing Countries; Endemic Diseases; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca; Onchocerciasis; Young Adult | 2010 |
Transforming growth factor-beta expression by host cells is elicited locally by the filarial nematode Onchocerca volvulus in hyporeactive patients independently from Wolbachia.
Topics: Animals; Anti-Bacterial Agents; Antiparasitic Agents; Doxycycline; Endothelium; Female; HIV Infections; Host-Parasite Interactions; Humans; Ivermectin; Lymphocytes; Macrophages; Male; Mast Cells; Onchocerca volvulus; Onchocerciasis; Rickettsiaceae Infections; Transforming Growth Factor beta; Wolbachia | 2010 |
Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Topics: Animals; Democratic Republic of the Congo; Endemic Diseases; Epidemiologic Methods; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Onchocerca; Onchocerciasis; Prevalence; Time Factors | 2011 |
The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors.
Topics: Administration, Oral; Aedes; Africa; Animals; Anopheles; Anthelmintics; Culicidae; Disease Models, Animal; Feeding Behavior; Female; Host-Parasite Interactions; Humans; Insect Vectors; Ivermectin; Malaria; Mosquito Control; Onchocerca volvulus; Onchocerciasis; Survival Analysis | 2010 |
Interruption of transmission of Onchocerca volvulus in the Oaxaca focus, Mexico.
Topics: Animals; Anthelmintics; Disease Transmission, Infectious; Humans; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis | 2010 |
Lack of active Onchocerca volvulus transmission in the northern Chiapas focus of Mexico.
Topics: Animals; Anthelmintics; Child; Child, Preschool; Disease Transmission, Infectious; Humans; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis | 2010 |
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Filaricides; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerca volvulus; Onchocerciasis | 2010 |
Community directed approach beyond ivermectin in Tanzania: a promising mechanism for the delivery of complex health interventions.
Topics: Antimalarials; Antiparasitic Agents; Antitubercular Agents; Community Health Services; Community Networks; Community Participation; Delivery of Health Care; Dietary Supplements; Endemic Diseases; Female; Humans; Ivermectin; Malaria; Onchocerciasis; Prospective Studies; Tanzania; Tuberculosis; Vitamin A; Vitamin A Deficiency | 2009 |
Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths.
Topics: Adolescent; Animals; Antiparasitic Agents; Child; Child, Preschool; Helminths; Humans; Intestines; Ivermectin; Onchocerciasis; Prevalence | 2010 |
Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
Topics: Adult; Attitude to Health; Community Health Services; Cross-Sectional Studies; Fear; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Perception; Pruritus; Rural Health Services; Self Concept; Stereotyping | 2010 |
Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.
Topics: Drug Industry; Filaricides; Gift Giving; Humans; International Cooperation; Ivermectin; Neglected Diseases; Onchocerciasis; Program Evaluation; Public-Private Sector Partnerships; Tropical Climate | 2011 |
Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity.
Topics: Adolescent; Anthelmintics; Asthma, Exercise-Induced; Child; Conjunctivitis, Allergic; Drug Administration Schedule; Ecuador; Eczema; Female; Humans; Hypersensitivity; Ivermectin; Logistic Models; Male; Odds Ratio; Onchocerciasis; Prevalence; Rhinitis; Risk Assessment; Risk Factors; Rural Population; Skin Tests; Time Factors | 2010 |
Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors.
Topics: Animals; Anopheles; Antiprotozoal Agents; Disease Vectors; Humans; Insecticides; Ivermectin; Onchocerciasis; Senegal; Survival Analysis | 2010 |
Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
Topics: Adult; Africa; Animals; Anthelmintics; Female; Humans; Infection Control; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Treatment Outcome; Young Adult | 2011 |
Where would I be without ivermectin? Capturing the benefits of community-directed treatment with ivermectin in Africa.
Topics: Adolescent; Adult; Africa; Age Distribution; Community Health Services; Cost of Illness; Epidemiologic Methods; Female; Filaricides; Humans; Ivermectin; Male; Medication Adherence; Middle Aged; Motivation; Onchocerciasis; Patient Compliance; Patient Satisfaction; Sex Distribution; Socioeconomic Factors; Young Adult | 2011 |
Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Drug Resistance; Female; Ghana; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Treatment Failure; Young Adult | 2011 |
Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations.
Topics: Animals; Communicable Disease Control; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Organizations; Public-Private Sector Partnerships; Trachoma; Tropical Climate | 2011 |
The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
Topics: Adult; Aged; Cameroon; Cross-Sectional Studies; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Nigeria; Odds Ratio; Onchocerciasis; Pruritus; Risk Factors; Rural Population; Skin Diseases, Parasitic; Sudan; Uganda | 2011 |
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anthelmintics; beta-Cyclodextrins; Brugia; Chemistry, Pharmaceutical; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Excipients; Filaricides; Humans; Ivermectin; Mebendazole; Onchocerca volvulus; Onchocerciasis | 2011 |
Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
Topics: Adolescent; Albendazole; Child; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Female; Filaricides; Ghana; Health Education; Humans; Ivermectin; Male; Onchocerciasis; Praziquantel; Rural Population; Schistosomiasis | 2011 |
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparasitic Agents; Cameroon; Child; Female; Humans; Interviews as Topic; Ivermectin; Male; Medication Adherence; Middle Aged; Nigeria; Onchocerciasis; Young Adult | 2011 |
Meeting of the International Task Force for Disease Eradication, April 2011.
Topics: Africa; Antiparasitic Agents; Biomedical Research; Comorbidity; Elephantiasis, Filarial; Endemic Diseases; Humans; Ivermectin; Loiasis; Onchocerciasis; Prevalence | 2011 |
[Eosinophilia and a subcutaneous nodule in patient from Equatorial Guinea].
Topics: Animals; Anthelmintics; Buttocks; Endemic Diseases; Eosinophilia; Equatorial Guinea; Facial Dermatoses; Female; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Spain; Subcutaneous Tissue; Young Adult | 2011 |
Beyond providing drugs: the Mectizan® donation stimulates new strategies in service delivery and in strengthening health systems.
Topics: Africa; Altruism; Antiparasitic Agents; Community Health Planning; Drug Industry; Humans; Ivermectin; Latin America; Onchocerciasis; Organizations | 2012 |
Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
Topics: Animals; Antiparasitic Agents; Endemic Diseases; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Services Needs and Demand; Humans; Ivermectin; Male; Motivation; Nigeria; Onchocerca; Onchocerciasis | 2011 |
African Programme for Onchocerciasis Control: meeting of National Task Forces, September 2011.
Topics: Africa; Community Networks; Filaricides; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular | 2011 |
Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
Topics: Adult; Animals; Cameroon; Child; Child, Preschool; Eye; Female; Filaricides; Health Care Surveys; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Simuliidae; Skin | 2011 |
Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparasitic Agents; Cameroon; Community Health Services; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Prohibitins; Time Factors; Young Adult | 2011 |
Chemokines and cytokines in patients with an occult Onchocerca volvulus infection.
Topics: Adult; Animals; Anthelmintics; Cytokines; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Serum | 2012 |
Nodding syndrome - South Sudan, 2011.
Topics: Adolescent; Animals; Anticonvulsants; Antiparasitic Agents; Case-Control Studies; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Disease Outbreaks; Head; Humans; Ivermectin; Movement Disorders; Nervous System Diseases; Odds Ratio; Onchocerca volvulus; Onchocerciasis; Risk Factors; Seizures; Sudan; Syndrome; United States | 2012 |
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Child; Child, Preschool; Disease Eradication; Female; Humans; Infant; Ivermectin; Male; Middle Aged; Nigeria; Onchocerca volvulus; Onchocerciasis; Prevalence; Public Health; Young Adult | 2012 |
Concurrence of dermatological and ophthalmological morbidity in onchocerciasis.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Antiparasitic Agents; Cameroon; Child; Coinfection; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Quality of Life; Simuliidae; Young Adult | 2012 |
Changes in stigma and discrimination of onchocerciasis in Africa.
Topics: Adolescent; Adult; Antiparasitic Agents; Community Health Workers; Democratic Republic of the Congo; Female; Focus Groups; Health Education; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prejudice; Prevalence; Rejection, Psychology; Social Perception; Social Stigma; Surveys and Questionnaires; Young Adult | 2012 |
Characteristics of persons who complied with and failed to comply with annual ivermectin treatment.
Topics: Adolescent; Adult; Antiparasitic Agents; Cameroon; Child; Drug Administration Schedule; Endemic Diseases; Female; Humans; Ivermectin; Male; Medication Adherence; Nigeria; Onchocerciasis; Socioeconomic Factors; Time Factors; Uganda; Young Adult | 2012 |
Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Base Sequence; Drug Resistance; Female; Fertility; Gene Frequency; Genes, Protozoan; Genotype; Genotyping Techniques; Humans; Ivermectin; Male; Middle Aged; Molecular Sequence Data; Onchocerca volvulus; Onchocerciasis; Parasite Load; Polymorphism, Single Nucleotide; Selection, Genetic; Tubulin; Young Adult | 2012 |
[Evaluation on implementation of the African programme for onchocerciasis control in Nigeria].
Topics: Community Health Services; Focus Groups; Humans; Interviews as Topic; Ivermectin; Neglected Diseases; Nigeria; Onchocerciasis; Program Development; Program Evaluation; Sampling Studies | 2012 |
Anogeissus leiocarpus extract on the parasite nematode Onchocerca ochengi and on drug resistant mutant strains of the free-living nematode Caenorhabditis elegans.
Topics: Albendazole; Animals; Anthelmintics; Caenorhabditis elegans; Combretaceae; Female; Ivermectin; Levamisole; Male; Mutation; Onchocerca; Onchocerciasis; Plant Extracts | 2012 |
Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.
Topics: Adult; Aged; Aged, 80 and over; Anthelmintics; Female; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Parasite Load; Prevalence; Rivers; Skin | 2012 |
Progress towards eliminating onchocerciasis in the WHO Region of the Americas in 2011: interruption of transmission in Guatemala and Mexico.
Topics: Endemic Diseases; Filaricides; Guatemala; Humans; Ivermectin; Mexico; Onchocerciasis; South America; World Health Organization | 2012 |
Primary Health Care in rural Malawi - a qualitative assessment exploring the relevance of the community-directed interventions approach.
Topics: Africa South of the Sahara; Community Health Services; Community-Based Participatory Research; Directly Observed Therapy; Endemic Diseases; Health Status Indicators; Humans; Interviews as Topic; Ivermectin; Malawi; Onchocerciasis; Outcome and Process Assessment, Health Care; Primary Health Care; Qualitative Research; Rural Health Services; Socioeconomic Factors | 2012 |
Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Endemic Diseases; Female; Humans; Ivermectin; Longitudinal Studies; Male; Mali; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Population; Senegal; Simuliidae; Young Adult | 2012 |
Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Helminthiasis; Humans; Infant; Intestinal Diseases, Parasitic; Ivermectin; Neglected Diseases; Onchocerciasis; Prevalence; Scabies; Soil; Tanzania; Young Adult | 2012 |
African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.
Topics: Africa; Community Networks; Filaricides; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular | 2012 |
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
Topics: Adolescent; Adult; Africa; Aged; Aged, 80 and over; Animals; Child; Child, Preschool; Communicable Disease Control; Costs and Cost Analysis; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Models, Statistical; Onchocerciasis; Young Adult | 2013 |
Community-directed treatment with ivermectin in two Nigerian communities: an analysis of first year start-up processes, costs and consequences.
Topics: Anthelmintics; Community Health Services; Costs and Cost Analysis; Endemic Diseases; Health Education; Health Services Research; Humans; Ivermectin; Nigeria; Onchocerciasis; Program Development; Rural Population | 2002 |
Onchocerciasis (river blindness). Report from the eleventh InterAmerican conference on onchocerciasis, Mexico City, Mexico.
Topics: Communicable Disease Control; Filaricides; Humans; Ivermectin; Latin America; Onchocerciasis; Population Surveillance | 2002 |
[Diagnostic image (105). A woman with painful nodules. Infection with O. volvulus].
Topics: Adolescent; Animals; Anthelmintics; Democratic Republic of the Congo; Female; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Refugees | 2002 |
Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin.
Topics: Animals; Anthelmintics; Biomarkers; Eosinophilia; Humans; Interleukin-5; Ivermectin; Lymphedema; Mast Cells; Mastocytosis, Cutaneous; Onchocerca; Onchocerciasis; Serine Endopeptidases; Tryptases | 2002 |
Rapid assessment method for prevalence and intensity of Loa loa infection.
Topics: Adolescent; Adult; Aged; Animals; Cameroon; Endemic Diseases; Filaricides; Humans; Ivermectin; Loa; Loiasis; Mass Screening; Middle Aged; Nigeria; Observation; Onchocerca volvulus; Onchocerciasis; Predictive Value of Tests; Prevalence; Risk Factors; Surveys and Questionnaires | 2002 |
The right word.
Topics: Clinical Trials as Topic; Developing Countries; Humans; Ivermectin; Malawi; Multicenter Studies as Topic; Onchocerciasis; Selection Bias; World Health Organization | 2003 |
Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
Topics: Animals; Anthelmintics; Antiparasitic Agents; Disease Progression; Humans; Ivermectin; Lymphocyte Activation; Lymphocytes; Microfilariae; Onchocerca volvulus; Onchocerciasis; Skin; Skin Diseases, Parasitic | 2003 |
Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution.
Topics: Animals; DNA, Helminth; Ecuador; Endemic Diseases; Humans; Insect Control; Insecticides; Ivermectin; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Prevalence; Seasons; Simuliidae; Water Supply | 2003 |
The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.
Topics: Adolescent; Adult; Aged; Antinematodal Agents; Child; Community Health Services; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Middle Aged; Nigeria; Onchocerciasis; Patient Acceptance of Health Care | 2002 |
[Onchocerciasis].
Topics: Antinematodal Agents; Antiparasitic Agents; Biopsy; Diagnosis, Differential; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Skin; Skin Diseases, Parasitic; Time Factors | 2003 |
Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships.
Topics: Humans; Ivermectin; Onchocerciasis; Orphan Drug Production; Rare Diseases; Research; Research Support as Topic; Voluntary Health Agencies; World Health Organization | 2003 |
Molecular cloning of an alpha-enolase from the human filarial parasite Onchocerca volvulus that binds human plasminogen.
Topics: Amino Acid Sequence; Animals; Anthelmintics; Cloning, Molecular; Cross Reactions; Embryo, Nonmammalian; Female; Helminth Proteins; Humans; Immune Sera; Ivermectin; Larva; Male; Molecular Sequence Data; Onchocerca volvulus; Onchocerciasis; Phosphopyruvate Hydratase; Plasminogen; Rabbits; Recombinant Fusion Proteins; Sequence Homology, Amino Acid | 2003 |
Adverse reactions following annual ivermectin treatment of onchocerciasis in Nigeria.
Topics: Adolescent; Adult; Anthelmintics; Child; Child, Preschool; Female; Humans; Interviews as Topic; Ivermectin; Male; Nigeria; Onchocerciasis; Surveys and Questionnaires | 2003 |
Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Topics: Adolescent; Adult; Aged; Cameroon; Child; Endemic Diseases; Female; Filaricides; Hospitalization; Humans; Ivermectin; Loiasis; Male; Middle Aged; Nervous System Diseases; Onchocerciasis; Prognosis; Retrospective Studies | 2003 |
Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach.
Topics: Adolescent; Adult; Animals; Anthelmintics; Bayes Theorem; Cluster Analysis; Female; Humans; Ivermectin; Male; Onchocerciasis; Prevalence; Residence Characteristics; Venezuela | 2003 |
Community-based treatment of onchocerciasis with ivermectin in southwest Nigeria: dermatological response to a singledose therapy.
Topics: Adult; Age Factors; Agricultural Workers' Diseases; Antiparasitic Agents; Community Health Services; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Pruritus; Sex Factors; Treatment Outcome | 2001 |
Progressive vision loss in a man from Cameroon.
Topics: Animals; Antiprotozoal Agents; Cameroon; Humans; Ivermectin; Male; Mansonella; Middle Aged; Onchocerciasis; Vision Disorders; Vision Tests | 2003 |
Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
Topics: Adolescent; Anthelmintics; Child; Child, Preschool; Community Health Services; Decision Making; Feasibility Studies; Health Care Surveys; Health Personnel; Helminthiasis; Humans; Intestinal Diseases, Parasitic; Ivermectin; Mebendazole; Onchocerciasis; Praziquantel; Schistosomiasis; Uganda | 2003 |
Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Animals; Child; Child, Preschool; Drug Administration Schedule; Drug Eruptions; Female; Filaricides; Humans; Insect Vectors; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Simuliidae; Uganda | 2003 |
[Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia].
Topics: Adult; Antinematodal Agents; Female; Humans; Ivermectin; Loiasis; Onchocerciasis; Ophthalmoscopy; Retinal Hemorrhage | 2004 |
Polymerase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico.
Topics: Animals; DNA, Helminth; Endemic Diseases; Female; Filaricides; Humans; Insect Vectors; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Simuliidae | 2004 |
Onchocerciasis (river blindness). Report from the twelfth InterAmerican Conference on Onchocerciasis, Manaus, Brazil.
Topics: Animals; Brazil; Developing Countries; Filaricides; Humans; Ivermectin; Onchocerciasis | 2003 |
Cutaneous onchocercoma.
Topics: Adult; Animals; Antiparasitic Agents; Diagnosis, Differential; Diptera; Disease Reservoirs; Filaricides; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Skin Diseases, Parasitic | 2004 |
Onchocerciasis.
Topics: Africa; Animals; Anthelmintics; Delivery of Health Care; Humans; Ivermectin; Latin America; Onchocerca volvulus; Onchocerciasis; Yemen | 2003 |
Profitable gifts: a history of the Merck Mectizan donation program and its implications for international health.
Topics: Community Health Planning; Developing Countries; Drug Industry; Financing, Organized; Gift Giving; History, 20th Century; History, 21st Century; Humans; International Cooperation; Ivermectin; Onchocerciasis | 2004 |
Mectizan Donation Program: evaluation of a public-private partnership.
Topics: Developing Countries; Drug Industry; Filaricides; Gift Giving; Humans; International Cooperation; Ivermectin; Onchocerciasis; Program Evaluation; Public Health | 2004 |
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Topics: Adolescent; Adult; Aged; Animals; Area Under Curve; Case-Control Studies; Drug Administration Schedule; Drug Resistance; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Skin; Treatment Outcome | 2004 |
Predictors for compliance with community directed ivermectin treatment in Bushenyi district of Uganda: qualitative results.
Topics: Community Health Workers; Filaricides; Health Education; Humans; Ivermectin; Onchocerciasis; Patient Compliance; Uganda | 2004 |
A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria.
Topics: Adult; Aged; Cohort Studies; Female; Humans; Ivermectin; Longitudinal Studies; Male; Middle Aged; Nigeria; Onchocerciasis | 2004 |
Efficiency of Simulium sanctipauli as a vector of Onchocerca volvulus in the forest zone of Ghana.
Topics: Animals; Anthelmintics; DNA, Helminth; Female; Ghana; Humans; Insect Vectors; Ivermectin; Nucleic Acid Hybridization; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Rural Population; Simuliidae; Statistics, Nonparametric | 2004 |
Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Topics: Adult; Animals; Endemic Diseases; Eye; Female; Filaricides; Follow-Up Studies; Ghana; Humans; Ivermectin; Male; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Skin; Treatment Outcome | 2004 |
Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa.
Topics: Adult; Alleles; Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Cloning, Molecular; Filaricides; Genes, Protozoan; Ghana; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Phylogeny; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Sequence Alignment | 2004 |
Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, central Cameroon.
Topics: Animals; Anthelmintics; Cameroon; Child; Child, Preschool; Community Health Services; Endemic Diseases; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Health | 2004 |
Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases.
Topics: Adult; Antiparasitic Agents; Female; Filaricides; Humans; Ivermectin; Onchocerciasis; Self Concept; Skin Diseases, Parasitic | 2004 |
The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Carrier State; Child; Child, Preschool; Female; Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Male; Middle Aged; Onchocerciasis; Simuliidae; Skin Diseases, Parasitic | 2004 |
Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?
Topics: Adult; Attitude of Health Personnel; Cameroon; Child; Community Health Services; Cross-Sectional Studies; Filaricides; Health Promotion; Humans; Ivermectin; Nigeria; Onchocerciasis; Program Evaluation | 2004 |
Onchocerciasis in a teenager from Africa.
Topics: Adolescent; Africa; Animals; Antiparasitic Agents; Biopsy, Needle; Follow-Up Studies; Humans; Immunohistochemistry; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Risk Assessment; Severity of Illness Index; Skin Diseases, Parasitic; Treatment Outcome | 2004 |
Onchocerciasis in Imo state, Nigeria (2): the prevalence, intensity and distribution in the upper Imo river basin.
Topics: Adolescent; Adult; Aged; Agriculture; Anthelmintics; Child; Child, Preschool; Environmental Monitoring; Epidemiological Monitoring; Female; Fisheries; Humans; Infant; Infant, Newborn; Ivermectin; Male; Middle Aged; Nigeria; Occupations; Onchocerciasis; Prevalence; Rivers; Sex Factors | 2004 |
Onchocerciasis (river blindness). Report from the thirteenth InterAmerican Conference on Onchocerciasis, Cartagena de Indias, Colombia.
Topics: Animals; Colombia; Developing Countries; Filaricides; Humans; Ivermectin; Onchocerciasis | 2004 |
Endemicity of onchocerciasis in some local government areas of Niger state.
Topics: Anthelmintics; Endemic Diseases; Female; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; Population Surveillance; Public Health Practice; Topography, Medical | 2004 |
Missed treatment opportunities, for pregnant and breast-feeding women, in onchocerciasis mass-treatment programmes in south-eastern Nigeria.
Topics: Adult; Breast Feeding; Contraindications; Female; Filaricides; Government Programs; Health Education; Health Services Research; Humans; Ivermectin; Nigeria; Onchocerciasis; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic | 2004 |
Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Topics: Adolescent; Adult; Age Distribution; Animals; Anthelmintics; Cameroon; Child; Child, Preschool; Disease Reservoirs; Endemic Diseases; Female; Humans; Ivermectin; Loa; Logistic Models; Loiasis; Male; Middle Aged; Nervous System Diseases; Onchocerciasis; Prevalence; Risk Factors; Sex Distribution | 2004 |
The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America.
Topics: Adult; Animals; Ecuador; Female; Filaricides; Guatemala; Humans; Ivermectin; Longitudinal Studies; Male; Mexico; Onchocerca volvulus; Onchocerciasis | 2004 |
Prevalence of antibodies to onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin.
Topics: Adolescent; Adult; Aged; Animals; Antibodies, Helminth; Enzyme-Linked Immunosorbent Assay; Female; Filaricides; Humans; Immunoglobulin G; Ivermectin; Male; Mexico; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Time Factors | 2005 |
Spatial and temporal variation in biting rates and parasite transmission potentials of onchocerciasis vectors in Ecuador.
Topics: Animals; Anthelmintics; Bites and Stings; Ecuador; Humans; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Seasons; Simuliidae; Space-Time Clustering; Time Factors | 2005 |
Satoshi Omura: in pursuit of nature's bounty.
Topics: Animals; Anti-Bacterial Agents; Filaricides; History, 20th Century; History, 21st Century; Humans; Ivermectin; Japan; Macrolides; Onchocerca volvulus; Onchocerciasis; Pest Control, Biological | 2005 |
Refusal to take ivermectin: the associated 'risk' factors in Hoima district, Uganda.
Topics: Adult; Attitude to Health; Endemic Diseases; Epidemiologic Methods; Female; Filaricides; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Rural Health; Treatment Refusal; Uganda | 2005 |
Adverse reactions to the ivermectin treatment of onchocerciasis patients: does infection with the human immunodeficiency virus play a role?
Topics: Adolescent; Adult; Anthelmintics; Follow-Up Studies; HIV Infections; HIV-1; Humans; Ivermectin; Onchocerciasis | 2005 |
Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results.
Topics: Adult; Anthelmintics; Attitude to Health; Body Height; Community Health Services; Cross-Sectional Studies; Drug Administration Schedule; Endemic Diseases; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Onchocerciasis; Patient Compliance; Social Support; Socioeconomic Factors; Uganda | 2005 |
Use of Geographic Information Systems in the development of prediction models for onchocerciasis control in Ethiopia.
Topics: Agriculture; Animals; Anthelmintics; Climate; Cluster Analysis; Databases, Factual; Endemic Diseases; Ethiopia; Forecasting; Geographic Information Systems; Humans; Insect Vectors; Ivermectin; Models, Theoretical; Onchocerciasis; Prevalence; Risk Assessment; Satellite Communications; Seasons; Simuliidae | 2005 |
Status of forest onchocerciasis in the Lower Cross River basin, Nigeria: entomologic profile after five years of ivermectin intervention.
Topics: Animals; Female; Humans; Insect Bites and Stings; Insect Vectors; Insecticides; Ivermectin; Nigeria; Onchocerca volvulus; Onchocerciasis; Rivers; Simuliidae; Trees | 2005 |
Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Topics: Animals; Burkina Faso; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; Ivermectin; Mansonella; Mansonelliasis; Microfilariae; Onchocerciasis; Population Surveillance; Prevalence; Rural Health; Time Factors; Wuchereria bancrofti | 2005 |
Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Cameroon; Child; Drug Resistance; Female; Fertility; Gene Frequency; Genotype; Humans; Ivermectin; Male; Middle Aged; Odds Ratio; Onchocerca volvulus; Onchocerciasis; Phenotype; Polymerase Chain Reaction; Polymorphism, Genetic; Tubulin | 2006 |
Lost in translation.
Topics: Communicable Diseases; Developing Countries; Diffusion of Innovation; Drug Industry; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis | 2005 |
Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus.
Topics: Animals; Antiparasitic Agents; ATP-Binding Cassette Transporters; Base Sequence; Exons; Female; Genetic Variation; Helminth Proteins; Humans; Introns; Ivermectin; Male; Molecular Sequence Data; Onchocerca volvulus; Onchocerciasis; Selection, Genetic | 2006 |
Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity.
Topics: Animals; Antiparasitic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA Primers; Genetic Markers; Genetic Variation; Genotype; Humans; Ivermectin; Linkage Disequilibrium; Onchocerca volvulus; Onchocerciasis; Selection, Genetic | 2006 |
The rapid monitoring of ivermectin treatment: will school-based surveys provide the answer?
Topics: Child; Cross-Sectional Studies; Delivery of Health Care; Endemic Diseases; Filaricides; Humans; Ivermectin; Nigeria; Onchocerciasis; Quality Assurance, Health Care; Registries; Schools; Sudan | 2005 |
Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Topics: Animals; Cameroon; Community Health Services; Drug Administration Schedule; Female; Filaricides; Guatemala; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Outcome Assessment, Health Care | 2005 |
Case records of the Massachusetts General Hospital. Case 39-2005. A 63-year-old woman with a positive serologic test for syphilis and persistent eosinophilia.
Topics: Anti-Bacterial Agents; Aorta; Aortography; Diagnosis, Differential; Eosinophilia; Female; Filaricides; Humans; Ivermectin; Middle Aged; Onchocerciasis; Penicillin G Benzathine; Syphilis; Syphilis Serodiagnosis; Ultrasonography | 2005 |
[African Program for Onchocerciasis Control (APOC): Onchocerca volvulus transmission by Simulium damnosum s. l. in two regions of the Central African Republic].
Topics: Animals; Bites and Stings; Central African Republic; Endemic Diseases; Female; Humans; Insect Control; Insect Vectors; Insecticides; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Seasons; Simuliidae | 2006 |
Transmission of Onchocerca volvulus and prospects for the elimination of its vector, the blackfly Simulium neavei in the Mpamba-Nkusi focus in Western Uganda.
Topics: Animals; Antiparasitic Agents; Brachyura; Ecosystem; Feeding Behavior; Female; Insect Bites and Stings; Insect Control; Insect Vectors; Insecticides; Ivermectin; Onchocerca volvulus; Onchocerciasis; Rivers; Simuliidae; Temefos; Uganda | 2006 |
A missionary with a swelling on her hip.
Topics: Animals; Congo; Female; Filaricides; Humans; Ivermectin; Middle Aged; Missionaries; Onchocerca; Onchocerciasis; Religious Missions | 2006 |
Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico.
Topics: Algorithms; Animals; DNA Primers; Endemic Diseases; Government Programs; Insect Vectors; Insecticides; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Prevalence; Seasons; Simuliidae; Time Factors | 2006 |
Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Topics: Adolescent; Adult; Animals; Binomial Distribution; Cameroon; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Likelihood Functions; Loa; Loiasis; Male; Middle Aged; Models, Biological; Onchocerca volvulus; Onchocerciasis; Population Dynamics; Predictive Value of Tests; Prevalence | 2006 |
Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Child, Preschool; Equatorial Guinea; Female; Humans; Infant; Infant, Newborn; Ivermectin; Long-Term Care; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Prevalence; Rural Health; Sex Distribution; Skin | 2006 |
Brian Oliver Lyndhurst Duke.
Topics: Africa; History, 20th Century; History, 21st Century; Humans; Ivermectin; Onchocerciasis; Parasitology; United Kingdom | 2006 |
Limb swelling with hypereosinophilia.
Topics: Adult; Antiparasitic Agents; Edema; Humans; Hypereosinophilic Syndrome; Ivermectin; Male; Onchocerciasis | 2006 |
Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus.
Topics: Africa, Western; Animals; Drug Resistance; Filaricides; Gene Frequency; Haemonchiasis; Haemonchus; Humans; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Sheep; Skin; Tubulin | 2006 |
Modeling targeted ivermectin treatment for controlling river blindness.
Topics: Animals; Disease Models, Animal; Drug Resistance; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2006 |
The future of onchocerciasis control in Africa.
Topics: Africa, Western; Community Health Services; Humans; Insecticides; Ivermectin; Onchocerciasis | 2006 |
Status of forest onchocerciasis in the Lower Cross River Basin, Nigeria: change in clinical and parasitological indices after 6 years of ivermectin intervention.
Topics: Animals; Antiparasitic Agents; Humans; Ivermectin; Nigeria; Onchocerca; Onchocerciasis; Trees | 2007 |
Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.
Topics: Adolescent; Adult; Africa; Antiparasitic Agents; Child; Community Health Services; Community Participation; Feasibility Studies; Female; Health Care Surveys; Humans; Ivermectin; Male; Medical Records; Onchocerciasis; Patient Compliance; Regional Medical Programs; Rural Health | 2007 |
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Topics: Adult; Aged; Animals; Anthelmintics; Antibodies, Helminth; Cells, Cultured; Cytokines; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunocompetence; Immunoglobulin G; Ivermectin; Male; Mansonelliasis; Middle Aged; Necatoriasis; Onchocerca volvulus; Onchocerciasis | 2007 |
Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control.
Topics: Africa; Animals; Antiparasitic Agents; Community Health Services; Humans; Ivermectin; Onchocerciasis; Program Evaluation | 2007 |
African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
Topics: Africa, Central; Antiparasitic Agents; Community Health Services; Female; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Ivermectin; Male; Onchocerciasis; Prevalence | 2007 |
Hanging groin and persistent pruritus in a patient from Burkina Faso.
Topics: Animals; Antiparasitic Agents; Burkina Faso; Female; Humans; Ivermectin; Middle Aged; Onchocerca; Onchocerciasis; Pruritus; Skin; Treatment Outcome | 2007 |
Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection.
Topics: Adult; Antiparasitic Agents; Disease Outbreaks; Disease Transmission, Infectious; Drug Administration Schedule; Ecuador; Endemic Diseases; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence | 2007 |
Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
Topics: Animals; Antiparasitic Agents; Community Health Services; Humans; Insect Control; Ivermectin; Onchocerciasis; Simuliidae; Uganda | 2007 |
Meeting of the International Task Force for Disease Eradication--11 January 2007.
Topics: Africa; Central America; Filaricides; Humans; Ivermectin; Onchocerciasis; South America | 2007 |
Uche Amazigo: overcoming onchocerciasis in Africa.
Topics: Community Health Services; Female; Filaricides; History, 21st Century; Humans; Ivermectin; Nigeria; Onchocerciasis; Public Health | 2007 |
Proteinuria and onchocerciasis in an endemic area in Cameroon under community-based treatment with ivermectin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cameroon; Child; Child, Preschool; Chronic Disease; Endemic Diseases; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca; Onchocerciasis; Prevalence; Proteinuria | 2007 |
The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
Topics: Adult; Amenorrhea; Animals; Antiparasitic Agents; Appetite; Female; Humans; Ivermectin; Libido; Lice Infestations; Male; Musculoskeletal Diseases; Nigeria; Onchocerciasis; Pain; Pediculus; Pruritus; Qualitative Research; Scalp Dermatoses; Skin Diseases; Treatment Outcome; Vision Disorders | 2007 |
Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin.
Topics: Alleles; Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational | 2007 |
Efficacy of ivermectin against Onchocerca volvulus in Ghana.
Topics: Animals; Drug Resistance; Filaricides; Ghana; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2007 |
Efficacy of ivermectin against Onchocerca volvulus in Ghana.
Topics: Animals; Drug Resistance; Filaricides; Ghana; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Skin | 2007 |
Efficacy of ivermectin against Onchocerca volvulus in Ghana.
Topics: Animals; Drug Resistance; Embryonic Development; Female; Filaricides; Ghana; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2007 |
Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
Topics: Animals; Anthelmintics; Antiparasitic Agents; Drug Resistance; Female; Genetic Carrier Screening; Genotype; Helminth Proteins; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Selection, Genetic; Tubulin | 2007 |
The future of onchocerciasis control in Africa.
Topics: Africa, Western; Antiparasitic Agents; Evidence-Based Medicine; Forecasting; Humans; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Public Health | 2007 |
Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
Topics: Aged; Animals; Antiparasitic Agents; Drug Resistance; Female; Helminth Proteins; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Polymorphism, Genetic; Reproduction; Selection, Genetic; Skin; South America; Tubulin | 2007 |
Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Population Surveillance; Prevalence; Tanzania | 2007 |
Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthelmintics; Community Health Services; Community Health Workers; Female; Health Care Costs; Health Education; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Rural Health Services | 2008 |
Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico.
Topics: Animals; Antigens, Helminth; DNA, Helminth; Enzyme-Linked Immunosorbent Assay; Filaricides; Humans; Incidence; Insect Vectors; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Simuliidae | 2008 |
The mitochondrial heat shock protein 60 (HSP60) is up-regulated in Onchocerca volvulus after the depletion of Wolbachia.
Topics: Animals; Anti-Bacterial Agents; Chaperonin 60; Doxycycline; Female; Humans; Immunohistochemistry; Ivermectin; Male; Microscopy, Electron; Mitochondria; Onchocerca volvulus; Onchocerciasis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Helminth; Symbiosis; Transcription, Genetic; Up-Regulation; Wolbachia | 2008 |
Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.
Topics: Albendazole; Anthelmintics; Antiparasitic Agents; Cost-Benefit Analysis; Drug Interactions; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; Praziquantel; Rural Health; Schistosomiasis | 2008 |
Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).
Topics: Adult; Aged; Animals; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Mass Screening; Middle Aged; Nigeria; Onchocerciasis; Prevalence | 2008 |
Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Topics: Adolescent; Adult; Age Distribution; Animals; Anthelmintics; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Insect Vectors; Ivermectin; Male; Microfilariae; Middle Aged; Nigeria; Onchocerca volvulus; Onchocerciasis; Population Dynamics; Prevalence; Rural Health; Sex Distribution; Simuliidae; Skin; Time Factors; Treatment Outcome | 2008 |
Ivermectin for onchocerciasis.
Topics: Drug Evaluation; Filaricides; Humans; Ivermectin; Lactones; Microfilariae; Onchocerciasis | 1982 |
Ivermectin in onchocerciasis.
Topics: Female; Humans; Ivermectin; Lactones; Male; Microfilariae; Onchocerciasis | 1984 |
Recent developments in the treatment of onchocerciasis.
Topics: Antiprotozoal Agents; Benzimidazoles; Diethylcarbamazine; Humans; Ivermectin; Lactones; Onchocerciasis; Suramin | 1984 |
The microfilaricidal activity of ivermectin in vitro and in vivo.
Topics: Animals; Anthelmintics; Brugia; Dirofilaria immitis; Dirofilariasis; Dose-Response Relationship, Drug; Female; Filariasis; Filaricides; Filarioidea; Ivermectin; Lactones; Mice; Mice, Inbred BALB C; Microfilariae; Onchocerca; Onchocerciasis | 1984 |
Onchocerca gibsoni: increase of circulating egg antigen with chemotherapy in bovines.
Topics: Animals; Anthelmintics; Antibodies, Monoclonal; Antigens, Surface; Cattle; Diethylcarbamazine; Female; Filaricides; Isothiocyanates; Ivermectin; Lactones; Male; Mebendazole; Onchocerca; Onchocerciasis; Ovum; Piperazines; Praziquantel; Thiocyanates | 1984 |
Efficacy of ivermectin against Onchocerca cervicalis microfilarial dermatitis in horses.
Topics: Animals; Anthelmintics; Dermatitis; Filaricides; Horse Diseases; Horses; Ivermectin; Lactones; Microfilariae; Onchocerca; Onchocerciasis | 1983 |
[Treatment of human onchocerciasis with ivermectin].
Topics: Administration, Oral; Adult; Anthelmintics; Humans; Ivermectin; Lactones; Male; Onchocerciasis | 1983 |
Efficacy of ivermectin (22,23-dihydroavermectin B1) against adult Setaria equina and microfilariae of Onchocerca cervicalis in ponies.
Topics: Animals; Filariasis; Filarioidea; Horse Diseases; Horses; Ivermectin; Lactones; Microfilariae; Onchocerca; Onchocerciasis; Setariasis | 1980 |
Anthelmintic efficacy of ivermectin given intramuscularly in horses.
Topics: Animals; Anthelmintics; Feces; Female; Filaricides; Horse Diseases; Horses; Injections, Intramuscular; Ivermectin; Lactones; Nematode Infections; Onchocerciasis; Parasite Egg Count; Skin; Strongyle Infections, Equine | 1982 |
Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
Topics: Adolescent; Adult; Animals; Cameroon; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Skin; Tablets | 1995 |
Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
Topics: Adolescent; Adult; Animals; Blotting, Western; CD4 Lymphocyte Count; CD4-CD8 Ratio; Drug Tolerance; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Skin; Uganda | 1995 |
Knowledge and attitudes toward onchocerciasis in the Thyolo highlands of Malawi.
Topics: Adult; Attitude; Female; Humans; Ivermectin; Malawi; Male; Middle Aged; Onchocerciasis; Patient Education as Topic | 1994 |
Drastic reduction of populations of Simulium sirbanum (Diptera: Simuliidae) in central Sierra Leone after 5 years of larviciding operations by the Onchocerciasis Control Programme.
Topics: Animals; Female; Humans; Insect Control; Insect Vectors; Ivermectin; Larva; Onchocerciasis; Sierra Leone; Simuliidae; Time Factors | 1995 |
Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
Topics: Animals; Guinea; Humans; Insect Control; Ivermectin; Onchocerca volvulus; Onchocerciasis; Patient Compliance; Prevalence; Simuliidae | 1995 |
Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Topics: Adolescent; Adult; Age Factors; Animals; Anterior Chamber; Antiparasitic Agents; Child; Cornea; Female; Humans; Insect Vectors; Ivermectin; Male; Mexico; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Simuliidae; Skin; Skin Diseases, Parasitic | 1995 |
Ivermectin detection in serum of onchocerciasis patients: relationship to adverse reactions.
Topics: Chromatography, High Pressure Liquid; Half-Life; Humans; Ivermectin; Logistic Models; Onchocerciasis; Skin | 1995 |
[An itching disease from the tropics: onchocerciasis as an imported disease].
Topics: Adult; Animals; Child; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Skin Diseases, Parasitic | 1994 |
Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins.
Topics: Animals; Antibodies, Monoclonal; Blood Proteins; Eosinophil Granule Proteins; Eosinophil Peroxidase; Eosinophils; HLA Antigens; Humans; Immunohistochemistry; Ivermectin; Lymph Nodes; Microfilariae; Microscopy, Electron; Necrosis; Onchocerca; Onchocerciasis; Peroxidases; Ribonucleases; Skin | 1994 |
Onchocerca volvulus and Schistosoma haematobium infection in southern Sierra Leone.
Topics: Adolescent; Animals; Child; Child, Preschool; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Health; Schistosomiasis haematobia; Sierra Leone | 1994 |
C-reactive protein and interleukin-6 are elevated in onchocerciasis patients after ivermectin treatment.
Topics: Biomarkers; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Humans; Immunodiffusion; Interleukin-6; Ivermectin; Onchocerciasis; Reference Values; Time Factors; Tumor Necrosis Factor-alpha | 1994 |
Ivermectin and onchocercal optic nerve lesions.
Topics: Humans; Ivermectin; Onchocerciasis; Optic Nerve Diseases | 1993 |
Supply of ivermectin in developing countries.
Topics: Developing Countries; Drug Costs; Drug Industry; Humans; Ivermectin; Onchocerciasis | 1993 |
How long do the effects of ivermectin on adult Onchocerca volvulus persist?
Topics: Adult; Animals; Female; Fertility; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis | 1993 |
Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
Topics: Adolescent; Adult; Animals; Carrier State; Child; Child, Preschool; Female; Humans; Infant; Insect Vectors; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Simuliidae; Skin; Uganda | 1993 |
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Topics: Animals; Antibodies, Helminth; Antibody Specificity; Antigens, Helminth; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukins; Ivermectin; Leukocytes, Mononuclear; Male; Onchocerca volvulus; Onchocerciasis; Skin | 1994 |
Neutrophil activation in ivermectin-treated onchocerciasis patients.
Topics: alpha 1-Antitrypsin; Cell Degranulation; Drug Eruptions; Fever; Humans; Ivermectin; Lactoferrin; Lymphadenitis; Neutrophils; Onchocerciasis; Pancreatic Elastase; Pruritus | 1993 |
Comparison of three strategies for mass distribution of ivermectin in Achi, Nigeria.
Topics: Cost-Benefit Analysis; Humans; Ivermectin; Medication Systems; Nigeria; Onchocerciasis | 1993 |
Entomological evaluation of ivermectin mass treatment against onchocerciasis.
Topics: Animals; Chi-Square Distribution; Evaluation Studies as Topic; Female; Humans; Insect Vectors; Ivermectin; Larva; Onchocerca; Onchocerciasis; Simuliidae | 1993 |
[Long-term effect of a single dose of ivermectin on skin microfilarial density in an endemic onchocerciasis area of North Cameroon].
Topics: Adult; Animals; Antiparasitic Agents; Cameroon; Child; Child, Preschool; Developing Countries; Female; Follow-Up Studies; Humans; Ivermectin; Male; Microfilariae; Onchocerciasis; Skin Diseases, Parasitic | 1993 |
[Parasitological efficacy of repeated treatments with ivermectin in an onchocerciasis focus in north Cameroon].
Topics: Adult; Animals; Cameroon; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Skin | 1993 |
Protein binding and ivermectin estimations in patients with onchocerciasis.
Topics: Administration, Oral; Blood Proteins; Chromatography, High Pressure Liquid; Female; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; Protein Binding; Saliva | 1993 |
Effect of ivermectin treatment on microfilarial load in patients with Onchocerca volvulus in Bebeka, Ethiopia.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Ethiopia; Female; Humans; Ivermectin; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis | 1993 |
Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment.
Topics: Animals; Ascariasis; Ascaris lumbricoides; Entamoebiasis; Feces; Fever; Headache; Hookworm Infections; Humans; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Parasitic Diseases; Prospective Studies; Schistosomiasis mansoni; Skin; Trichuriasis | 1993 |
Effect of ivermectin prophylaxis on antibody responses to Onchocerca volvulus recombinant antigens in experimentally infected chimpanzees.
Topics: Animals; Anthelmintics; Antibody Formation; Antigens, Helminth; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Ivermectin; Onchocerca volvulus; Onchocerciasis; Pan troglodytes; Recombinant Proteins; Time Factors | 1995 |
Reversal of amenorrhoea after Mectizan treatment.
Topics: Adult; Amenorrhea; Female; Filaricides; Humans; Ivermectin; Onchocerciasis | 1995 |
[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Topics: Adult; Aged; Animals; Arthralgia; C-Reactive Protein; Cameroon; Diethylcarbamazine; Female; Fever; Filaricides; Headache; Hematuria; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Onchocerciasis; Parasitemia; Proteinuria; Pruritus | 1995 |
[Comparison between various methods of pregnancy screening during a large-scale ivermectin treatment in Cameroon].
Topics: Adolescent; Adult; Cameroon; Contraindications; Female; Follow-Up Studies; Humans; Interviews as Topic; Ivermectin; Mass Screening; Middle Aged; Onchocerciasis; Population Surveillance; Pregnancy; Pregnancy Tests; Sensitivity and Specificity; Surveys and Questionnaires | 1995 |
Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectin.
Topics: Adolescent; Adult; Antigens, Helminth; Antinematodal Agents; Cell Division; Cells, Cultured; Female; Humans; Ivermectin; Leukocytes, Mononuclear; Male; Middle Aged; Onchocerciasis | 1996 |
[Ivermectin in the treatment of onchocercosis].
Topics: Antinematodal Agents; Body Weight; Humans; Ivermectin; Onchocerciasis; Treatment Outcome | 1995 |
[Ivermectin: problems with donation and distribution].
Topics: Africa; Antinematodal Agents; Community Health Services; Health Services Needs and Demand; Humans; Ivermectin; Mobile Health Units; Onchocerciasis | 1995 |
Ivermectin distribution and the cultural context of forest onchocerciasis in South Province, Cameroon.
Topics: Antinematodal Agents; Cameroon; Culture; Disease Susceptibility; Health Care Costs; Health Education; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Onchocerciasis; Surveys and Questionnaires | 1996 |
Integrated control of Onchocerca volvulus infection in a hyperendemic zone in Sierra Leone.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Child; Combined Modality Therapy; Community Participation; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Patient Education as Topic; Prevalence; Program Evaluation; Sierra Leone | 1996 |
Community-based ivermectin distributors: onchocerciasis control at the village level in Plateau State, Nigeria.
Topics: Antinematodal Agents; Community Health Workers; Community Participation; Filaricides; Humans; Ivermectin; Nigeria; Onchocerciasis | 1996 |
Resumption of menstruation in three women with secondary amenorrhoea after treatment with ivermectin.
Topics: Adult; Amenorrhea; Animals; Antinematodal Agents; Female; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 1995 |
[Transfer of drug industry technologies to developing countries].
Topics: Antimalarials; Antiparasitic Agents; Developing Countries; Humans; Immunotherapy; Ivermectin; Onchocerciasis; Technology Transfer; Technology, Pharmaceutical; Vaccines | 1996 |
Ivermectin-based onchocerciasis control in Cameroon.
Topics: Cameroon; Communicable Disease Control; Filaricides; Health Education; Health Services Accessibility; Humans; Ivermectin; Onchocerciasis; Rural Health | 1996 |
Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Topics: Adult; Animals; Antiparasitic Agents; Child; Eosinophils; Female; Follow-Up Studies; Humans; Ivermectin; Liberia; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; Skin Diseases, Parasitic | 1995 |
Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus.
Topics: Adipose Tissue; Animals; Area Under Curve; Fascia; Female; Filaricides; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Radioimmunoassay; Skin | 1996 |
Elevated serum angiotensin-converting enzyme activity in onchocerciasis.
Topics: Adult; Antinematodal Agents; Developing Countries; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Peptidyl-Dipeptidase A; Sierra Leone | 1996 |
Immunohistological studies on an Onchocerca volvulus ankyrin (EI).
Topics: Animals; Anthelmintics; Antibodies, Helminth; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis | 1996 |
Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Ivermectin; Macrolides; Mice; Mice, Inbred CBA; Microfilariae; Onchocerca volvulus; Onchocerciasis; Time Factors | 1996 |
Femoral hernia--a not so unusual presentation of onchocerciasis.
Topics: Anthelmintics; Hernia, Femoral; Humans; Ivermectin; Nigeria; Onchocerciasis | 1996 |
RANTES in onchocerciasis: changes with ivermectin treatment.
Topics: Adolescent; Adult; Aged; Chemokine CCL5; Child; Female; Humans; Interleukin-6; Interleukin-8; Ivermectin; Male; Middle Aged; Onchocerciasis; Tumor Necrosis Factor-alpha | 1996 |
From the Food and Drug Administration.
Topics: Antinematodal Agents; Drug Approval; Drug Information Services; Equipment and Supplies; Evaluation Studies as Topic; Humans; Ivermectin; Onchocerciasis; Reagent Kits, Diagnostic; Strongyloidiasis; Substance Abuse Detection; United States; United States Food and Drug Administration | 1997 |
Evaluation of serological assays for diagnosis of onchocercosis.
Topics: Animals; Anthelmintics; Antigens, Helminth; Chi-Square Distribution; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Ghana; Humans; Immunoblotting; Immunoglobulin G; Ivermectin; Onchocerca; Onchocerciasis; Reproducibility of Results; Sensitivity and Specificity | 1997 |
[Microfilarial loads of onchocerca and experimental vectorial capacity of Simulium soubrense-Simulium sanctipauli group in the forest zone of Ivory Coast].
Topics: Animals; Antinematodal Agents; Cote d'Ivoire; Female; Humans; Insect Vectors; Ivermectin; Male; Onchocerciasis; Simuliidae; Trees | 1996 |
Assessment of vector microfilarial uptake as a comparatively non-invasive technique for monitoring onchocerciasis treatment campaigns in the Americas.
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Child; Clinical Laboratory Techniques; Drug Monitoring; Guatemala; Humans; Insect Vectors; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Public Health Administration; Simuliidae; Skin | 1997 |
Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice.
Topics: Animals; Antinematodal Agents; CD4-Positive T-Lymphocytes; Interferon-gamma; Interleukin-5; Ivermectin; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Microfilariae; Onchocerciasis; Severe Combined Immunodeficiency; Skin; Spleen; Th2 Cells | 1997 |
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Antinematodal Agents; Endemic Diseases; Female; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Nervous System Diseases; Onchocerca volvulus; Onchocerciasis; Risk Factors | 1997 |
Rapid assessment of onchocerciasis prevalence and a model for selecting communities for ivermectin distribution in West Africa.
Topics: Algorithms; Analysis of Variance; Humans; Ivermectin; Linear Models; Mass Screening; Models, Statistical; Nigeria; Onchocerciasis; Prevalence; Risk Assessment | 1997 |
Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Burkina Faso; Child; Child, Preschool; Combined Modality Therapy; Female; Filaricides; Humans; Infant; Insect Control; Ivermectin; Male; Middle Aged; Models, Statistical; Onchocerciasis; Population Surveillance; Prevalence; Program Evaluation; Simuliidae; Time Factors | 1997 |
The entry of ivermectin and suramin into Onchocerca ochengi nodules.
Topics: Animals; Cattle; Cattle Diseases; Female; Filaricides; Ivermectin; Onchocerciasis; Suramin | 1997 |
Effect of mass treatments with ivermectin, with only partial compliance, on prevalence and intensity of O. volvulus infection in adults and in untreated 4 and 5 year-old children in Burundi.
Topics: Adult; Aged; Animals; Burundi; Child, Preschool; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Patient Compliance; Prevalence; Public Health Administration; Severity of Illness Index; Treatment Outcome | 1997 |
Reduced prevalence of onchocerciasis following mass treatment with ivermectin.
Topics: Adult; Endemic Diseases; Filaricides; Humans; Ivermectin; Male; Mass Screening; Nigeria; Onchocerciasis; Population Surveillance; Prevalence; Skin | 1997 |
Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador.
Topics: Animals; Child, Preschool; Cohort Studies; Community Health Services; Ecuador; Filaricides; Humans; Infant; Ivermectin; Onchocerciasis; Prevalence; Random Allocation; Simuliidae | 1997 |
Immunohistological studies on macrophages in lymph nodes of onchocerciasis patients after treatment with ivermectin.
Topics: Adult; Aged; Animals; Antibodies, Helminth; Antibodies, Monoclonal; Filaricides; Humans; Ivermectin; Lymph Nodes; Macrophages; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis | 1997 |
Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
Topics: Adolescent; Adult; Africa, Western; Aged; Child; Child, Preschool; Filaricides; Humans; Ivermectin; Middle Aged; Onchocerciasis; Pilot Projects; Treatment Outcome | 1997 |
[Apropos of 5 new cases of onchocerciasis edema].
Topics: Animals; Arm; Cameroon; Cote d'Ivoire; Diethylcarbamazine; Edema; Eosinophilia; Fluorescent Antibody Technique, Indirect; Humans; Immunoelectrophoresis; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Serologic Tests; Skin | 1997 |
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Brain Diseases; Cerebrospinal Fluid; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Onchocerciasis | 1998 |
[10 years of mectizan donation].
Topics: Africa; Chemoprevention; Drug Industry; Endemic Diseases; Filaricides; Follow-Up Studies; Humans; International Cooperation; Ivermectin; Onchocerciasis; Voluntary Health Agencies; World Health Organization | 1997 |
Onchocerciasis control in Uganda: how can self-sustaining, community-based treatment with ivermectin be achieved?
Topics: Anthelmintics; Attitude to Health; Community Health Services; Endemic Diseases; Health Education; Humans; Ivermectin; Onchocerciasis; Patient Acceptance of Health Care; Program Development; Rural Population; Uganda | 1998 |
Onchocerciasis control in Uganda.
Topics: Animals; Filaricides; Humans; Insect Control; Ivermectin; Onchocerciasis; Uganda | 1998 |
Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda).
Topics: Adult; Animals; Antiparasitic Agents; Cell Count; Child; Chymases; Female; Filaricides; Granuloma; Histamine; Humans; Immunoglobulin E; Ivermectin; Male; Mast Cells; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Serine Endopeptidases; Skin Diseases, Parasitic; Tryptases | 1998 |
Detection of Onchocerca volvulus DNA in pools of wild-caught Simulium ochraceum by use of the polymerase chain reaction.
Topics: Animals; Anthelmintics; DNA, Helminth; Guatemala; Humans; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Simuliidae | 1998 |
Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan Rivers in western Nigeria.
Topics: Adult; Aged; Antiparasitic Agents; Ethnicity; Female; Filaricides; Humans; Interviews as Topic; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Rejection, Psychology; Sick Role; Skin Diseases, Parasitic; Stereotyping | 1998 |
The Onchocerciasis Elimination Program for the Americas: a history of partnership.
Topics: Americas; Humans; International Cooperation; Ivermectin; Onchocerciasis; Onchocerciasis, Ocular; Pan American Health Organization | 1998 |
Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antinematodal Agents; Child; Community Participation; Female; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Program Evaluation; Surveys and Questionnaires; Travel; Treatment Refusal | 1998 |
Determination of sample sizes for the estimation of Onchocerca volvulus (Filarioidea: Onchocercidae) infection rates in biting populations of Simulium ochraceum s.l. (Diptera: Simuliidae) and its application to ivermectin control programs.
Topics: Animals; Anthelmintics; Diptera; Female; Guatemala; Humans; Insect Bites and Stings; Ivermectin; Larva; Mexico; Onchocerca volvulus; Onchocerciasis; Prevalence; Sample Size | 1998 |
Willingness to pay for community-based ivermectin distribution: a study of three onchocerciasis-endemic communities in Nigeria.
Topics: Adult; Aged; Antinematodal Agents; Community Health Services; Fees, Pharmaceutical; Female; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis | 1998 |
Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Burundi; Child; Child, Preschool; Cohort Studies; Drug Administration Schedule; Female; Filaricides; Humans; Ivermectin; Male; Morbidity; Onchocerca; Onchocerciasis; Pruritus; Public Health; Skin Diseases, Parasitic | 1998 |
Ivermectin influence on the mast cell activity in nodules of onchocerciasis patients.
Topics: Animals; Anthelmintics; Female; Humans; Immunoglobulin E; Ivermectin; Mast Cells; Onchocerca volvulus; Onchocerciasis | 1998 |
Control of onchocerciasis: challenges for the future.
Topics: Filaricides; Forecasting; Ivermectin; Onchocerciasis; Parasitology; Public Health | 1998 |
Mectizan delivery systems and cost recovery in the Central African Republic.
Topics: Central African Republic; Filaricides; Health Care Costs; Health Expenditures; Health Services Needs and Demand; Humans; Ivermectin; Onchocerciasis | 1998 |
Onchocerciasis: changes in transmission in Mexico.
Topics: Filaricides; Humans; Ivermectin; Mexico; Onchocerciasis; Rural Health Services | 1998 |
Problems and perspectives of managing an onchocerciasis control programme: a case study from Plateau state, Nigeria.
Topics: Filaricides; Health Plan Implementation; Humans; Ivermectin; Nigeria; Onchocerciasis; Program Evaluation; Rural Health Services | 1998 |
The burden of Onchocerca volvulus in Sudan.
Topics: Animals; Filaricides; Ivermectin; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Pruritus; Skin Diseases, Parasitic; Sudan | 1998 |
The burden of onchocerciasis in Uganda.
Topics: Filaricides; Humans; Ivermectin; Onchocerciasis; Prevalence; Rural Health; Skin Diseases, Parasitic; Topography, Medical; Uganda | 1998 |
Partnerships between non-governmental development organizations.
Topics: Filaricides; Humans; Interinstitutional Relations; International Agencies; International Cooperation; Ivermectin; Onchocerciasis; Program Evaluation | 1998 |
Onchocerciasis: a Latin American perspective.
Topics: Child; Ecuador; Eye Infections, Parasitic; Filaricides; Humans; Ivermectin; Latin America; Onchocerciasis; Rural Health; Skin Diseases, Parasitic | 1998 |
The donation of Mectizan.
Topics: Drug Industry; Filaricides; Humans; Ivermectin; Onchocerciasis; Organizational Culture | 1998 |
Cameroon and Chad: cost recovery.
Topics: Cameroon; Chad; Community Health Services; Filaricides; Health Care Costs; Health Care Reform; Humans; Ivermectin; Onchocerciasis | 1998 |
Problems and perspective in programme management: the case of the National Onchocerciasis Control Programme in Nigeria.
Topics: Filaricides; Health Plan Implementation; Humans; Ivermectin; Nigeria; Onchocerciasis | 1998 |
Community perspective on Mectizan's role as a catalyst for the formation of novel partnerships.
Topics: Africa; Community Health Services; Filaricides; Humans; International Cooperation; Ivermectin; Onchocerciasis; Rural Health Services | 1998 |
The challenge of establishing community-directed treatment with Mectizan in Uganda.
Topics: Community Health Services; Filaricides; Health Personnel; Humans; Ivermectin; Onchocerciasis; Program Evaluation; Rural Health; Uganda | 1998 |
Animal models--Onchocerca ochengi and the development of chemotherapeutic and chemoprophylactic agents for onchocerciasis.
Topics: Animals; Cattle; Disease Models, Animal; Filaricides; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Parasitology; Suramin | 1998 |
Ivermectin distribution for onchocerciasis in Africa.
Topics: Africa; Filaricides; Humans; Ivermectin; Onchocerciasis | 1999 |
Knowledge, attitudes and practices during a community-level ivermectin distribution campaign in Guatemala.
Topics: Community Health Planning; Developing Countries; Female; Guatemala; Health Education; Health Knowledge, Attitudes, Practice; Health Services Research; Humans; Indians, Central American; Ivermectin; Male; Onchocerciasis; Patient Participation; Primary Prevention; Surveys and Questionnaires | 1995 |
Maintaining compliance to ivermectin in communities in two West African countries.
Topics: Adolescent; Adult; Antinematodal Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Patient Compliance; Randomized Controlled Trials as Topic; Regression Analysis; Sierra Leone; Surveys and Questionnaires | 1996 |
Ivermectin distribution using community volunteers in Kabarole district, Uganda.
Topics: Adult; Anthelmintics; Catchment Area, Health; Community Health Services; Female; Health Care Costs; Health Policy; Humans; Ivermectin; Male; Onchocerciasis; Program Evaluation; Public Health Administration; Uganda; Volunteers; Workforce | 1998 |
Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Antiparasitic Agents; Child; Child, Preschool; Cohort Studies; Endemic Diseases; Enzyme-Linked Immunosorbent Assay; Filaricides; Humans; Infant; Infant, Newborn; Ivermectin; Longitudinal Studies; Mexico; Microfilariae; Onchocerca volvulus; Onchocerciasis; Recombinant Proteins; Skin; Skin Diseases, Parasitic | 1999 |
Population biology of human onchocerciasis.
Topics: Adolescent; Adult; Age Factors; Animals; Anthelmintics; Burkina Faso; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Epidemiologic Methods; Female; Humans; Infant; Insect Vectors; Ivermectin; Life Cycle Stages; Male; Models, Biological; Models, Statistical; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Population Dynamics; Prevalence; Simuliidae | 1999 |
The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda.
Topics: Community Health Services; Filaricides; Humans; Ivermectin; Onchocerciasis; Primary Health Care; Program Evaluation; Regional Medical Programs; Retrospective Studies; Statistics as Topic; Uganda | 1998 |
Onchocerciasis.
Topics: Community Participation; Filaricides; Humans; Ivermectin; Onchocerciasis; Tropical Medicine; Water | 1999 |
Analysis of renal function in onchocerciasis patients before and after therapy.
Topics: Adult; Albuminuria; Animals; Anthelmintics; Blood Chemical Analysis; Blood Glucose; Cohort Studies; Cross-Sectional Studies; Female; Glycoproteins; Guinea; Humans; Ivermectin; Kidney; Kidney Function Tests; Male; Membrane Glycoproteins; Middle Aged; Onchocerca volvulus; Onchocerciasis; Reference Values; Serum Albumin; Trypsin Inhibitor, Kunitz Soybean; Ultrasonography | 1999 |
Willingness to pay for the maintenance of equity in a local ivermectin distribution scheme in Toro, Northern Nigeria.
Topics: Adult; Attitude to Health; Community Health Services; Cross-Sectional Studies; Drug Costs; Female; Filaricides; Humans; Income; Ivermectin; Male; Middle Aged; Nigeria; Occupations; Onchocerciasis; Random Allocation; Surveys and Questionnaires | 1999 |
Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl is the vector.
Topics: Adult; Animals; Endemic Diseases; Epidemiologic Methods; Filaricides; Fresh Water; Humans; Insect Vectors; Ivermectin; Male; Onchocerciasis; Population Surveillance; Prevalence; Reproducibility of Results; Risk Factors; Sampling Studies; Simuliidae; Topography, Medical; Uganda | 1999 |
Can community leaders' preferences be used to proxy those of the community as a whole?
Topics: Attitude to Health; Community Health Services; Data Collection; Financing, Personal; Health Care Surveys; Humans; Interviews as Topic; Ivermectin; Leadership; Nigeria; Onchocerciasis; Prevalence | 1999 |
Health education to school children in Okpatu, Nigeria: impact on onchocerciasis-related knowledge.
Topics: Adolescent; Anthelmintics; Child; Female; Health Education; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Male; Nigeria; Onchocerciasis; School Health Services | 1999 |
[Diagnostic case. Onchocerciasis].
Topics: Adult; Animals; Eosinophilia; Filaricides; Humans; Ivermectin; Leg Dermatoses; Male; Onchocerca volvulus; Onchocerciasis | 1999 |
Detection of Onchocerca volvulus infection in Simulium ochraceum sensu lato: comparison of a PCR assay and fly dissection in a Mexican hypoendemic community.
Topics: Animals; Blotting, Southern; Dissection; DNA, Helminth; Endemic Diseases; Female; Filaricides; Insect Vectors; Ivermectin; Mexico; Onchocerca volvulus; Onchocerciasis; Polymerase Chain Reaction; Prevalence; Simuliidae | 1999 |
Community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda: the selection and validation of indicators for monitoring sustainability at the district level.
Topics: Community Health Services; Disease Management; Filaricides; Humans; Ivermectin; Onchocerciasis; Program Evaluation; Uganda | 1999 |
The community-directed, ivermectin-treatment programme for onchocerciasis control in Uganda--an evaluative study (1993-1997).
Topics: Community Health Workers; Filaricides; Health Care Costs; Humans; Ivermectin; Onchocerciasis; Program Evaluation; Uganda | 1999 |
Community-perceived benefits of ivermectin treatment in northeastern Nigeria.
Topics: Adult; Anthelmintics; Community-Institutional Relations; Female; Focus Groups; Health Education; Humans; Interviews as Topic; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Pilot Projects; Public Opinion; Rural Population; Surveys and Questionnaires | 2000 |
A health club for a community school in south-eastern Nigeria: influence on adult perception of onchocerciasis and compliance with community-based ivermectin therapy.
Topics: Adult; Aged; Child; Filaricides; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Ivermectin; Middle Aged; Nigeria; Onchocerciasis; Patient Compliance; Surveys and Questionnaires | 2000 |
Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis.
Topics: Adult; Animals; Biopsy; Chemokine CCL11; Chemokine CCL5; Chemokines; Chemokines, CC; Chemotaxis, Leukocyte; Cytokines; Dermatologic Surgical Procedures; Dermis; Ecuador; Endothelium, Vascular; Eosinophilia; Female; Humans; Ivermectin; Leukocyte Count; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis | 2000 |
Onchocerciasis presenting with lower extremity, hypopigmented macules.
Topics: Adolescent; Animals; Antiparasitic Agents; Antiprotozoal Agents; Diagnosis, Differential; Female; Humans; Hypopigmentation; Ivermectin; Leg; Onchocerca; Onchocerciasis; Skin; Skin Diseases, Parasitic | 2000 |
Community financing of local ivermectin distribution in Nigeria: potential payment and cost-recovery outlook.
Topics: Adult; Attitude to Health; Community Participation; Cost-Benefit Analysis; Drug Costs; Endemic Diseases; Female; Filaricides; Financing, Personal; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Program Evaluation; Surveys and Questionnaires | 2000 |
The prevalence of onchocerciasis and other parasitic infestations on an oil palm plantation in Ghana.
Topics: Adult; Agricultural Workers' Diseases; Agriculture; Animals; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Parasitic Diseases; Prevalence | 2000 |
Community views on health programmes in Uganda.
Topics: Attitude to Health; Community Health Services; Cooperative Behavior; Family Relations; Filaricides; Focus Groups; Humans; Ivermectin; Onchocerciasis; Rural Population; Uganda | 2000 |
[Mass treatment of onchocerciasis in 1996].
Topics: Filaricides; Guinea; Health Promotion; Humans; Ivermectin; Mali; Onchocerciasis; Senegal | 1995 |
Factors affecting adverse event reporting during mass ivermectin treatment for onchocerciasis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Child, Preschool; Female; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerca; Onchocerciasis; Regression Analysis; Rural Population; Sex Factors; Surveys and Questionnaires; Treatment Refusal | 2000 |
Controlling onchocerciasis by community-directed, ivermectin-treatment programmes in Uganda: why do some communities succeed and others fail?
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Communicable Disease Control; Community Health Services; Community Health Workers; Community Participation; Culture; Endemic Diseases; Female; Filaricides; Health Education; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Reward; Uganda | 2000 |
Onchocerciasis (river blindness). Report from the eighth InterAmerican conference on onchocerciasis, Caracas, Venezuela.
Topics: Filaricides; Humans; Ivermectin; Onchocerciasis; South America | 1999 |
Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Topics: Africa; Animals; Antinematodal Agents; Endemic Diseases; Female; Geography; Humans; Ivermectin; Loa; Loiasis; Onchocerca volvulus; Onchocerciasis; Prevalence | 2000 |
Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
Topics: Adult; Community Health Workers; Community Participation; Endemic Diseases; Female; Filaricides; Health Surveys; Home Care Services; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Population Surveillance; Prevalence; Primary Health Care; Treatment Outcome | 2000 |
What is the real target for ivermectin resistance selection in Onchocerca volvulus?
Topics: Animals; Anthelmintics; Communicable Disease Control; Drug Resistance; Humans; Ivermectin; Life Cycle Stages; Microfilariae; Onchocerca volvulus; Onchocerciasis; Reproduction | 2000 |
Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela.
Topics: Adolescent; Adult; Animals; Anthelmintics; Child; Child, Preschool; Humans; Ivermectin; Linear Models; Microfilariae; Onchocerca volvulus; Onchocerciasis; Prevalence; Prohibitins; Rural Population; Skin; Venezuela | 2000 |
Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure.
Topics: Animals; Antibodies, Helminth; Filaricides; Follow-Up Studies; Humans; Ivermectin; Lymphocyte Activation; Onchocerca volvulus; Onchocerciasis; Treatment Outcome | 2001 |
Longitudinal studies of skin microfilaria and antibody conversion rates in children living in an endemic focus of onchocerciasis in Nigeria.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Child; Endemic Diseases; Humans; Ivermectin; Longitudinal Studies; Microfilariae; Nigeria; Onchocerca volvulus; Onchocerciasis; Predictive Value of Tests; Skin Diseases, Parasitic | 2000 |
Onchocerciasis (river blindness).
Topics: Americas; Disease Outbreaks; Female; Humans; Incidence; Ivermectin; Male; Onchocerciasis; Treatment Outcome | 2001 |
[Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
Topics: Adult; Aged; Animals; Anthelmintics; Brain Diseases; Cameroon; Humans; Intracranial Embolism; Ivermectin; Loa; Loiasis; Microfilariae; Middle Aged; Onchocerciasis; Parasitemia | 2000 |
Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria.
Topics: Adolescent; Adult; Aged; Anthelmintics; Child; Child, Preschool; Community Health Services; Female; Humans; Infant; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Patient Compliance | 2001 |
Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda.
Topics: Adolescent; Adult; Aged; Attitude of Health Personnel; Community Health Services; Community Health Workers; Community-Institutional Relations; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Personnel Selection; Personnel Turnover; Rural Health Services; Uganda; Volunteers | 2001 |
Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
Topics: Animals; Anti-Bacterial Agents; Case-Control Studies; Doxycycline; Drug Therapy, Combination; Female; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Skin; Wolbachia | 2001 |
One in the eye for river blindness.
Topics: Animals; Anti-Bacterial Agents; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Wolbachia | 2001 |
Onchocerciasis (river blindness).
Topics: Central America; Communicable Disease Control; Filaricides; Humans; Ivermectin; Mexico; Onchocerciasis; South America | 2001 |
Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
Topics: Community Health Workers; Culture; Family; Female; Filaricides; Health Knowledge, Attitudes, Practice; Humans; Interpersonal Relations; Ivermectin; Male; Onchocerciasis; Social Responsibility; Social Support; Women; Workload | 2001 |
Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
Topics: Adolescent; Adult; Aged; Animals; Cameroon; Child; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Neurotoxicity Syndromes; Onchocerciasis; Predictive Value of Tests; Prevalence; Sensitivity and Specificity | 2001 |
Pruritus and eosinophilia in a 14-year-old girl from Liberia.
Topics: Adolescent; Dermatitis; Diagnosis, Differential; Eosinophilia; Female; Filaricides; Humans; Ivermectin; Onchocerciasis; Pruritus | 2001 |
Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon.
Topics: Animals; Cameroon; Cattle; Disease Reservoirs; Filaricides; Humans; Insect Bites and Stings; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prevalence; Simuliidae; Socioeconomic Factors | 2001 |
Community-based ivermectin therapy for onchocerciasis: comparison of three methods of dose assessment.
Topics: Adult; Animals; Antinematodal Agents; Arm; Body Height; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Ivermectin; Male; Nigeria; Onchocerca; Onchocerciasis | 2001 |
Onchocerciasis control in Nigeria: will households be able to afford community-directed treatment with ivermectin?
Topics: Adult; Animals; Community Health Services; Family Characteristics; Filaricides; Health Expenditures; Humans; Ivermectin; Middle Aged; Nigeria; Onchocerciasis; Surveys and Questionnaires | 2001 |
Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
Topics: Animals; Antinematodal Agents; Communicable Disease Control; Computer Simulation; Filaricides; Humans; Insect Vectors; Ivermectin; Onchocerca volvulus; Onchocerciasis; Software | 2001 |
Control of onchocerciasis today: status and challenges.
Topics: Africa; Americas; Animals; Blindness; Filaricides; Humans; Insect Control; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prevalence; Skin; Treatment Outcome | 2001 |
Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Topics: Adolescent; Adult; Child; Child, Preschool; Community Health Services; Community Participation; Female; Filaricides; Health Plan Implementation; Humans; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Patient Compliance; Rural Health Services; Surveys and Questionnaires | 2002 |
Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions.
Topics: Adolescent; Adult; Calcium-Binding Proteins; Calgranulin B; Diethylcarbamazine; DNA, Bacterial; Filaricides; Humans; Ivermectin; Leukocyte L1 Antigen Complex; Male; Membrane Glycoproteins; Neural Cell Adhesion Molecules; Onchocerciasis; Symbiosis; Wolbachia | 2002 |
Validation of reports of nodules dissolution after repeated ivermectin treatment of onchocerciasis in southeastern Nigeria.
Topics: Dose-Response Relationship, Drug; Endemic Diseases; Filaricides; Humans; Ivermectin; Nigeria; Onchocerciasis; Random Allocation; Treatment Outcome | 2001 |
[Diagnostic image (82). A man with different leg colors. Onchocerciasis].
Topics: Adult; Antiparasitic Agents; Filaricides; Humans; Ivermectin; Male; Onchocerciasis; Pigmentation Disorders; Pruritus; Sierra Leone; Skin Diseases, Parasitic; Skin Pigmentation | 2002 |
[Human onchocerciasis and "sowda" in the Republic of Yemen].
Topics: Animals; Disease Transmission, Infectious; Environment; Filaricides; Humans; Ivermectin; Onchocerca; Onchocerciasis; Yemen; Zoonoses | 2001 |
Using ivermectin-treatment coverage among schoolchildren monitored by schoolteachers as a proxy of population coverage in areas of Uganda where onchocerciasis is endemic.
Topics: Adolescent; Child; Child, Preschool; Endemic Diseases; Female; Filaricides; Health Care Surveys; Humans; Ivermectin; Male; Onchocerciasis; Registries; Uganda | 2002 |
Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Topics: Community Health Services; Decision Making; Filaricides; Health Care Costs; Health Education; Humans; Ivermectin; Onchocerciasis; Operations Research; Program Evaluation; Uganda | 2002 |
The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Topics: Adolescent; Adult; Age Distribution; Aged; Antiparasitic Agents; Central African Republic; Child; Cross-Sectional Studies; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Pruritus; Sex Distribution; Skin Diseases, Parasitic | 2002 |
Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Topics: Africa; Animals; Communicable Disease Control; Filaricides; Humans; Ivermectin; Likelihood Functions; Onchocerca volvulus; Onchocerciasis | 2002 |
Community response to repeated annual ivermectin treatment of onchocerciasis in Nigeria.
Topics: Anthelmintics; Attitude to Health; Geography; Humans; Ivermectin; Nigeria; Onchocerciasis; Patient Compliance | 2002 |
Ivermectin in human onchocerciasis: a clinical-pathological study of skin lesions before and three days after treatment.
Topics: Animals; Antiparasitic Agents; Humans; Ivermectin; Lymphatic System; Onchocerciasis; Skin; Skin Diseases, Parasitic; Time Factors | 1992 |
Improvement in seizures after ivermectin.
Topics: Adolescent; Adult; Child; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Seizures | 1992 |
Microepidemiology of onchocerciasis in Guatemala: dispersal and survival of Simulium ochraceum.
Topics: Animals; Female; Guatemala; Humans; Insect Vectors; Ivermectin; Onchocerca; Onchocerciasis; Simuliidae; Time Factors | 1992 |
Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Female; Guatemala; Humans; Ivermectin; Male; Microfilariae; Onchocerca; Onchocerciasis; Prevalence; Skin; Treatment Refusal | 1992 |
The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala.
Topics: Animals; Female; Guatemala; Humans; Insect Vectors; Ivermectin; Larva; Onchocerca; Onchocerciasis; Seasons; Simuliidae | 1992 |
Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.
Topics: Animals; Bacterial Proteins; Cytokines; Dermatitis; Eosinophilia; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Ivermectin; Leukocyte Count; Lymphocyte Subsets; Male; Microfilariae; Onchocerciasis; Parasite Egg Count; Phenotype; Phytohemagglutinins; Statistics as Topic; Streptolysins | 1992 |
Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Granulocytes; Immunoglobulin E; Immunoglobulin G; Ivermectin; Microfilariae; Molecular Weight; Onchocerca; Onchocerciasis; Pan troglodytes | 1992 |
Adverse reactions to ivermectin in reactive onchodermatitis.
Topics: Adult; Edema; Female; Humans; Ivermectin; Middle Aged; Onchocerciasis | 1991 |
Expatriates treated with ivermectin.
Topics: Adult; Africa, Central; Africa, Western; Emigration and Immigration; Female; Humans; Ivermectin; Male; Onchocerciasis; Recurrence; United States | 1991 |
Expatriates treated with ivermectin.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Eruptions; Drug Evaluation; Humans; In Vitro Techniques; Ivermectin; Middle Aged; Onchocerciasis; Sierra Leone; United Kingdom | 1991 |
Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment.
Topics: Animals; Biopsy; Humans; Immunohistochemistry; Ivermectin; Lymph Nodes; Microfilariae; Microscopy, Electron; Onchocerca; Onchocerciasis; Skin | 1991 |
The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin.
Topics: Animals; Female; Humans; Ivermectin; Male; Microfilariae; Onchocerca; Onchocerciasis | 1991 |
Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Cell Division; Eosinophils; Guatemala; Humans; Immunity; Ivermectin; Leukocyte Count; Leukocytes; Male; Microfilariae; Middle Aged; Onchocerciasis; T-Lymphocytes | 1991 |
Fight over data disrupts Michigan State project.
Topics: History, 20th Century; Humans; Ivermectin; Michigan; Onchocerciasis; Scientific Misconduct; Sudan; United States; United States Office of Research Integrity; Universities | 1991 |
Subtle early features of onchocerciasis in a European.
Topics: Adult; Buttocks; Edema; Female; Humans; Ivermectin; Onchocerciasis; Pruritus; Thigh | 1991 |
Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus.
Topics: Humans; Ivermectin; Mexico; Onchocerciasis; Radioimmunoassay; Sudan; Tissue Distribution | 1991 |
Ivermectin in the treatment of onchocerciasis in Britain.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Recurrence | 1991 |
Ivermectin therapy: a 5-year follow-up.
Topics: Animals; Female; Follow-Up Studies; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Skin | 1991 |
Safety of and compliance with community-based ivermectin therapy.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Ivermectin; Liberia; Male; Microfilariae; Onchocerciasis; Population Surveillance; Skin | 1990 |
Distribution of ivermectin by health workers.
Topics: Administration, Oral; Blindness; Community Health Workers; Developing Countries; Health Policy; Humans; Ivermectin; Onchocerciasis | 1990 |
Adverse reactions in expatriates treated with ivermectin.
Topics: Adult; Africa, Western; Drug Hypersensitivity; Emigration and Immigration; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; United Kingdom | 1990 |
Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Child; Community Health Services; Female; Fetal Death; Follow-Up Studies; Humans; Infant, Newborn; Ivermectin; Liberia; Middle Aged; Onchocerciasis; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Retrospective Studies; Rural Health | 1990 |
Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Ivermectin; Liberia; Male; Microfilariae; Middle Aged; Onchocerciasis; Prevalence; Skin | 1991 |
Migration and death of skin-dwelling Onchocerca volvulus microfilariae after treatment with ivermectin.
Topics: Adult; Animals; Biopsy, Needle; Humans; Ivermectin; Lymph Nodes; Male; Microfilariae; Onchocerca; Onchocerciasis; Skin | 1991 |
Knowledge, attitudes and perceptions (KAP) of onchocerciasis: a survey among residents in an endemic area in Guatemala targeted for mass chemotherapy with ivermectin.
Topics: Adolescent; Adult; Aged; Attitude to Health; Female; Guatemala; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Patient Acceptance of Health Care; Terminology as Topic | 1991 |
[A new microfilaricide in the therapeutic arsenal of the ophthalmologist].
Topics: Blindness; Filariasis; Humans; Ivermectin; Loiasis; Onchocerciasis | 1990 |
Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection.
Topics: Child; Child, Preschool; Cohort Studies; Humans; Incidence; Ivermectin; Liberia; Onchocerciasis; Prevalence; Skin | 1990 |
Effect of mass treatment of a human population with ivermectin on transmission of Onchocerca volvulus by Simulium yahense in Liberia, West Africa.
Topics: Animals; Humans; Insect Vectors; Ivermectin; Liberia; Onchocerca; Onchocerciasis; Prevalence; Simuliidae | 1990 |
OCP intercountry collaboration.
Topics: Africa, Western; Animals; Humans; Insect Control; Insect Vectors; Insecticides; International Cooperation; Ivermectin; Onchocerciasis; Simuliidae | 1990 |
Ocular and systemic side effects following ivermectin treatment in onchocerciasis patients from Sierra Leone.
Topics: Animals; Eye; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Sierra Leone; Skin | 1990 |
Computer simulation of the long term effects of vector control and drug treatment regimes on onchocerciasis in a village community in Sierra Leone.
Topics: Animals; Computer Simulation; Humans; Insect Control; Insect Vectors; Ivermectin; Onchocerciasis; Sierra Leone; Simuliidae | 1990 |
Observations on the reproductive biology of Onchocerca volvulus.
Topics: Animals; Female; Humans; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Reproduction; Skin | 1990 |
Onchocerciasis control in regard to PHC/BHS.
Topics: Burkina Faso; Community Health Services; Humans; Ivermectin; Onchocerciasis | 1990 |
Prospective evaluation of onchocerciasis control strategies.
Topics: Africa, Western; Animals; Computer Simulation; Evaluation Studies as Topic; Female; Humans; Insect Control; Ivermectin; Male; Onchocerciasis; Software | 1990 |
Mectizan donation and the Mectizan Expert Committee.
Topics: Drug Industry; Humans; Ivermectin; Onchocerciasis; Public Health; World Health Organization | 1990 |
[Onchocerciasis in travelers to the tropics].
Topics: Adult; Animals; Antibodies, Helminth; Eosinophilia; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Skin; Time Factors; Travel; Tropical Climate | 1990 |
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. II. Evaluation in the light of mass campaigns on the effect of yearly or half-yearly administration of single oral doses of 100, 150 or
Topics: Administration, Oral; Adult; Cote d'Ivoire; Humans; Ivermectin; Male; Onchocerciasis; Population Surveillance; Time Factors | 1989 |
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children].
Topics: Administration, Oral; Adolescent; Child; Cote d'Ivoire; Female; Humans; Ivermectin; Male; Onchocerciasis | 1989 |
Side-effects of ivermectin in treatment of onchocerciasis.
Topics: Adult; Animals; Blindness; Drug Evaluation; Eye Diseases; Female; Follow-Up Studies; Humans; Ivermectin; Male; Microfilariae; Onchocerciasis; Prospective Studies; Severity of Illness Index; Skin | 1989 |
Dynamics of microfilariae of Onchocerca volvulus over the first 72 hours after treatment with ivermectin.
Topics: Adult; Animals; Blood; Guatemala; Humans; Ivermectin; Male; Microfilariae; Onchocerca; Onchocerciasis; Skin; Time Factors; Urine | 1989 |
A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.
Topics: Animals; Female; Ghana; Humans; Insect Vectors; Ivermectin; Male; Microfilariae; Onchocerca; Onchocerciasis; Simuliidae; Skin; Time Factors | 1989 |
A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Ghana; Humans; Hypotension, Orthostatic; Ivermectin; Male; Middle Aged; Onchocerciasis; Risk Factors; Time Factors | 1989 |
Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials.
Topics: Africa, Western; Animals; Dyspnea; Fever; Humans; Hypotension, Orthostatic; Ivermectin; Microfilariae; Onchocerciasis; Pain; Skin | 1989 |
Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions.
Topics: Adolescent; Adult; Animals; Child; Female; Humans; Ivermectin; Liberia; Male; Microfilariae; Middle Aged; Onchocerciasis; Patient Acceptance of Health Care; Population Surveillance; Rural Population; Skin | 1989 |
The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus.
Topics: Adult; Analysis of Variance; Animals; Humans; Insect Vectors; Ivermectin; Male; Microfilariae; Onchocerca; Onchocerciasis; Simuliidae; Skin | 1989 |
[The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
Topics: Filariasis; Humans; Ivermectin; Loiasis; Mansonelliasis; Onchocerciasis | 1989 |
[After ivermectin, is it necessary to look again for a macrofilaricide?].
Topics: Animals; Anthelmintics; Filaricides; Humans; Ivermectin; Onchocerciasis | 1989 |
[Ivermectin. A new drug against onchocerciasis].
Topics: Humans; Ivermectin; Onchocerciasis | 1989 |
The control of onchocerciasis.
Topics: Africa, Western; Animals; Blindness; Communicable Disease Control; Humans; Insect Vectors; Ivermectin; Onchocerciasis; World Health Organization | 1989 |
[Ivermectin and the reduction of the rate of infection of simuliids in a forest focus of human onchocerciasis].
Topics: Animals; Cote d'Ivoire; Humans; Ivermectin; Larva; Onchocerca; Onchocerciasis; Simuliidae | 1987 |
Prolongation of prothrombin time with ivermectin.
Topics: Adolescent; Adult; Humans; Ivermectin; Male; Onchocerciasis; Prothrombin Time | 1988 |
[Onchocerciasis in travelers and migrants--latent ocular lesions].
Topics: Adolescent; Adult; Animals; Child; Cornea; Female; Humans; Ivermectin; Male; Microfilariae; Microscopy; Onchocerca; Onchocerciasis; Transients and Migrants; Travel | 1988 |
Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
Topics: Adult; Aged; Animals; Filariasis; Humans; Ivermectin; Loa; Loiasis; Male; Mansonella; Mansonelliasis; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis | 1988 |
Ivermectin in equine lichen tropicus.
Topics: Animals; Antiparasitic Agents; Horse Diseases; Horses; Ivermectin; Miliaria; Onchocerciasis; Skin Diseases, Parasitic | 1988 |
Efficacy of ivermectin in paste and injectable formulations against microfilariae of Onchocerca cervicalis and resolution of associated dermatitis in horses.
Topics: Animals; Antiparasitic Agents; Biopsy; Dermatitis; Horse Diseases; Horses; Injections, Intramuscular; Ivermectin; Microfilariae; Ointments; Onchocerciasis; Skin Diseases, Parasitic | 1988 |
Autoantibody induced by experimental Onchocerca infection. Effect of different routes of administration of microfilariae and of treatment with diethylcarbamazine citrate and ivermectin.
Topics: Animals; Antibodies, Helminth; Autoantibodies; Corneal Diseases; Diethylcarbamazine; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Immunoglobulin G; Ivermectin; Keratitis; Male; Microfilariae; Onchocerca; Onchocerciasis | 1988 |
Ivermectin prophylaxis against experimental Onchocerca volvulus infection in chimpanzees.
Topics: Animals; Female; Ivermectin; Larva; Male; Onchocerca; Onchocerciasis; Pan troglodytes; Skin | 1988 |
Verification of ineffectual activity of ivermectin against adult Onchocerca spp in the ligamentum nuchae of horses.
Topics: Animals; Female; Horse Diseases; Horses; Ivermectin; Ligaments; Male; Onchocerca; Onchocerciasis | 1988 |
Drug activity against Onchocerca gutturosa males in vitro: a model for chemotherapeutic research on onchocerciasis.
Topics: Animals; Anthelmintics; Brugia; Filaricides; Ivermectin; Levamisole; Male; Movement; Onchocerca; Onchocerciasis; Piperazines; Thiazoles | 1987 |
Cutaneous onchocerciasis.
Topics: Adult; Antiparasitic Agents; Humans; Ivermectin; Male; Onchocerciasis; Skin Diseases, Parasitic | 1987 |
Onchocerciasis--a potential revolution in its treatment.
Topics: Eye Diseases; Humans; Ivermectin; Onchocerciasis | 1987 |
Single dose therapy with ivermectin for onchocerciasis.
Topics: Animals; Drug Administration Schedule; Eye Diseases; Follow-Up Studies; Humans; Ivermectin; Onchocerca; Onchocerciasis; Skin | 1987 |
Evaluation of drugs against Onchocerca microfiliariae in an inbred mouse model.
Topics: Animals; Anthelmintics; Diethylcarbamazine; Disease Models, Animal; Drug Evaluation, Preclinical; Elapid Venoms; Female; Filaricides; Ivermectin; Lactones; Lymphocyte Depletion; Mice; Mice, Inbred CBA; Microfilariae; Onchocerciasis; Skin; T-Lymphocytes | 1986 |
Primate model for onchocerciasis research.
Topics: Animals; Disease Models, Animal; Ivermectin; Microfilariae; Onchocerca; Onchocerciasis; Pan troglodytes | 1987 |
Merck donates drug for river blindness.
Topics: Drug Industry; Humans; Ivermectin; Onchocerciasis; World Health Organization | 1987 |
Development in the Guinea savanna.
Topics: Animals; Developing Countries; Guinea-Bissau; Humans; Insect Vectors; Ivermectin; Onchocerciasis | 1987 |
River blindness: a gamble pays off.
Topics: Africa, Western; Humans; Insect Vectors; Ivermectin; Lactones; Onchocerciasis; Simuliidae; World Health Organization | 1986 |
Treatment of equine onchocerciasis with ivermectin paste.
Topics: Animals; Anthelmintics; Ectoparasitic Infestations; Female; Filaricides; Horse Diseases; Horses; Ivermectin; Lactones; Male; Ointments; Onchocerciasis | 1986 |
The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Topics: Adolescent; Adult; Anthelmintics; Dose-Response Relationship, Drug; Eye; Filaricides; Humans; Ivermectin; Lactones; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Skin | 1985 |
Onchocerciasis now.
Topics: Filaricides; Humans; Insect Control; Insect Vectors; Ivermectin; Lactones; Onchocerciasis | 1985 |